Annotation Id	Term	Number of TFs	Proportion of times significant (p < 0.05)	Median Rank
WP4659	Gastrin signaling pathway	30	0.989	16
WP2828	Bladder cancer	30	0.977	22
WP3611	Photodynamic therapy-induced AP-1 survival signaling	30	0.973	14
WP3646	Hepatitis C and hepatocellular carcinoma	30	0.971	21
WP4659	Gastrin signaling pathway	20	0.961	18
WP2828	Bladder cancer	20	0.94	21
WP615	Senescence and autophagy in cancer	30	0.937	17
WP5087	Malignant pleural mesothelioma	30	0.935	22
WP3646	Hepatitis C and hepatocellular carcinoma	20	0.933	22
WP3611	Photodynamic therapy-induced AP-1 survival signaling	20	0.93	13
WP710	DNA damage response (only ATM dependent)	30	0.925	31
WP366	TGF-beta signaling pathway	30	0.915	48
WP4263	Pancreatic adenocarcinoma pathway	30	0.913	35
WP2261	Glioblastoma signaling pathways	30	0.911	44.75
WP1545	miRNAs involved in DNA damage response	30	0.891	61.75
WP1742	TP53 network	30	0.883	53
WP366	TGF-beta signaling pathway	20	0.879	47
WP710	DNA damage response (only ATM dependent)	20	0.878	36
WP3617	Photodynamic therapy-induced NF-kB survival signaling	30	0.877	16
WP2431	Spinal cord injury	30	0.876	34
WP236	Adipogenesis	30	0.875	45.5
WP4806	EGFR tyrosine kinase inhibitor resistance	30	0.874	60
WP5087	Malignant pleural mesothelioma	20	0.873	27
WP2586	Aryl hydrocarbon receptor Netpath	30	0.872	56.75
WP615	Senescence and autophagy in cancer	20	0.871	20
WP4216	Chromosomal and microsatellite instability in colorectal cancer	30	0.865	56
WP4659	Gastrin signaling pathway	10	0.863	23
WP1545	miRNAs involved in DNA damage response	20	0.862	60
WP3624	Lung fibrosis	30	0.859	30
WP4263	Pancreatic adenocarcinoma pathway	20	0.857	45
WP4685	Melanoma	30	0.846	63
WP3888	VEGFA-VEGFR2 signaling pathway	30	0.845	68
WP4674	Head and neck squamous cell carcinoma	30	0.842	65.5
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	30	0.841	73.5
WP1742	TP53 network	20	0.839	53
WP2261	Glioblastoma signaling pathways	20	0.839	53
WP4754	IL-18 signaling pathway	30	0.838	30
WP2586	Aryl hydrocarbon receptor Netpath	20	0.836	54.75
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	30	0.834	77.75
WP3617	Photodynamic therapy-induced NF-kB survival signaling	20	0.833	26
WP4216	Chromosomal and microsatellite instability in colorectal cancer	20	0.833	58
WP3981	miRNA regulation of prostate cancer signaling pathways	30	0.832	77.5
WP2431	Spinal cord injury	20	0.831	38
WP4172	PI3K-Akt signaling pathway	30	0.831	50
WP2882	Nuclear receptors meta-pathway	30	0.83	41
WP5094	Orexin receptor pathway	30	0.828	50
WP4298	Acute viral myocarditis	30	0.823	51.25
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	30	0.817	61
WP2828	Bladder cancer	10	0.816	24
WP4806	EGFR tyrosine kinase inhibitor resistance	20	0.814	62
WP5094	Orexin receptor pathway	20	0.811	49
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	20	0.808	72.75
WP3287	Overview of nanoparticle effects	30	0.803	75
WP49	IL-2 signaling pathway	30	0.803	87.5
WP5098	T-cell activation SARS-CoV-2	30	0.803	59
WP530	Cytokines and inflammatory response	30	0.802	37.5
WP3646	Hepatitis C and hepatocellular carcinoma	10	0.801	27
WP4685	Melanoma	20	0.796	67
WP236	Adipogenesis	20	0.794	58
WP1984	Integrated breast cancer pathway	30	0.793	71
WP5055	Burn wound healing	30	0.792	39
WP3624	Lung fibrosis	20	0.788	34.25
WP176	Folate metabolism	30	0.788	49
WP4816	TGF-beta receptor signaling in skeletal dysplasias	30	0.785	77
WP2374	Oncostatin M signaling pathway	30	0.784	66
WP560	TGF-beta receptor signaling	30	0.782	79
WP2882	Nuclear receptors meta-pathway	20	0.781	43
WP3981	miRNA regulation of prostate cancer signaling pathways	20	0.78	79
WP1533	Vitamin B12 metabolism	30	0.78	54
WP4172	PI3K-Akt signaling pathway	20	0.778	51
WP2849	Hematopoietic stem cell differentiation	30	0.778	75
WP4674	Head and neck squamous cell carcinoma	20	0.777	66
WP1971	Integrated cancer pathway	30	0.772	63.75
WP3611	Photodynamic therapy-induced AP-1 survival signaling	10	0.77	19
WP1545	miRNAs involved in DNA damage response	10	0.766	55.5
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	30	0.764	85.75
WP4754	IL-18 signaling pathway	20	0.762	32
WP5098	T-cell activation SARS-CoV-2	20	0.754	62
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	30	0.753	67.5
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	20	0.752	78
WP3303	RAC1/PAK1/p38/MMP2 pathway	30	0.75	85
WP4891	COVID-19 adverse outcome pathway	30	0.75	57.25
WP1984	Integrated breast cancer pathway	20	0.749	71
WP3287	Overview of nanoparticle effects	20	0.749	74.75
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	30	0.749	96.5
WP45	G1 to S cell cycle control	30	0.748	60.25
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	20	0.747	78.5
WP3888	VEGFA-VEGFR2 signaling pathway	20	0.747	82
WP4298	Acute viral myocarditis	20	0.747	61
WP4216	Chromosomal and microsatellite instability in colorectal cancer	10	0.746	53
WP4484	Control of immune tolerance by vasoactive intestinal peptide	30	0.744	71.5
WP530	Cytokines and inflammatory response	20	0.742	39.5
WP254	Apoptosis	30	0.739	61
WP4155	Endometrial cancer	30	0.737	92
WP5055	Burn wound healing	20	0.733	45
WP366	TGF-beta signaling pathway	10	0.73	59
WP176	Folate metabolism	20	0.73	56
WP2374	Oncostatin M signaling pathway	20	0.729	72.5
WP4255	Non-small cell lung cancer	30	0.729	98
WP710	DNA damage response (only ATM dependent)	10	0.728	49
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	20	0.727	74.5
WP49	IL-2 signaling pathway	20	0.724	84
WP205	IL-7 signaling pathway	30	0.721	105.75
WP1533	Vitamin B12 metabolism	20	0.717	63
WP138	Androgen receptor signaling pathway	30	0.714	90
WP2873	Aryl hydrocarbon receptor pathway	30	0.714	91
WP2261	Glioblastoma signaling pathways	10	0.712	57
WP5087	Malignant pleural mesothelioma	10	0.712	38.5
WP1742	TP53 network	10	0.71	57.75
WP1971	Integrated cancer pathway	20	0.709	78.25
WP306	Focal adhesion	30	0.709	100
WP4816	TGF-beta receptor signaling in skeletal dysplasias	20	0.705	88
WP4666	Hepatitis B infection	30	0.704	96
WP615	Senescence and autophagy in cancer	10	0.701	38.75
WP2849	Hematopoietic stem cell differentiation	20	0.699	86
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	20	0.696	74.5
WP4658	Small cell lung cancer	30	0.696	88
WP4155	Endometrial cancer	20	0.694	88
WP560	TGF-beta receptor signaling	20	0.693	88.25
WP5097	CCL18 signaling pathway	30	0.692	98
WP2586	Aryl hydrocarbon receptor Netpath	10	0.691	64.75
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	30	0.69	107.25
WP4970	Galanin receptor pathway	30	0.688	107
WP15	Selenium micronutrient network	30	0.687	89
WP4666	Hepatitis B infection	20	0.686	93
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	30	0.686	92
WP45	G1 to S cell cycle control	20	0.685	62.75
WP4263	Pancreatic adenocarcinoma pathway	10	0.682	55.75
WP4484	Control of immune tolerance by vasoactive intestinal peptide	20	0.679	76
WP1530	miRNA regulation of DNA damage response	30	0.676	83.5
WP707	DNA damage response	30	0.676	83.5
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	30	0.673	122.5
WP4806	EGFR tyrosine kinase inhibitor resistance	10	0.672	69
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	10	0.67	75.25
WP4970	Galanin receptor pathway	20	0.67	101
WP4659	Gastrin signaling pathway	5	0.669	37
WP254	Apoptosis	20	0.667	68.5
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	30	0.665	91.5
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	20	0.664	105
WP4891	COVID-19 adverse outcome pathway	20	0.664	68.75
WP4658	Small cell lung cancer	20	0.663	86
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	30	0.661	103
WP2431	Spinal cord injury	10	0.659	51
WP3303	RAC1/PAK1/p38/MMP2 pathway	20	0.659	95
WP707	DNA damage response	20	0.659	84
WP2324	AGE/RAGE pathway	30	0.658	104
WP4673	Male infertility	30	0.658	111
WP3981	miRNA regulation of prostate cancer signaling pathways	10	0.655	78
WP2873	Aryl hydrocarbon receptor pathway	20	0.655	91
WP205	IL-7 signaling pathway	20	0.654	103.5
WP4255	Non-small cell lung cancer	20	0.654	106
WP5094	Orexin receptor pathway	10	0.651	63.5
WP4674	Head and neck squamous cell carcinoma	10	0.649	71
WP5083	Neuroinflammation and glutamatergic signaling	30	0.649	111.25
WP3617	Photodynamic therapy-induced NF-kB survival signaling	10	0.647	52.5
WP1530	miRNA regulation of DNA damage response	20	0.647	91
WP138	Androgen receptor signaling pathway	20	0.646	105
WP179	Cell cycle	30	0.643	77
WP4262	Breast cancer pathway	30	0.642	114
WP5097	CCL18 signaling pathway	20	0.641	98.25
WP2355	Corticotropin-releasing hormone signaling pathway	30	0.641	124
WP2877	Vitamin D receptor pathway	30	0.64	101
WP3640	Imatinib and chronic myeloid leukemia	30	0.64	126.25
WP15	Selenium micronutrient network	20	0.638	99
WP306	Focal adhesion	20	0.637	104
WP4396	Nonalcoholic fatty liver disease	30	0.636	115
WP4685	Melanoma	10	0.635	73
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	20	0.635	110.5
WP4262	Breast cancer pathway	20	0.635	105.5
WP4747	Netrin-UNC5B signaling pathway	30	0.629	122
WP2882	Nuclear receptors meta-pathway	10	0.626	66.5
WP4155	Endometrial cancer	10	0.626	82
WP453	Inflammatory response pathway	30	0.623	109
WP4659	Gastrin signaling pathway	4	0.622	40
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	30	0.622	124.5
WP4673	Male infertility	20	0.62	112
WP2865	IL1 and megakaryocytes in obesity	30	0.619	121.25
WP3651	Pathways affected in adenoid cystic carcinoma	30	0.616	137.5
WP5088	Prostaglandin signaling	30	0.614	92
WP3893	Development and heterogeneity of the ILC family	30	0.612	115.5
WP4172	PI3K-Akt signaling pathway	10	0.61	67
WP49	IL-2 signaling pathway	10	0.61	84.5
WP2328	Allograft Rejection	20	0.61	98
WP5098	T-cell activation SARS-CoV-2	10	0.608	73.75
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	30	0.608	127
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	30	0.607	123
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	30	0.605	150
WP1971	Integrated cancer pathway	10	0.604	88
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	10	0.604	81
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	10	0.604	87.5
WP1984	Integrated breast cancer pathway	10	0.602	78.75
WP2324	AGE/RAGE pathway	20	0.602	113
WP2877	Vitamin D receptor pathway	20	0.601	115.5
WP5115	Network map of SARS-CoV-2 signaling pathway	30	0.6	99
WP2037	Prolactin signaling pathway	30	0.598	130.5
WP5083	Neuroinflammation and glutamatergic signaling	20	0.596	119.5
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	20	0.596	105
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	20	0.595	119.25
WP4494	Selective expression of chemokine receptors during T-cell polarization	30	0.593	119.75
WP179	Cell cycle	20	0.591	95
WP5088	Prostaglandin signaling	20	0.589	98.25
WP2328	Allograft Rejection	30	0.589	118
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	30	0.587	131
WP3646	Hepatitis C and hepatocellular carcinoma	5	0.586	43.5
WP4754	IL-18 signaling pathway	10	0.586	67
WP236	Adipogenesis	10	0.585	88
WP2828	Bladder cancer	5	0.584	42.5
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	30	0.584	134
WP2355	Corticotropin-releasing hormone signaling pathway	20	0.581	124.5
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	20	0.581	119
WP286	IL-3 signaling pathway	30	0.581	136.75
WP3888	VEGFA-VEGFR2 signaling pathway	10	0.579	93
WP45	G1 to S cell cycle control	10	0.579	82.5
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	20	0.579	115.25
WP3624	Lung fibrosis	10	0.578	75
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	20	0.578	112
WP3611	Photodynamic therapy-induced AP-1 survival signaling	5	0.572	42.5
WP5095	Overview of proinflammatory and profibrotic mediators	20	0.564	102
WP5095	Overview of proinflammatory and profibrotic mediators	30	0.564	113.5
WP4666	Hepatitis B infection	10	0.562	99.5
WP5115	Network map of SARS-CoV-2 signaling pathway	20	0.562	115
WP4658	Small cell lung cancer	10	0.559	95
WP5055	Burn wound healing	10	0.557	83
WP4255	Non-small cell lung cancer	10	0.555	108
WP4262	Breast cancer pathway	10	0.555	100
WP2374	Oncostatin M signaling pathway	10	0.554	94
WP4396	Nonalcoholic fatty liver disease	20	0.554	134
WP3646	Hepatitis C and hepatocellular carcinoma	4	0.553	46.25
WP1545	miRNAs involved in DNA damage response	5	0.552	65.75
WP4298	Acute viral myocarditis	10	0.552	86.75
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	30	0.55	135.75
WP707	DNA damage response	10	0.549	107
WP1772	Apoptosis modulation and signaling	30	0.549	134
WP69	T-cell receptor (TCR) signaling pathway	30	0.549	139.75
WP138	Androgen receptor signaling pathway	10	0.548	106
WP4925	Unfolded protein response	30	0.548	149.75
WP4216	Chromosomal and microsatellite instability in colorectal cancer	5	0.547	68
WP1539	Angiogenesis	30	0.547	147
WP673	ErbB signaling pathway	20	0.545	129
WP4462	Platelet-mediated interactions with vascular and circulating cells	30	0.545	134.25
WP1530	miRNA regulation of DNA damage response	10	0.544	109
WP205	IL-7 signaling pathway	10	0.544	101
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	10	0.544	98
WP3640	Imatinib and chronic myeloid leukemia	20	0.544	133.25
WP3998	Prader-Willi and Angelman syndrome	30	0.544	150
WP4707	Aspirin and miRNAs	20	0.543	140.5
WP710	DNA damage response (only ATM dependent)	5	0.542	66.5
WP3611	Photodynamic therapy-induced AP-1 survival signaling	4	0.54	49
WP453	Inflammatory response pathway	20	0.54	126.75
WP2828	Bladder cancer	4	0.539	52.5
WP366	TGF-beta signaling pathway	5	0.538	68.5
WP4494	Selective expression of chemokine receptors during T-cell polarization	20	0.538	128.5
WP4493	Cells and molecules involved in local acute inflammatory response	30	0.538	142
WP2249	Metastatic brain tumor	20	0.535	145
WP4659	Gastrin signaling pathway	3	0.534	46.5
WP3287	Overview of nanoparticle effects	10	0.534	95
WP4970	Galanin receptor pathway	10	0.534	115
WP4747	Netrin-UNC5B signaling pathway	20	0.533	137
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	20	0.532	135.75
WP4707	Aspirin and miRNAs	30	0.532	152.25
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	20	0.531	132
WP2249	Metastatic brain tumor	30	0.528	151.5
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	20	0.527	134.25
WP673	ErbB signaling pathway	30	0.527	146
WP2849	Hematopoietic stem cell differentiation	10	0.526	107.75
WP710	DNA damage response (only ATM dependent)	4	0.525	70
WP530	Cytokines and inflammatory response	10	0.524	98.75
WP1772	Apoptosis modulation and signaling	20	0.524	140.5
WP4928	MAPK pathway in congenital thyroid cancer	20	0.524	137.25
WP3893	Development and heterogeneity of the ILC family	20	0.523	134
WP4216	Chromosomal and microsatellite instability in colorectal cancer	4	0.521	75
WP2865	IL1 and megakaryocytes in obesity	20	0.521	138.5
WP1545	miRNAs involved in DNA damage response	4	0.519	69.5
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	10	0.519	109
WP4816	TGF-beta receptor signaling in skeletal dysplasias	10	0.519	110
WP176	Folate metabolism	10	0.517	97.5
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	20	0.517	138.75
WP5087	Malignant pleural mesothelioma	5	0.516	62.5
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	10	0.516	120.25
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	10	0.514	112
WP560	TGF-beta receptor signaling	10	0.514	106
WP3680	Physico-chemical features and toxicity-associated pathways	20	0.514	143.5
WP254	Apoptosis	10	0.513	106.75
WP3651	Pathways affected in adenoid cystic carcinoma	20	0.511	148.25
WP2037	Prolactin signaling pathway	20	0.51	144
WP3303	RAC1/PAK1/p38/MMP2 pathway	10	0.507	110
WP286	IL-3 signaling pathway	20	0.507	141.75
WP2586	Aryl hydrocarbon receptor Netpath	5	0.506	81.5
WP1742	TP53 network	5	0.505	72
WP615	Senescence and autophagy in cancer	5	0.505	66
WP1449	Regulation of toll-like receptor signaling pathway	30	0.504	154.25
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	30	0.504	161.5
WP4478	LTF danger signal response pathway	30	0.504	154.75
WP673	ErbB signaling pathway	10	0.502	114
WP399	Wnt signaling pathway and pluripotency	30	0.501	160.75
WP4482	Vitamin D in inflammatory diseases	30	0.501	156.75
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	10	0.5	137.75
WP69	T-cell receptor (TCR) signaling pathway	20	0.499	153
WP1533	Vitamin B12 metabolism	10	0.498	109.5
WP399	Wnt signaling pathway and pluripotency	20	0.498	145.75
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	20	0.496	153.25
WP4141	PI3K/AKT/mTOR - VitD3 signaling	30	0.496	159.5
WP4481	Resistin as a regulator of inflammation	30	0.495	162
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	5	0.494	87.25
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	30	0.494	163
WP4969	RAS and bradykinin pathways in COVID-19	30	0.494	160.75
WP3680	Physico-chemical features and toxicity-associated pathways	30	0.493	156
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	10	0.492	120
WP2249	Metastatic brain tumor	10	0.492	132.5
WP474	Endochondral ossification	30	0.491	159.5
WP4808	Endochondral ossification with skeletal dysplasias	30	0.491	159.5
WP1742	TP53 network	4	0.49	78.75
WP2261	Glioblastoma signaling pathways	5	0.49	85
WP129	Matrix metalloproteinases	30	0.489	170.75
WP1545	miRNAs involved in DNA damage response	3	0.487	78.5
WP366	TGF-beta signaling pathway	4	0.487	77
WP5087	Malignant pleural mesothelioma	4	0.487	65
WP3998	Prader-Willi and Angelman syndrome	20	0.487	153.75
WP2828	Bladder cancer	3	0.485	64
WP4925	Unfolded protein response	20	0.482	158.75
WP3658	Wnt/beta-catenin signaling pathway in leukemia	30	0.479	162.5
WP314	Fas ligand pathway and stress induction of heat shock proteins	30	0.478	166.75
WP4928	MAPK pathway in congenital thyroid cancer	30	0.477	159.5
WP5094	Orexin receptor pathway	5	0.475	86
WP4541	Hippo-Merlin signaling dysregulation	30	0.475	168
WP4484	Control of immune tolerance by vasoactive intestinal peptide	10	0.474	133.25
WP474	Endochondral ossification	20	0.474	153.25
WP4808	Endochondral ossification with skeletal dysplasias	20	0.474	153.25
WP5097	CCL18 signaling pathway	10	0.473	120
WP34	Ovarian infertility	30	0.472	166.5
WP306	Focal adhesion	10	0.471	122
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	20	0.471	155.5
WP289	Myometrial relaxation and contraction pathways	30	0.471	165
WP179	Cell cycle	10	0.47	133
WP1539	Angiogenesis	20	0.469	165.25
WP3892	Development of pulmonary dendritic cells and macrophage subsets	30	0.469	173.25
WP4018	Clear cell renal cell carcinoma pathways	30	0.469	171.75
WP3981	miRNA regulation of prostate cancer signaling pathways	5	0.466	95.25
WP2431	Spinal cord injury	5	0.465	84.25
WP4496	Signal transduction through IL1R	30	0.465	172.5
WP2870	Extracellular vesicle-mediated signaling in recipient cells	30	0.464	171.25
WP5063	FOXP3 in COVID-19	30	0.463	178.75
WP4806	EGFR tyrosine kinase inhibitor resistance	5	0.461	89
WP4493	Cells and molecules involved in local acute inflammatory response	20	0.461	166.5
WP129	Matrix metalloproteinases	20	0.46	169
WP75	Toll-like receptor signaling pathway	30	0.46	181
WP4928	MAPK pathway in congenital thyroid cancer	10	0.459	129.25
WP3646	Hepatitis C and hepatocellular carcinoma	3	0.458	61.5
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	4	0.458	100.5
WP2882	Nuclear receptors meta-pathway	5	0.458	92
WP2355	Corticotropin-releasing hormone signaling pathway	10	0.457	135
WP4216	Chromosomal and microsatellite instability in colorectal cancer	3	0.456	79.5
WP4155	Endometrial cancer	5	0.455	96.25
WP4969	RAS and bradykinin pathways in COVID-19	20	0.455	174
WP437	EGF/EGFR signaling pathway	30	0.455	169
WP2586	Aryl hydrocarbon receptor Netpath	4	0.454	87.5
WP4891	COVID-19 adverse outcome pathway	10	0.453	148.25
WP4263	Pancreatic adenocarcinoma pathway	5	0.452	82.25
WP408	Oxidative stress response	30	0.452	174.75
WP5098	T-cell activation SARS-CoV-2	5	0.451	99
WP2877	Vitamin D receptor pathway	10	0.451	132.5
WP4482	Vitamin D in inflammatory diseases	20	0.451	169
WP2431	Spinal cord injury	4	0.45	87
WP4806	EGFR tyrosine kinase inhibitor resistance	4	0.45	91
WP4329	miRNAs involvement in the immune response in sepsis	30	0.45	179
WP3611	Photodynamic therapy-induced AP-1 survival signaling	3	0.449	70
WP3617	Photodynamic therapy-induced NF-kB survival signaling	5	0.449	99.25
WP4496	Signal transduction through IL1R	20	0.449	169
WP2873	Aryl hydrocarbon receptor pathway	10	0.448	135
WP5083	Neuroinflammation and glutamatergic signaling	10	0.448	137.75
WP34	Ovarian infertility	20	0.448	169.25
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	20	0.447	168.25
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	20	0.446	167.5
WP2261	Glioblastoma signaling pathways	4	0.445	93.5
WP4478	LTF danger signal response pathway	20	0.445	172
WP2018	RANKL/RANK signaling pathway	30	0.443	175
WP710	DNA damage response (only ATM dependent)	3	0.442	80.5
WP615	Senescence and autophagy in cancer	4	0.442	78
WP4172	PI3K-Akt signaling pathway	5	0.442	96
WP3658	Wnt/beta-catenin signaling pathway in leukemia	20	0.441	160.75
WP399	Wnt signaling pathway and pluripotency	10	0.44	131
WP4155	Endometrial cancer	4	0.439	95
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	10	0.439	148.75
WP4141	PI3K/AKT/mTOR - VitD3 signaling	20	0.439	171.75
WP4462	Platelet-mediated interactions with vascular and circulating cells	20	0.438	175.75
WP4685	Melanoma	5	0.436	93
WP4149	White fat cell differentiation	30	0.436	173.75
WP5094	Orexin receptor pathway	4	0.435	95
WP5115	Network map of SARS-CoV-2 signaling pathway	10	0.435	153
WP5063	FOXP3 in COVID-19	20	0.435	171.75
WP314	Fas ligand pathway and stress induction of heat shock proteins	20	0.434	174.75
WP2034	Leptin signaling pathway	30	0.434	185.75
WP2324	AGE/RAGE pathway	10	0.433	143.5
WP1449	Regulation of toll-like receptor signaling pathway	20	0.433	183.5
WP170	Nuclear receptors	30	0.433	183
WP3601	Lipid particles composition	30	0.433	202.75
WP1742	TP53 network	3	0.432	103.25
WP3981	miRNA regulation of prostate cancer signaling pathways	4	0.432	97.25
WP15	Selenium micronutrient network	10	0.432	141.25
WP2516	ATM signaling pathway	30	0.432	188.25
WP4754	IL-18 signaling pathway	5	0.431	114
WP2328	Allograft Rejection	10	0.431	171.75
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	10	0.431	142.5
WP5095	Overview of proinflammatory and profibrotic mediators	10	0.431	172.5
WP430	Statin inhibition of cholesterol production	30	0.431	203.25
WP3680	Physico-chemical features and toxicity-associated pathways	10	0.43	137.25
WP3617	Photodynamic therapy-induced NF-kB survival signaling	4	0.428	110.75
WP4172	PI3K-Akt signaling pathway	4	0.428	92
WP4136	Fibrin complement receptor 3 signaling pathway	30	0.428	189.5
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	4	0.427	102.75
WP2882	Nuclear receptors meta-pathway	4	0.427	101
WP4707	Aspirin and miRNAs	10	0.427	137.25
WP4481	Resistin as a regulator of inflammation	20	0.427	173.5
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	30	0.427	185.75
WP4263	Pancreatic adenocarcinoma pathway	4	0.426	84.75
WP4685	Melanoma	4	0.426	102
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	5	0.426	93.25
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	10	0.426	142.75
WP3651	Pathways affected in adenoid cystic carcinoma	10	0.423	136
WP2446	Retinoblastoma gene in cancer	30	0.423	210.75
WP364	IL-6 signaling pathway	30	0.422	191
WP1984	Integrated breast cancer pathway	5	0.421	106
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	5	0.421	114.25
WP45	G1 to S cell cycle control	5	0.421	121.25
WP289	Myometrial relaxation and contraction pathways	20	0.421	176
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	30	0.42	181.25
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	3	0.419	98.25
WP2586	Aryl hydrocarbon receptor Netpath	3	0.418	92.25
WP4541	Hippo-Merlin signaling dysregulation	20	0.418	175.5
WP5087	Malignant pleural mesothelioma	3	0.417	75.5
WP4674	Head and neck squamous cell carcinoma	5	0.417	93
WP3640	Imatinib and chronic myeloid leukemia	10	0.417	140
WP366	TGF-beta signaling pathway	3	0.416	80
WP3998	Prader-Willi and Angelman syndrome	10	0.416	154.25
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	10	0.416	165.25
WP5098	T-cell activation SARS-CoV-2	4	0.415	107
WP313	Hepatocyte growth factor receptor signaling	30	0.415	179
WP4674	Head and neck squamous cell carcinoma	4	0.413	102
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	30	0.413	203
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	10	0.412	150
WP3995	Prion disease pathway	30	0.412	186.25
WP49	IL-2 signaling pathway	5	0.411	105.25
WP2870	Extracellular vesicle-mediated signaling in recipient cells	20	0.411	181.25
WP2839	Hair follicle development: organogenesis - part 2 of 3	30	0.411	187.5
WP1971	Integrated cancer pathway	5	0.41	115.75
WP4673	Male infertility	10	0.41	139
WP2516	ATM signaling pathway	20	0.41	198.5
WP1984	Integrated breast cancer pathway	4	0.408	109.25
WP127	IL-5 signaling pathway	10	0.408	149
WP2839	Hair follicle development: organogenesis - part 2 of 3	20	0.408	170.75
WP4659	Gastrin signaling pathway	2	0.407	61.5
WP236	Adipogenesis	5	0.406	109
WP3888	VEGFA-VEGFR2 signaling pathway	5	0.406	120
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	4	0.405	116.5
WP1403	AMP-activated protein kinase (AMPK) signaling	30	0.405	191
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	30	0.405	192
WP2881	Estrogen receptor pathway	30	0.405	194.5
WP75	Toll-like receptor signaling pathway	20	0.404	213
WP4329	miRNAs involvement in the immune response in sepsis	20	0.403	192
WP5094	Orexin receptor pathway	3	0.402	96
WP1971	Integrated cancer pathway	4	0.402	120.25
WP408	Oxidative stress response	20	0.402	177
WP49	IL-2 signaling pathway	4	0.401	109.25
WP127	IL-5 signaling pathway	20	0.401	172.25
WP2261	Glioblastoma signaling pathways	3	0.4	96
WP4494	Selective expression of chemokine receptors during T-cell polarization	10	0.4	194.75
WP170	Nuclear receptors	20	0.4	182.75
WP2034	Leptin signaling pathway	20	0.4	189
WP4564	Neural crest cell migration during development	30	0.4	186.25
WP2431	Spinal cord injury	3	0.399	99
WP286	IL-3 signaling pathway	10	0.398	153.5
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	20	0.396	192.5
WP4666	Hepatitis B infection	5	0.395	112.25
WP4136	Fibrin complement receptor 3 signaling pathway	20	0.395	212.5
WP2446	Retinoblastoma gene in cancer	20	0.394	214.5
WP4262	Breast cancer pathway	5	0.393	114
WP3893	Development and heterogeneity of the ILC family	10	0.393	183.75
WP395	IL-4 signaling pathway	30	0.393	191.5
WP1772	Apoptosis modulation and signaling	10	0.392	168.5
WP3601	Lipid particles composition	20	0.392	221.5
WP2880	Glucocorticoid receptor pathway	30	0.392	196.5
WP45	G1 to S cell cycle control	4	0.39	123.25
WP4970	Galanin receptor pathway	5	0.39	120.75
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	30	0.39	202.5
WP3941	Oxidative damage response	30	0.39	195.75
WP4298	Acute viral myocarditis	5	0.389	110.5
WP5088	Prostaglandin signaling	10	0.389	167.75
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	20	0.389	179
WP2839	Hair follicle development: organogenesis - part 2 of 3	10	0.388	155.5
WP2882	Nuclear receptors meta-pathway	3	0.387	105
WP4658	Small cell lung cancer	4	0.387	110
WP707	DNA damage response	4	0.387	128
WP5055	Burn wound healing	5	0.387	129
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	3	0.386	106.25
WP615	Senescence and autophagy in cancer	3	0.386	91
WP4483	Relationship between inflammation, COX-2 and EGFR	30	0.386	186
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	30	0.386	232.5
WP4754	IL-18 signaling pathway	4	0.385	129.5
WP313	Hepatocyte growth factor receptor signaling	20	0.385	180
WP437	EGF/EGFR signaling pathway	20	0.385	181.5
WP3599	Transcription factor regulation in adipogenesis	30	0.385	196
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	30	0.385	196
WP4685	Melanoma	3	0.384	106
WP4658	Small cell lung cancer	5	0.384	118
WP4396	Nonalcoholic fatty liver disease	10	0.384	183
WP4263	Pancreatic adenocarcinoma pathway	3	0.383	97
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	5	0.383	126.75
WP430	Statin inhibition of cholesterol production	20	0.382	230.5
WP231	TNF-alpha signaling pathway	30	0.382	217
WP1530	miRNA regulation of DNA damage response	4	0.381	132.75
WP363	Wnt signaling pathway	20	0.38	176.5
WP2858	Ectoderm differentiation	30	0.38	197.5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	30	0.38	198.5
WP707	DNA damage response	5	0.379	129
WP4925	Unfolded protein response	10	0.379	167.25
WP205	IL-7 signaling pathway	5	0.378	114
WP127	IL-5 signaling pathway	30	0.378	188
WP4172	PI3K-Akt signaling pathway	3	0.377	110.5
WP5092	Interactions of natural killer cells in pancreatic cancer	30	0.377	212.25
WP1530	miRNA regulation of DNA damage response	5	0.376	132.75
WP2037	Prolactin signaling pathway	10	0.376	155
WP4018	Clear cell renal cell carcinoma pathways	20	0.376	207.75
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	20	0.376	233
WP619	Type II interferon signaling (IFNG)	30	0.376	242
WP4666	Hepatitis B infection	4	0.375	116.25
WP69	T-cell receptor (TCR) signaling pathway	10	0.375	170
WP4698	Vitamin D-sensitive calcium signaling in depression	30	0.375	215.5
WP4155	Endometrial cancer	3	0.374	102
WP363	Wnt signaling pathway	30	0.374	191
WP4495	IL-10 anti-inflammatory signaling pathway	30	0.373	198
WP453	Inflammatory response pathway	10	0.372	182.25
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	10	0.372	161.25
WP4298	Acute viral myocarditis	4	0.371	117
WP2018	RANKL/RANK signaling pathway	20	0.371	194.5
WP4483	Relationship between inflammation, COX-2 and EGFR	20	0.371	181.5
WP712	Estrogen signaling pathway	20	0.371	187.75
WP5121	Sphingolipid metabolism in senescence	30	0.371	191.25
WP4262	Breast cancer pathway	4	0.37	118
WP4747	Netrin-UNC5B signaling pathway	10	0.37	163
WP3892	Development of pulmonary dendritic cells and macrophage subsets	20	0.369	200.5
WP254	Apoptosis	5	0.368	136.75
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	10	0.367	161
WP2881	Estrogen receptor pathway	20	0.367	202.75
WP1545	miRNAs involved in DNA damage response	2	0.366	91.25
WP673	ErbB signaling pathway	5	0.366	120
WP363	Wnt signaling pathway	10	0.366	155
WP4331	Neovascularisation processes	30	0.366	205
WP3624	Lung fibrosis	5	0.365	132
WP3941	Oxidative damage response	20	0.365	185
WP4844	Influence of laminopathies on Wnt signaling	30	0.365	209.25
WP2849	Hematopoietic stem cell differentiation	5	0.364	137.75
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	10	0.364	184
WP5055	Burn wound healing	4	0.363	136
WP4816	TGF-beta receptor signaling in skeletal dysplasias	5	0.363	129.75
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	20	0.363	198.5
WP4564	Neural crest cell migration during development	20	0.362	183.25
WP619	Type II interferon signaling (IFNG)	20	0.362	254.75
WP23	B cell receptor signaling pathway	30	0.362	209.25
WP4540	Hippo signaling regulation pathways	30	0.362	205
WP3617	Photodynamic therapy-induced NF-kB survival signaling	3	0.361	146.5
WP3658	Wnt/beta-catenin signaling pathway in leukemia	10	0.361	160.75
WP4495	IL-10 anti-inflammatory signaling pathway	20	0.361	204.25
WP4565	Neural crest cell migration in cancer	30	0.361	200
WP4806	EGFR tyrosine kinase inhibitor resistance	3	0.36	98
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	5	0.36	129.25
WP4541	Hippo-Merlin signaling dysregulation	10	0.36	158
WP5044	Kynurenine pathway and links to cell senescence	20	0.36	198
WP5092	Interactions of natural killer cells in pancreatic cancer	20	0.36	211.75
WP1984	Integrated breast cancer pathway	3	0.359	117.75
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	20	0.359	217.5
WP673	ErbB signaling pathway	4	0.358	125.5
WP2865	IL1 and megakaryocytes in obesity	10	0.358	186.25
WP2828	Bladder cancer	2	0.357	100.5
WP4255	Non-small cell lung cancer	5	0.357	127.25
WP364	IL-6 signaling pathway	20	0.357	221
WP712	Estrogen signaling pathway	30	0.356	195
WP3624	Lung fibrosis	4	0.355	128.5
WP2858	Ectoderm differentiation	20	0.355	202
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	30	0.355	203.5
WP4255	Non-small cell lung cancer	4	0.353	129
WP3287	Overview of nanoparticle effects	5	0.353	140.5
WP560	TGF-beta receptor signaling	5	0.353	129.75
WP1539	Angiogenesis	10	0.353	175.75
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	10	0.353	179
WP5121	Sphingolipid metabolism in senescence	20	0.353	191.5
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	4	0.352	135
WP176	Folate metabolism	5	0.352	144.5
WP3981	miRNA regulation of prostate cancer signaling pathways	3	0.351	113
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	10	0.351	193.25
WP1403	AMP-activated protein kinase (AMPK) signaling	20	0.351	209.5
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	30	0.351	210
WP254	Apoptosis	4	0.35	141
WP3888	VEGFA-VEGFR2 signaling pathway	4	0.35	123
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	30	0.35	240.25
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	30	0.35	197.75
WP2446	Retinoblastoma gene in cancer	10	0.349	213.75
WP236	Adipogenesis	4	0.348	123
WP474	Endochondral ossification	10	0.348	179.75
WP4808	Endochondral ossification with skeletal dysplasias	10	0.348	179.75
WP1971	Integrated cancer pathway	3	0.347	137
WP45	G1 to S cell cycle control	3	0.347	135.25
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	20	0.347	207.75
WP2064	Neural crest differentiation	30	0.347	229.5
WP530	Cytokines and inflammatory response	5	0.346	202.25
WP3995	Prion disease pathway	20	0.346	201
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	30	0.346	228.5
WP138	Androgen receptor signaling pathway	5	0.345	131
WP2880	Glucocorticoid receptor pathway	20	0.345	201
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	20	0.345	218.25
WP2332	Interleukin-11 signaling pathway	30	0.345	216.25
WP3646	Hepatitis C and hepatocellular carcinoma	2	0.344	93.5
WP4674	Head and neck squamous cell carcinoma	3	0.344	107.5
WP4928	MAPK pathway in congenital thyroid cancer	5	0.344	130.5
WP4655	Cytosolic DNA-sensing pathway	30	0.343	275.5
WP2878	PPAR-alpha pathway	20	0.342	213.25
WP3599	Transcription factor regulation in adipogenesis	20	0.342	201.75
WP205	IL-7 signaling pathway	4	0.341	119
WP4970	Galanin receptor pathway	4	0.34	141.5
WP4478	LTF danger signal response pathway	10	0.34	242
WP395	IL-4 signaling pathway	20	0.34	210.5
WP2249	Metastatic brain tumor	5	0.339	135
WP4483	Relationship between inflammation, COX-2 and EGFR	10	0.339	180.5
WP382	MAPK signaling pathway	30	0.339	216
WP4961	STING pathway in Kawasaki-like disease and COVID-19	30	0.339	217
WP2877	Vitamin D receptor pathway	5	0.338	160
WP4149	White fat cell differentiation	20	0.338	201.75
WP1434	Osteopontin signaling	30	0.338	232.25
WP2878	PPAR-alpha pathway	30	0.338	237
WP5110	Familial hyperlipidemia type 3	30	0.338	227
WP231	TNF-alpha signaling pathway	20	0.337	230.5
WP4928	MAPK pathway in congenital thyroid cancer	4	0.336	131.5
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	30	0.336	214.75
WP138	Androgen receptor signaling pathway	4	0.335	128.5
WP5044	Kynurenine pathway and links to cell senescence	10	0.335	181.75
WP2374	Oncostatin M signaling pathway	5	0.334	138.5
WP4524	Alternative pathway of fetal androgen synthesis	30	0.334	241
WP2249	Metastatic brain tumor	4	0.332	136.75
WP4484	Control of immune tolerance by vasoactive intestinal peptide	5	0.332	197.75
WP4969	RAS and bradykinin pathways in COVID-19	10	0.332	206.75
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	20	0.332	218
WP4754	IL-18 signaling pathway	3	0.331	138
WP2873	Aryl hydrocarbon receptor pathway	5	0.331	162
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	20	0.331	256.75
WP3611	Photodynamic therapy-induced AP-1 survival signaling	2	0.33	103.25
WP49	IL-2 signaling pathway	3	0.329	124.75
WP1533	Vitamin B12 metabolism	5	0.329	168
WP314	Fas ligand pathway and stress induction of heat shock proteins	10	0.329	191.25
WP3941	Oxidative damage response	10	0.328	177.75
WP4658	Small cell lung cancer	3	0.327	124
WP5098	T-cell activation SARS-CoV-2	3	0.327	125.5
WP707	DNA damage response	3	0.327	137.75
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	4	0.327	150.5
WP399	Wnt signaling pathway and pluripotency	5	0.327	137
WP382	MAPK signaling pathway	20	0.327	212
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	20	0.327	222.25
WP1530	miRNA regulation of DNA damage response	3	0.326	142.75
WP4655	Cytosolic DNA-sensing pathway	20	0.326	301.75
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	5	0.325	138
WP4496	Signal transduction through IL1R	10	0.325	205.25
WP1434	Osteopontin signaling	20	0.325	240.75
WP3594	Circadian rhythm genes	30	0.325	232
WP4216	Chromosomal and microsatellite instability in colorectal cancer	2	0.324	105
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	3	0.324	122.75
WP129	Matrix metalloproteinases	10	0.324	229.75
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	10	0.324	174.75
WP712	Estrogen signaling pathway	10	0.324	174.25
WP4262	Breast cancer pathway	3	0.323	127.5
WP3303	RAC1/PAK1/p38/MMP2 pathway	5	0.322	138
WP1742	TP53 network	2	0.321	142
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	5	0.321	185.25
WP289	Myometrial relaxation and contraction pathways	10	0.32	175.5
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	20	0.32	213
WP176	Folate metabolism	4	0.319	153
WP3287	Overview of nanoparticle effects	4	0.319	151.5
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	5	0.319	130.5
WP710	DNA damage response (only ATM dependent)	2	0.318	98
WP179	Cell cycle	4	0.318	157
WP2849	Hematopoietic stem cell differentiation	4	0.318	142.5
WP2877	Vitamin D receptor pathway	4	0.318	146.5
WP5121	Sphingolipid metabolism in senescence	10	0.317	176
WP205	IL-7 signaling pathway	3	0.316	119.5
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	4	0.316	176.75
WP306	Focal adhesion	5	0.316	138
WP3680	Physico-chemical features and toxicity-associated pathways	5	0.316	149
WP1449	Regulation of toll-like receptor signaling pathway	10	0.315	230
WP530	Cytokines and inflammatory response	4	0.314	240.75
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	10	0.314	184.5
WP366	TGF-beta signaling pathway	2	0.313	96.5
WP179	Cell cycle	5	0.313	166.25
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	20	0.313	202.75
WP61	Notch signaling pathway (Netpath)	30	0.313	222.75
WP4493	Cells and molecules involved in local acute inflammatory response	10	0.312	240.5
WP61	Notch signaling pathway (Netpath)	20	0.311	207.25
WP5111	Familial hyperlipidemia type 4	30	0.311	249.5
WP5087	Malignant pleural mesothelioma	2	0.31	90
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	5	0.31	160.75
WP5097	CCL18 signaling pathway	5	0.31	145
WP4565	Neural crest cell migration in cancer	20	0.31	191.75
WP4342	Vitamins A and D - action mechanisms	30	0.31	234.5
WP4666	Hepatitis B infection	3	0.309	127.25
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	5	0.309	146
WP4482	Vitamin D in inflammatory diseases	10	0.309	196
WP2064	Neural crest differentiation	20	0.309	224
WP306	Focal adhesion	4	0.308	133
WP236	Adipogenesis	3	0.307	117
WP4844	Influence of laminopathies on Wnt signaling	20	0.307	217.25
WP5083	Neuroinflammation and glutamatergic signaling	5	0.306	157
WP5095	Overview of proinflammatory and profibrotic mediators	5	0.306	237.25
WP5094	Orexin receptor pathway	2	0.305	106
WP673	ErbB signaling pathway	3	0.305	125.75
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	4	0.305	138.5
WP15	Selenium micronutrient network	5	0.305	175
WP5063	FOXP3 in COVID-19	10	0.305	228
WP4961	STING pathway in Kawasaki-like disease and COVID-19	20	0.305	230.5
WP3929	Chemokine signaling pathway	30	0.305	249.5
WP5055	Burn wound healing	3	0.304	161
WP2516	ATM signaling pathway	10	0.304	223
WP4141	PI3K/AKT/mTOR - VitD3 signaling	10	0.304	183.5
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	10	0.304	179.75
WP75	Toll-like receptor signaling pathway	10	0.304	252.25
WP4205	MET in type 1 papillary renal cell carcinoma	30	0.304	212.75
WP4223	Ras signaling	30	0.304	223
WP2586	Aryl hydrocarbon receptor Netpath	2	0.303	116.5
WP5115	Network map of SARS-CoV-2 signaling pathway	5	0.303	192.5
WP4462	Platelet-mediated interactions with vascular and circulating cells	10	0.303	280.75
WP4698	Vitamin D-sensitive calcium signaling in depression	20	0.303	211.5
WP5110	Familial hyperlipidemia type 3	20	0.303	255
WP4970	Galanin receptor pathway	3	0.302	140.75
WP2374	Oncostatin M signaling pathway	4	0.302	149.5
WP4816	TGF-beta receptor signaling in skeletal dysplasias	4	0.302	142
WP2034	Leptin signaling pathway	10	0.302	199
WP61	Notch signaling pathway (Netpath)	10	0.302	174.75
WP304	Kit receptor signaling pathway	30	0.302	214
WP45	G1 to S cell cycle control	2	0.301	145.5
WP2328	Allograft Rejection	5	0.301	219.5
WP2882	Nuclear receptors meta-pathway	2	0.3	114
WP4172	PI3K-Akt signaling pathway	2	0.3	110
WP2328	Allograft Rejection	4	0.3	235.5
WP1533	Vitamin B12 metabolism	4	0.299	173.25
WP5095	Overview of proinflammatory and profibrotic mediators	4	0.299	230.5
WP4136	Fibrin complement receptor 3 signaling pathway	10	0.299	254
WP4481	Resistin as a regulator of inflammation	10	0.299	207.5
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	20	0.299	210.75
WP3303	RAC1/PAK1/p38/MMP2 pathway	4	0.298	143.5
WP4331	Neovascularisation processes	20	0.298	217
WP4685	Melanoma	2	0.297	131.25
WP4919	Neuroinflammation	30	0.297	218.5
WP2261	Glioblastoma signaling pathways	2	0.296	102.25
WP4564	Neural crest cell migration during development	10	0.296	182.5
WP23	B cell receptor signaling pathway	20	0.296	233.25
WP5111	Familial hyperlipidemia type 4	20	0.296	254.75
WP2332	Interleukin-11 signaling pathway	20	0.295	218
WP4540	Hippo signaling regulation pathways	20	0.295	220
WP2355	Corticotropin-releasing hormone signaling pathway	5	0.294	149.75
WP4707	Aspirin and miRNAs	5	0.294	169.75
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	20	0.294	217
WP4524	Alternative pathway of fetal androgen synthesis	20	0.294	263.25
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	2	0.293	112.75
WP34	Ovarian infertility	10	0.293	195
WP2877	Vitamin D receptor pathway	3	0.292	154
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	4	0.292	138
WP4484	Control of immune tolerance by vasoactive intestinal peptide	4	0.292	251.5
WP3892	Development of pulmonary dendritic cells and macrophage subsets	10	0.292	199
WP262	Ebstein-Barr virus LMP1 signaling	30	0.292	246.75
WP2431	Spinal cord injury	2	0.291	115
WP179	Cell cycle	3	0.291	156.75
WP5097	CCL18 signaling pathway	4	0.291	145.5
WP4249	Hedgehog signaling pathway	20	0.291	212.25
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	20	0.291	220.25
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	30	0.291	240
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	3	0.29	155.75
WP3594	Circadian rhythm genes	20	0.29	252
WP4016	DNA IR-damage and cellular response via ATR	30	0.29	358.75
WP4249	Hedgehog signaling pathway	30	0.29	236.75
WP3981	miRNA regulation of prostate cancer signaling pathways	2	0.289	134.75
WP4298	Acute viral myocarditis	3	0.289	133.75
WP3888	VEGFA-VEGFR2 signaling pathway	3	0.287	129
WP560	TGF-beta receptor signaling	4	0.287	144
WP2839	Hair follicle development: organogenesis - part 2 of 3	5	0.287	160.25
WP615	Senescence and autophagy in cancer	2	0.286	118
WP2873	Aryl hydrocarbon receptor pathway	4	0.286	185.25
WP170	Nuclear receptors	10	0.285	197
WP4249	Hedgehog signaling pathway	10	0.285	190
WP262	Ebstein-Barr virus LMP1 signaling	20	0.285	261
WP5044	Kynurenine pathway and links to cell senescence	30	0.285	227.75
WP3624	Lung fibrosis	3	0.284	152.5
WP4329	miRNAs involvement in the immune response in sepsis	10	0.284	253.75
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	2	0.283	144.25
WP4018	Clear cell renal cell carcinoma pathways	10	0.283	217.5
WP2526	PDGF pathway	30	0.283	231
WP4255	Non-small cell lung cancer	3	0.282	132
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	10	0.282	242.25
WP254	Apoptosis	3	0.281	168.75
WP1772	Apoptosis modulation and signaling	4	0.281	192.5
WP3893	Development and heterogeneity of the ILC family	5	0.281	224.75
WP558	Complement and coagulation cascades	20	0.281	276.5
WP2507	Nanomaterial induced apoptosis	30	0.281	255.5
WP4155	Endometrial cancer	2	0.28	117
WP3640	Imatinib and chronic myeloid leukemia	5	0.28	153.5
WP4891	COVID-19 adverse outcome pathway	5	0.28	222.5
WP3680	Physico-chemical features and toxicity-associated pathways	4	0.279	149.25
WP399	Wnt signaling pathway and pluripotency	4	0.279	136
WP4494	Selective expression of chemokine receptors during T-cell polarization	5	0.279	257.25
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	30	0.279	244
WP5108	Familial  hyperlipidemia type 1	30	0.279	279.25
WP558	Complement and coagulation cascades	30	0.279	292.75
WP127	IL-5 signaling pathway	5	0.278	149.75
WP3651	Pathways affected in adenoid cystic carcinoma	5	0.278	147.5
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	10	0.278	207.25
WP437	EGF/EGFR signaling pathway	10	0.278	199.75
WP4919	Neuroinflammation	20	0.278	223.5
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	30	0.278	234.75
WP3617	Photodynamic therapy-induced NF-kB survival signaling	2	0.277	186
WP2849	Hematopoietic stem cell differentiation	3	0.277	161.25
WP4925	Unfolded protein response	5	0.277	196.25
WP4205	MET in type 1 papillary renal cell carcinoma	20	0.277	215
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	10	0.276	204
WP1971	Integrated cancer pathway	2	0.275	147
WP5083	Neuroinflammation and glutamatergic signaling	4	0.275	172.25
WP5115	Network map of SARS-CoV-2 signaling pathway	4	0.275	199
WP1403	AMP-activated protein kinase (AMPK) signaling	10	0.275	220
WP5092	Interactions of natural killer cells in pancreatic cancer	10	0.275	228
WP4241	Type 2 papillary renal cell carcinoma	20	0.275	239.25
WP430	Statin inhibition of cholesterol production	10	0.274	311
WP4565	Neural crest cell migration in cancer	10	0.274	191.5
WP3680	Physico-chemical features and toxicity-associated pathways	3	0.273	136
WP382	MAPK signaling pathway	10	0.273	201
WP4241	Type 2 papillary renal cell carcinoma	30	0.273	250.25
WP5112	Familial hyperlipidemia type 5	30	0.273	279.25
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	3	0.272	139
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	5	0.272	177
WP3995	Prion disease pathway	10	0.272	195.25
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	20	0.272	223.5
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	30	0.272	240.25
WP4217	Ebola virus pathway in host	30	0.272	280
WP2839	Hair follicle development: organogenesis - part 2 of 3	4	0.271	154.5
WP2324	AGE/RAGE pathway	5	0.271	181
WP2858	Ectoderm differentiation	10	0.271	208.5
WP4674	Head and neck squamous cell carcinoma	2	0.27	115
WP2878	PPAR-alpha pathway	10	0.27	215.75
WP408	Oxidative stress response	10	0.27	207
WP5053	Development of ureteric collection system	30	0.27	242
WP4263	Pancreatic adenocarcinoma pathway	2	0.269	102
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	5	0.269	175.75
WP453	Inflammatory response pathway	5	0.269	224.5
WP4541	Hippo-Merlin signaling dysregulation	5	0.269	159
WP2848	Pluripotent stem cell differentiation pathway	20	0.269	255.5
WP5108	Familial  hyperlipidemia type 1	20	0.269	296
WP4673	Male infertility	5	0.268	162.25
WP185	Integrin-mediated cell adhesion	30	0.268	253
WP4211	Transcriptional cascade regulating adipogenesis	30	0.268	236.25
WP138	Androgen receptor signaling pathway	3	0.267	144
WP3640	Imatinib and chronic myeloid leukemia	4	0.267	157.75
WP4673	Male infertility	4	0.267	160
WP304	Kit receptor signaling pathway	10	0.267	210
WP5053	Development of ureteric collection system	20	0.267	246.75
WP1544	MicroRNAs in cardiomyocyte hypertrophy	30	0.267	239
WP299	Nuclear receptors in lipid metabolism and toxicity	30	0.267	286
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	30	0.267	252
WP4806	EGFR tyrosine kinase inhibitor resistance	2	0.266	108.5
WP3998	Prader-Willi and Angelman syndrome	3	0.266	183.25
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	10	0.266	212.5
WP2880	Glucocorticoid receptor pathway	10	0.266	197.75
WP313	Hepatocyte growth factor receptor signaling	10	0.266	197.25
WP2857	Mesodermal commitment pathway	20	0.266	237
WP304	Kit receptor signaling pathway	20	0.266	224.75
WP3287	Overview of nanoparticle effects	3	0.265	162.5
WP4928	MAPK pathway in congenital thyroid cancer	3	0.265	147.5
WP15	Selenium micronutrient network	4	0.265	178
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	4	0.265	227
WP4707	Aspirin and miRNAs	4	0.265	181.25
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	5	0.265	236.5
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	10	0.265	286
WP453	Inflammatory response pathway	4	0.264	244.75
WP286	IL-3 signaling pathway	5	0.264	178.75
WP2018	RANKL/RANK signaling pathway	10	0.264	207
WP4495	IL-10 anti-inflammatory signaling pathway	10	0.264	233.25
WP4561	Cell migration and invasion through p75NTR	30	0.264	225.5
WP127	IL-5 signaling pathway	4	0.263	151.5
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	4	0.263	185.25
WP363	Wnt signaling pathway	5	0.263	150.25
WP3998	Prader-Willi and Angelman syndrome	5	0.263	178.75
WP2507	Nanomaterial induced apoptosis	20	0.263	261.25
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	20	0.263	234.75
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	3	0.262	138.5
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	5	0.262	237
WP4925	Unfolded protein response	4	0.261	190.5
WP4241	Type 2 papillary renal cell carcinoma	10	0.261	219
WP3982	miRNA regulation of p53 pathway in prostate cancer	20	0.261	286.75
WP3651	Pathways affected in adenoid cystic carcinoma	4	0.26	153
WP3998	Prader-Willi and Angelman syndrome	4	0.26	173
WP2870	Extracellular vesicle-mediated signaling in recipient cells	10	0.26	206.5
WP2857	Mesodermal commitment pathway	30	0.26	256
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	30	0.26	242.5
WP2355	Corticotropin-releasing hormone signaling pathway	4	0.259	153.75
WP306	Focal adhesion	3	0.258	129
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	4	0.258	202
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	4	0.257	155
WP4891	COVID-19 adverse outcome pathway	4	0.257	293.5
WP2857	Mesodermal commitment pathway	10	0.257	209.5
WP299	Nuclear receptors in lipid metabolism and toxicity	20	0.257	278
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	30	0.257	320.25
WP1984	Integrated breast cancer pathway	2	0.256	121
WP4262	Breast cancer pathway	2	0.256	126
WP176	Folate metabolism	3	0.256	184.5
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	4	0.256	227.5
WP5088	Prostaglandin signaling	5	0.256	237
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	10	0.256	298.5
WP4844	Influence of laminopathies on Wnt signaling	10	0.256	219
WP2839	Hair follicle development: organogenesis - part 2 of 3	3	0.255	162
WP2064	Neural crest differentiation	10	0.255	210.25
WP5112	Familial hyperlipidemia type 5	20	0.255	290.5
WP363	Wnt signaling pathway	4	0.254	150.75
WP4494	Selective expression of chemokine receptors during T-cell polarization	4	0.254	266.75
WP1772	Apoptosis modulation and signaling	5	0.254	203
WP3658	Wnt/beta-catenin signaling pathway in leukemia	5	0.254	166
WP43	Oxidation by cytochrome P450	30	0.254	345.75
WP1530	miRNA regulation of DNA damage response	2	0.253	139
WP205	IL-7 signaling pathway	2	0.253	145.25
WP2324	AGE/RAGE pathway	4	0.253	177
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	5	0.253	199.5
WP3959	DNA IR-double strand breaks and cellular response via ATM	30	0.253	316
WP5049	Glycolysis in senescence	30	0.253	299.5
WP179	Cell cycle	2	0.252	152.75
WP4754	IL-18 signaling pathway	2	0.252	138.5
WP2884	NRF2 pathway	30	0.252	276.5
WP49	IL-2 signaling pathway	2	0.251	142
WP4223	Ras signaling	20	0.251	241.5
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	20	0.251	249
WP1528	Physiological and pathological hypertrophy of the heart	30	0.251	239.25
WP61	Notch signaling pathway (Netpath)	4	0.25	162.25
WP2446	Retinoblastoma gene in cancer	5	0.25	214
WP673	ErbB signaling pathway	2	0.249	130
WP707	DNA damage response	2	0.249	136
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	5	0.249	200.5
WP395	IL-4 signaling pathway	10	0.249	218
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	4	0.248	177.5
WP3601	Lipid particles composition	10	0.248	298.25
WP619	Type II interferon signaling (IFNG)	10	0.248	286
WP4217	Ebola virus pathway in host	20	0.248	282
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	3	0.247	153.5
WP5095	Overview of proinflammatory and profibrotic mediators	3	0.247	238.5
WP5115	Network map of SARS-CoV-2 signaling pathway	3	0.247	194
WP286	IL-3 signaling pathway	4	0.247	174.25
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	5	0.247	218.5
WP69	T-cell receptor (TCR) signaling pathway	5	0.247	197.75
WP43	Oxidation by cytochrome P450	20	0.247	326
WP5097	CCL18 signaling pathway	3	0.246	153.25
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	10	0.246	262.5
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	10	0.246	215.75
WP5098	T-cell activation SARS-CoV-2	2	0.245	142.25
WP399	Wnt signaling pathway and pluripotency	3	0.245	144.25
WP2874	Liver X receptor pathway	20	0.245	290
WP3929	Chemokine signaling pathway	20	0.245	271.5
WP3888	VEGFA-VEGFR2 signaling pathway	2	0.243	116
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	3	0.243	184.5
WP1528	Physiological and pathological hypertrophy of the heart	20	0.243	237
WP4146	Macrophage markers	30	0.243	300.5
WP4658	Small cell lung cancer	2	0.242	130.5
WP2865	IL1 and megakaryocytes in obesity	5	0.242	233.75
WP5044	Kynurenine pathway and links to cell senescence	5	0.242	183
WP2884	NRF2 pathway	20	0.242	292
WP2848	Pluripotent stem cell differentiation pathway	30	0.242	253
WP5055	Burn wound healing	2	0.241	164
WP4541	Hippo-Merlin signaling dysregulation	4	0.241	159
WP289	Myometrial relaxation and contraction pathways	5	0.241	172
WP3851	TLR4 signaling and tolerance	20	0.241	267.5
WP3959	DNA IR-double strand breaks and cellular response via ATM	20	0.241	325.75
WP1533	Vitamin B12 metabolism	3	0.24	199.5
WP2037	Prolactin signaling pathway	5	0.24	173
WP364	IL-6 signaling pathway	10	0.24	280.75
WP2874	Liver X receptor pathway	30	0.24	275.5
WP1539	Angiogenesis	5	0.239	233.25
WP712	Estrogen signaling pathway	5	0.239	186
WP2881	Estrogen receptor pathway	10	0.239	227.25
WP4561	Cell migration and invasion through p75NTR	20	0.239	224.25
WP5083	Neuroinflammation and glutamatergic signaling	3	0.238	172.5
WP2526	PDGF pathway	20	0.238	245.5
WP5109	Familial hyperlipidemia type 2	30	0.238	312.75
WP2374	Oncostatin M signaling pathway	3	0.237	145.75
WP4747	Netrin-UNC5B signaling pathway	5	0.237	178.75
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	5	0.237	168.25
WP3303	RAC1/PAK1/p38/MMP2 pathway	3	0.236	158.5
WP3893	Development and heterogeneity of the ILC family	4	0.236	244.5
WP5088	Prostaglandin signaling	4	0.236	228.75
WP61	Notch signaling pathway (Netpath)	5	0.236	165
WP560	TGF-beta receptor signaling	3	0.235	163
WP2446	Retinoblastoma gene in cancer	4	0.235	207.25
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	10	0.235	258.75
WP3982	miRNA regulation of p53 pathway in prostate cancer	30	0.235	289.75
WP4666	Hepatitis B infection	2	0.234	131.75
WP530	Cytokines and inflammatory response	3	0.234	306
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	4	0.234	216.75
WP4482	Vitamin D in inflammatory diseases	5	0.234	216.75
WP5110	Familial hyperlipidemia type 3	10	0.234	318.25
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	30	0.234	249
WP363	Wnt signaling pathway	3	0.233	152.5
WP4484	Control of immune tolerance by vasoactive intestinal peptide	3	0.233	419
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	20	0.233	330.75
WP3935	Leptin-insulin signaling overlap	30	0.233	273.75
WP4298	Acute viral myocarditis	2	0.232	141
WP2873	Aryl hydrocarbon receptor pathway	3	0.232	197.5
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	5	0.232	188.75
WP4205	MET in type 1 papillary renal cell carcinoma	10	0.232	204
WP3297	EV release from cardiac cells and their functional effects	20	0.232	285.5
WP4016	DNA IR-damage and cellular response via ATR	20	0.232	374.25
WP3297	EV release from cardiac cells and their functional effects	30	0.232	263.75
WP4816	TGF-beta receptor signaling in skeletal dysplasias	3	0.231	158.75
WP2865	IL1 and megakaryocytes in obesity	4	0.231	229.5
WP3941	Oxidative damage response	4	0.231	181
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	5	0.231	179.5
WP4698	Vitamin D-sensitive calcium signaling in depression	10	0.231	225
WP4919	Neuroinflammation	10	0.231	233.5
WP2877	Vitamin D receptor pathway	2	0.23	155
WP2328	Allograft Rejection	3	0.23	224
WP1438	Influenza A virus infection	4	0.23	465.5
WP4483	Relationship between inflammation, COX-2 and EGFR	5	0.23	204.5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	10	0.23	239.5
WP3286	Copper homeostasis	20	0.23	243.25
WP4211	Transcriptional cascade regulating adipogenesis	20	0.23	258.5
WP466	DNA replication	30	0.23	533
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	4	0.229	176.25
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	30	0.229	322.75
WP712	Estrogen signaling pathway	4	0.228	179.5
WP1449	Regulation of toll-like receptor signaling pathway	5	0.228	243.75
WP3941	Oxidative damage response	5	0.228	183
WP2446	Retinoblastoma gene in cancer	3	0.227	197.25
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	4	0.227	233.5
WP4396	Nonalcoholic fatty liver disease	5	0.227	221.5
WP5053	Development of ureteric collection system	10	0.227	233
WP4204	Tumor suppressor activity of SMARCB1	30	0.227	258.5
WP4970	Galanin receptor pathway	2	0.226	206
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	3	0.226	200
WP69	T-cell receptor (TCR) signaling pathway	4	0.226	201.5
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	4	0.226	186
WP2857	Mesodermal commitment pathway	5	0.226	181
WP2878	PPAR-alpha pathway	5	0.226	195.75
WP23	B cell receptor signaling pathway	10	0.226	230
WP2332	Interleukin-11 signaling pathway	10	0.226	218.75
WP3599	Transcription factor regulation in adipogenesis	10	0.226	235.75
WP1544	MicroRNAs in cardiomyocyte hypertrophy	20	0.226	252.5
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	30	0.226	252
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	5	0.225	196
WP3594	Circadian rhythm genes	10	0.225	245
WP5111	Familial hyperlipidemia type 4	10	0.225	322.5
WP4874	CAMKK2 pathway	30	0.225	254.25
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	2	0.224	163
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	3	0.224	166.5
WP5044	Kynurenine pathway and links to cell senescence	4	0.224	192.25
WP4329	miRNAs involvement in the immune response in sepsis	5	0.223	288.75
WP1434	Osteopontin signaling	10	0.223	289
WP4342	Vitamins A and D - action mechanisms	20	0.223	249.5
WP254	Apoptosis	2	0.222	173.25
WP2249	Metastatic brain tumor	3	0.222	163.5
WP61	Notch signaling pathway (Netpath)	3	0.222	154.5
WP4149	White fat cell differentiation	10	0.222	218.25
WP236	Adipogenesis	2	0.221	134.5
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	5	0.221	175
WP3286	Copper homeostasis	10	0.221	225.5
WP127	IL-5 signaling pathway	3	0.22	163
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	5	0.22	182
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	10	0.22	237.5
WP15	Selenium micronutrient network	3	0.219	194.5
WP4249	Hedgehog signaling pathway	4	0.219	188.25
WP2858	Ectoderm differentiation	5	0.219	177.75
WP314	Fas ligand pathway and stress induction of heat shock proteins	5	0.219	213
WP4540	Hippo signaling regulation pathways	10	0.219	226
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	20	0.219	257.5
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	2	0.218	422.5
WP4925	Unfolded protein response	3	0.218	221.25
WP3658	Wnt/beta-catenin signaling pathway in leukemia	4	0.218	177.75
WP231	TNF-alpha signaling pathway	10	0.218	273
WP5109	Familial hyperlipidemia type 2	20	0.218	321.5
WP3998	Prader-Willi and Angelman syndrome	2	0.216	197.5
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	3	0.216	164.75
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	4	0.216	174.5
WP4493	Cells and molecules involved in local acute inflammatory response	5	0.216	280.5
WP3299	let-7 inhibition of ES cell reprogramming	10	0.216	217
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	10	0.216	228.5
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	3	0.215	162.75
WP4541	Hippo-Merlin signaling dysregulation	3	0.215	156.5
WP4478	LTF danger signal response pathway	5	0.215	297.5
WP4331	Neovascularisation processes	10	0.215	231
WP272	Blood clotting cascade	20	0.215	307.5
WP3942	PPAR signaling pathway	30	0.215	428
WP4191	Caloric restriction and aging	30	0.215	265.75
WP4255	Non-small cell lung cancer	2	0.214	136
WP1772	Apoptosis modulation and signaling	3	0.214	196.5
WP712	Estrogen signaling pathway	3	0.214	197
WP4496	Signal transduction through IL1R	5	0.214	256.75
WP4008	NO/cGMP/PKG mediated neuroprotection	20	0.214	297.5
WP138	Androgen receptor signaling pathway	2	0.213	141
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	3	0.213	210.25
WP2037	Prolactin signaling pathway	4	0.213	171.5
WP314	Fas ligand pathway and stress induction of heat shock proteins	4	0.213	205.25
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	20	0.213	277.75
WP1539	Angiogenesis	4	0.212	216.75
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	4	0.212	190.5
WP75	Toll-like receptor signaling pathway	5	0.212	258.5
WP4961	STING pathway in Kawasaki-like disease and COVID-19	10	0.212	259.25
WP2355	Corticotropin-releasing hormone signaling pathway	3	0.211	160.75
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	3	0.211	448
WP4494	Selective expression of chemokine receptors during T-cell polarization	3	0.211	405.5
WP4396	Nonalcoholic fatty liver disease	4	0.211	206
WP3982	miRNA regulation of p53 pathway in prostate cancer	10	0.211	297.75
WP4146	Macrophage markers	20	0.211	357.5
WP3851	TLR4 signaling and tolerance	30	0.211	279.75
WP3972	PDGFR-beta pathway	30	0.211	262.25
WP4483	Relationship between inflammation, COX-2 and EGFR	4	0.21	211.5
WP474	Endochondral ossification	5	0.21	205.75
WP4808	Endochondral ossification with skeletal dysplasias	5	0.21	205.75
WP3287	Overview of nanoparticle effects	2	0.209	384.25
WP3680	Physico-chemical features and toxicity-associated pathways	2	0.209	161.5
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	4	0.209	175.5
WP4141	PI3K/AKT/mTOR - VitD3 signaling	5	0.209	215.5
WP4249	Hedgehog signaling pathway	5	0.209	195.75
WP262	Ebstein-Barr virus LMP1 signaling	10	0.209	290.25
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	10	0.209	305.5
WP4655	Cytosolic DNA-sensing pathway	10	0.209	375.75
WP5033	Genes associated with the development of rheumatoid arthritis	20	0.209	290.25
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	2	0.208	216
WP286	IL-3 signaling pathway	3	0.208	174.25
WP2034	Leptin signaling pathway	4	0.208	205
WP1438	Influenza A virus infection	5	0.208	483.25
WP2064	Neural crest differentiation	5	0.208	200
WP4481	Resistin as a regulator of inflammation	5	0.208	231
WP1604	Codeine and morphine metabolism	30	0.208	469.75
WP3299	let-7 inhibition of ES cell reprogramming	30	0.208	245.5
WP2849	Hematopoietic stem cell differentiation	2	0.207	170
WP3658	Wnt/beta-catenin signaling pathway in leukemia	3	0.207	165.75
WP289	Myometrial relaxation and contraction pathways	4	0.207	186
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	4	0.207	183
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	5	0.207	211.75
WP4969	RAS and bradykinin pathways in COVID-19	5	0.207	253.25
WP5063	FOXP3 in COVID-19	5	0.207	256
WP3929	Chemokine signaling pathway	10	0.207	271.5
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	10	0.207	223.75
WP4561	Cell migration and invasion through p75NTR	10	0.207	226.75
WP558	Complement and coagulation cascades	10	0.207	310
WP3299	let-7 inhibition of ES cell reprogramming	20	0.207	255.25
WP3942	PPAR signaling pathway	20	0.207	415
WP3624	Lung fibrosis	2	0.206	177.75
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	3	0.206	174
WP176	Folate metabolism	2	0.205	198.5
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	20	0.205	329.5
WP2507	Nanomaterial induced apoptosis	10	0.204	269
WP2848	Pluripotent stem cell differentiation pathway	10	0.204	247.75
WP3630	NAD metabolism, sirtuins and aging	30	0.204	274.75
WP3303	RAC1/PAK1/p38/MMP2 pathway	2	0.203	157.5
WP453	Inflammatory response pathway	3	0.203	303.25
WP5063	FOXP3 in COVID-19	4	0.203	294.75
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	5	0.203	203.75
WP5092	Interactions of natural killer cells in pancreatic cancer	5	0.203	236
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	10	0.203	242
WP4673	Male infertility	3	0.202	162
WP5121	Sphingolipid metabolism in senescence	3	0.202	186
WP2858	Ectoderm differentiation	4	0.202	182
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	30	0.202	284.75
WP1533	Vitamin B12 metabolism	2	0.201	244.25
WP4707	Aspirin and miRNAs	3	0.201	250.5
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	3	0.201	305.75
WP4141	PI3K/AKT/mTOR - VitD3 signaling	4	0.201	206
WP4844	Influence of laminopathies on Wnt signaling	4	0.201	213.25
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	5	0.201	275
WP5112	Familial hyperlipidemia type 5	10	0.201	355
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	20	0.201	278
WP4329	miRNAs involvement in the immune response in sepsis	4	0.2	294
WP299	Nuclear receptors in lipid metabolism and toxicity	10	0.2	287.75
WP4823	Genes controlling nephrogenesis	30	0.2	299.75
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	2	0.199	150.5
WP306	Focal adhesion	2	0.199	128.5
WP5044	Kynurenine pathway and links to cell senescence	3	0.199	208.5
WP129	Matrix metalloproteinases	5	0.199	276.5
WP4136	Fibrin complement receptor 3 signaling pathway	5	0.199	283.75
WP4462	Platelet-mediated interactions with vascular and circulating cells	5	0.199	373.25
WP5121	Sphingolipid metabolism in senescence	5	0.199	196.5
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	3	0.198	172
WP474	Endochondral ossification	4	0.198	195.75
WP4808	Endochondral ossification with skeletal dysplasias	4	0.198	195.75
WP2870	Extracellular vesicle-mediated signaling in recipient cells	5	0.198	228.5
WP1528	Physiological and pathological hypertrophy of the heart	10	0.198	237.5
WP5049	Glycolysis in senescence	20	0.198	322.75
WP5115	Network map of SARS-CoV-2 signaling pathway	2	0.197	179
WP4969	RAS and bradykinin pathways in COVID-19	4	0.197	269
WP437	EGF/EGFR signaling pathway	5	0.197	193
WP3596	miR-517 relationship with ARCN1 and USP1	10	0.197	223.5
WP2839	Hair follicle development: organogenesis - part 2 of 3	2	0.196	188.5
WP5097	CCL18 signaling pathway	2	0.196	170.25
WP1438	Influenza A virus infection	3	0.196	461.75
WP4844	Influence of laminopathies on Wnt signaling	5	0.196	222.25
WP3851	TLR4 signaling and tolerance	10	0.196	286.75
WP5121	Sphingolipid metabolism in senescence	4	0.195	190.25
WP5108	Familial  hyperlipidemia type 1	10	0.195	344.5
WP3935	Leptin-insulin signaling overlap	20	0.195	301.25
WP4823	Genes controlling nephrogenesis	20	0.195	320.5
WP272	Blood clotting cascade	30	0.195	318.5
WP3286	Copper homeostasis	30	0.195	259.25
WP3640	Imatinib and chronic myeloid leukemia	3	0.194	161.5
WP4483	Relationship between inflammation, COX-2 and EGFR	3	0.194	221.25
WP2363	Gastric cancer network 2	10	0.194	231.25
WP3630	NAD metabolism, sirtuins and aging	20	0.194	286.25
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	3	0.193	179.75
WP2857	Mesodermal commitment pathway	4	0.193	196.25
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	30	0.193	282.25
WP129	Matrix metalloproteinases	4	0.192	284.75
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	5	0.192	251.75
WP4223	Ras signaling	10	0.192	239
WP195	IL-1 signaling pathway	20	0.192	286
WP4191	Caloric restriction and aging	20	0.192	267.25
WP428	Wnt signaling	20	0.192	263.75
WP5033	Genes associated with the development of rheumatoid arthritis	30	0.192	278.5
WP5036	Angiotensin II receptor type 1 pathway	30	0.192	289
WP3941	Oxidative damage response	3	0.191	189.75
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	3	0.191	179.5
WP1449	Regulation of toll-like receptor signaling pathway	4	0.191	242
WP4496	Signal transduction through IL1R	4	0.191	246.5
WP2446	Retinoblastoma gene in cancer	2	0.19	184.5
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	4	0.19	185.25
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	30	0.19	308.5
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	3	0.189	270.25
WP2516	ATM signaling pathway	5	0.189	229.5
WP185	Integrin-mediated cell adhesion	20	0.189	281.75
WP4312	Rett syndrome causing genes	20	0.189	285.5
WP2853	Endoderm differentiation	30	0.189	303
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	2	0.188	406.25
WP4249	Hedgehog signaling pathway	3	0.188	197.25
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	20	0.188	274
WP399	Wnt signaling pathway and pluripotency	2	0.187	145
WP4747	Netrin-UNC5B signaling pathway	4	0.187	187
WP2034	Leptin signaling pathway	5	0.187	215.25
WP4008	NO/cGMP/PKG mediated neuroprotection	10	0.187	292.5
WP3972	PDGFR-beta pathway	20	0.187	268.25
WP5036	Angiotensin II receptor type 1 pathway	20	0.187	290.25
WP2795	Cardiac hypertrophic response	30	0.187	266
WP2249	Metastatic brain tumor	2	0.186	394.75
WP4891	COVID-19 adverse outcome pathway	3	0.186	419.25
WP2064	Neural crest differentiation	4	0.186	197.25
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	4	0.186	205.25
WP4564	Neural crest cell migration during development	5	0.186	201.75
WP2197	Endothelin pathways	30	0.186	284.25
WP4816	TGF-beta receptor signaling in skeletal dysplasias	2	0.185	166
WP1539	Angiogenesis	3	0.185	213.5
WP2324	AGE/RAGE pathway	3	0.185	181
WP2363	Gastric cancer network 2	4	0.185	211.5
WP2516	ATM signaling pathway	4	0.185	234.75
WP2878	PPAR-alpha pathway	4	0.185	214.5
WP170	Nuclear receptors	5	0.185	223.25
WP3286	Copper homeostasis	5	0.185	228
WP428	Wnt signaling	10	0.185	231.75
WP2643	Nanoparticle-mediated activation of receptor signaling	20	0.185	268.5
WP3651	Pathways affected in adenoid cystic carcinoma	3	0.184	170.5
WP69	T-cell receptor (TCR) signaling pathway	3	0.183	198
WP2880	Glucocorticoid receptor pathway	5	0.183	217.5
WP3959	DNA IR-double strand breaks and cellular response via ATM	10	0.183	324.75
WP2289	Drug induction of bile acid pathway	30	0.183	347.5
WP3893	Development and heterogeneity of the ILC family	3	0.182	276.25
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	3	0.182	204.5
WP5088	Prostaglandin signaling	3	0.182	243.25
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	3	0.182	257.75
WP4481	Resistin as a regulator of inflammation	4	0.182	218.5
WP4482	Vitamin D in inflammatory diseases	4	0.182	210
WP3892	Development of pulmonary dendritic cells and macrophage subsets	5	0.182	200.25
WP2526	PDGF pathway	10	0.182	244.5
WP195	IL-1 signaling pathway	30	0.182	286.25
WP2643	Nanoparticle-mediated activation of receptor signaling	30	0.182	268.75
WP313	Hepatocyte growth factor receptor signaling	5	0.181	206.5
WP4241	Type 2 papillary renal cell carcinoma	5	0.181	224.5
WP4538	Regulatory circuits of the STAT3 signaling pathway	30	0.181	311
WP15	Selenium micronutrient network	2	0.18	228.25
WP2865	IL1 and megakaryocytes in obesity	3	0.18	289.75
WP1403	AMP-activated protein kinase (AMPK) signaling	4	0.18	210.5
WP4462	Platelet-mediated interactions with vascular and circulating cells	4	0.18	435.25
WP5092	Interactions of natural killer cells in pancreatic cancer	4	0.18	238.25
WP4342	Vitamins A and D - action mechanisms	10	0.18	289.25
WP5083	Neuroinflammation and glutamatergic signaling	2	0.179	177
WP2037	Prolactin signaling pathway	3	0.179	170
WP3995	Prion disease pathway	4	0.179	207.75
WP43	Oxidation by cytochrome P450	10	0.179	351.25
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	20	0.179	304.5
WP4290	Metabolic reprogramming in colon cancer	30	0.179	455.75
WP481	Insulin signaling	30	0.179	286
WP4541	Hippo-Merlin signaling dysregulation	2	0.178	153.75
WP5095	Overview of proinflammatory and profibrotic mediators	2	0.178	267
WP2878	PPAR-alpha pathway	3	0.178	199.5
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	4	0.178	209.75
WP75	Toll-like receptor signaling pathway	4	0.178	246.5
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	2	0.177	157.5
WP5121	Sphingolipid metabolism in senescence	2	0.177	389.75
WP530	Cytokines and inflammatory response	2	0.177	405.5
WP560	TGF-beta receptor signaling	2	0.177	163.5
WP3982	miRNA regulation of p53 pathway in prostate cancer	5	0.177	316.25
WP3995	Prion disease pathway	5	0.177	222
WP619	Type II interferon signaling (IFNG)	5	0.177	299.75
WP3651	Pathways affected in adenoid cystic carcinoma	2	0.176	157
WP61	Notch signaling pathway (Netpath)	2	0.176	159.75
WP4493	Cells and molecules involved in local acute inflammatory response	4	0.176	330.5
WP34	Ovarian infertility	5	0.176	224.5
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	20	0.176	289.25
WP4479	Supression of HMGB1 mediated inflammation by THBD	20	0.176	348
WP5072	Modulators of TCR signaling and T cell activation	30	0.176	311
WP2857	Mesodermal commitment pathway	3	0.175	176.25
WP4478	LTF danger signal response pathway	4	0.175	437.5
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	5	0.175	314.75
WP4016	DNA IR-damage and cellular response via ATR	10	0.175	361.5
WP4239	Epithelial to mesenchymal transition in colorectal cancer	20	0.175	300
WP466	DNA replication	20	0.175	518.5
WP4874	CAMKK2 pathway	20	0.175	257
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	2	0.174	158
WP2034	Leptin signaling pathway	3	0.174	196.5
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	4	0.174	248.5
WP3286	Copper homeostasis	4	0.174	218.5
WP1403	AMP-activated protein kinase (AMPK) signaling	5	0.174	222.25
WP430	Statin inhibition of cholesterol production	5	0.174	330.5
WP3972	PDGFR-beta pathway	10	0.174	263.75
WP727	Monoamine transport	20	0.174	308.75
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	2	0.173	185
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	5	0.173	272.75
WP23	B cell receptor signaling pathway	5	0.173	219
WP4565	Neural crest cell migration in cancer	5	0.173	208.5
WP4524	Alternative pathway of fetal androgen synthesis	10	0.173	310
WP2289	Drug induction of bile acid pathway	20	0.173	335
WP4204	Tumor suppressor activity of SMARCB1	20	0.173	272
WP2374	Oncostatin M signaling pathway	2	0.172	156
WP3658	Wnt/beta-catenin signaling pathway in leukemia	2	0.172	195.25
WP4136	Fibrin complement receptor 3 signaling pathway	4	0.172	283
WP4241	Type 2 papillary renal cell carcinoma	4	0.172	233
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	4	0.172	415.5
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	4	0.172	267
WP4495	IL-10 anti-inflammatory signaling pathway	5	0.172	260
WP2874	Liver X receptor pathway	10	0.172	331.5
WP516	Hypertrophy model	10	0.172	267.5
WP2853	Endoderm differentiation	20	0.172	305
WP3640	Imatinib and chronic myeloid leukemia	2	0.171	178
WP3941	Oxidative damage response	2	0.171	249.25
WP712	Estrogen signaling pathway	2	0.171	389.25
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	3	0.171	219.25
WP4844	Influence of laminopathies on Wnt signaling	3	0.171	214.5
WP2870	Extracellular vesicle-mediated signaling in recipient cells	4	0.171	224.5
WP2363	Gastric cancer network 2	5	0.171	217.5
WP2197	Endothelin pathways	20	0.171	294.25
WP98	Prostaglandin synthesis and regulation	20	0.171	280.5
WP4197	Immune response to tuberculosis	30	0.171	514.25
WP534	Glycolysis and gluconeogenesis	30	0.171	411.25
WP2018	RANKL/RANK signaling pathway	5	0.17	224
WP4146	Macrophage markers	10	0.17	378.5
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	20	0.17	287.5
WP2858	Ectoderm differentiation	3	0.169	187
WP408	Oxidative stress response	4	0.169	218.5
WP382	MAPK signaling pathway	5	0.169	215
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	10	0.169	343.25
WP5102	Familial partial lipodystrophy (FPLD)	30	0.169	302.25
WP1772	Apoptosis modulation and signaling	2	0.168	203
WP289	Myometrial relaxation and contraction pathways	3	0.168	177
WP4747	Netrin-UNC5B signaling pathway	3	0.168	194
WP34	Ovarian infertility	4	0.168	222.5
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	4	0.168	233.25
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	10	0.168	271.5
WP4312	Rett syndrome causing genes	30	0.168	288.5
WP727	Monoamine transport	30	0.168	304.5
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	2	0.167	216.5
WP5053	Development of ureteric collection system	5	0.167	246.25
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	10	0.167	266.5
WP4217	Ebola virus pathway in host	10	0.167	293.5
WP2272	Pathogenic Escherichia coli infection	30	0.167	285.5
WP428	Wnt signaling	30	0.167	290.5
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	2	0.166	146
WP2507	Nanomaterial induced apoptosis	4	0.166	268.75
WP3982	miRNA regulation of p53 pathway in prostate cancer	4	0.166	338.25
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	4	0.166	281.5
WP304	Kit receptor signaling pathway	5	0.166	216.25
WP1604	Codeine and morphine metabolism	20	0.166	461.5
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	20	0.166	303
WP4239	Epithelial to mesenchymal transition in colorectal cancer	30	0.166	307
WP4479	Supression of HMGB1 mediated inflammation by THBD	30	0.166	324.75
WP581	EPO receptor signaling	30	0.166	301.5
WP2328	Allograft Rejection	2	0.165	254.75
WP2873	Aryl hydrocarbon receptor pathway	2	0.165	240.75
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	2	0.165	384.25
WP382	MAPK signaling pathway	4	0.165	196.5
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	5	0.165	230.75
WP4540	Hippo signaling regulation pathways	5	0.165	205.5
WP1544	MicroRNAs in cardiomyocyte hypertrophy	10	0.165	258.75
WP4191	Caloric restriction and aging	10	0.165	259.5
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	10	0.165	253.25
WP4823	Genes controlling nephrogenesis	10	0.165	297.25
WP3943	Robo4 and VEGF signaling pathways crosstalk	20	0.165	289.5
WP3943	Robo4 and VEGF signaling pathways crosstalk	30	0.165	285.25
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	30	0.165	426.5
WP4673	Male infertility	2	0.164	153
WP23	B cell receptor signaling pathway	4	0.164	218.5
WP4018	Clear cell renal cell carcinoma pathways	4	0.164	228.25
WP437	EGF/EGFR signaling pathway	4	0.164	207
WP4949	16p11.2 proximal deletion syndrome	10	0.164	263.25
WP98	Prostaglandin synthesis and regulation	30	0.164	293.75
WP1438	Influenza A virus infection	2	0.163	433.5
WP5063	FOXP3 in COVID-19	3	0.163	439.5
WP170	Nuclear receptors	4	0.163	227.75
WP304	Kit receptor signaling pathway	4	0.163	217.25
WP2881	Estrogen receptor pathway	5	0.163	263.75
WP4149	White fat cell differentiation	5	0.163	230.75
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	5	0.163	305.5
WP5109	Familial hyperlipidemia type 2	10	0.163	355
WP4949	16p11.2 proximal deletion syndrome	20	0.163	268
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	30	0.163	296.5
WP4141	PI3K/AKT/mTOR - VitD3 signaling	3	0.162	222.5
WP2884	NRF2 pathway	10	0.162	328.25
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	3	0.161	209.25
WP314	Fas ligand pathway and stress induction of heat shock proteins	3	0.161	230.25
WP4329	miRNAs involvement in the immune response in sepsis	3	0.161	382.25
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	4	0.161	308.25
WP408	Oxidative stress response	5	0.161	219
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	20	0.161	290.5
WP4197	Immune response to tuberculosis	20	0.161	492.5
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	20	0.161	398
WP2355	Corticotropin-releasing hormone signaling pathway	2	0.16	159.5
WP363	Wnt signaling pathway	2	0.16	154.5
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	2	0.16	281.5
WP1449	Regulation of toll-like receptor signaling pathway	3	0.16	228.5
WP4396	Nonalcoholic fatty liver disease	3	0.16	210
WP2874	Liver X receptor pathway	5	0.16	458
WP272	Blood clotting cascade	10	0.16	332
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	10	0.16	293
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	10	0.16	274.75
WP2118	Arrhythmogenic right ventricular cardiomyopathy	30	0.16	296
WP4357	NRF2-ARE regulation	30	0.16	287
WP2857	Mesodermal commitment pathway	2	0.159	169
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	2	0.159	397.25
WP23	B cell receptor signaling pathway	3	0.159	197.75
WP2848	Pluripotent stem cell differentiation pathway	4	0.159	246.5
WP430	Statin inhibition of cholesterol production	4	0.159	375
WP516	Hypertrophy model	20	0.159	268
WP2583	T cell receptor and co-stimulatory signaling	30	0.159	286.5
WP4008	NO/cGMP/PKG mediated neuroprotection	30	0.159	303.5
WP531	DNA mismatch repair	30	0.159	514
WP2878	PPAR-alpha pathway	2	0.158	272.25
WP313	Hepatocyte growth factor receptor signaling	4	0.158	199.5
WP5053	Development of ureteric collection system	4	0.158	232.25
WP299	Nuclear receptors in lipid metabolism and toxicity	5	0.158	296.75
WP3594	Circadian rhythm genes	5	0.158	238.5
WP364	IL-6 signaling pathway	5	0.158	285.75
WP4655	Cytosolic DNA-sensing pathway	5	0.158	363.5
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	10	0.158	327
WP2583	T cell receptor and co-stimulatory signaling	20	0.158	285
WP4585	Cancer immunotherapy by PD-1 blockade	20	0.158	313.5
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	30	0.158	293.25
WP4946	DNA repair pathways, full network	30	0.158	556
WP4484	Control of immune tolerance by vasoactive intestinal peptide	2	0.157	416
WP170	Nuclear receptors	3	0.157	217.25
WP4241	Type 2 papillary renal cell carcinoma	3	0.157	222.75
WP231	TNF-alpha signaling pathway	5	0.157	264
WP428	Wnt signaling	5	0.157	208.25
WP2447	Amyotrophic lateral sclerosis (ALS)	10	0.157	269.5
WP3943	Robo4 and VEGF signaling pathways crosstalk	10	0.157	275.5
WP4585	Cancer immunotherapy by PD-1 blockade	30	0.157	320.25
WP51	Regulation of actin cytoskeleton	30	0.157	316
WP697	Estrogen metabolism	30	0.157	411
WP127	IL-5 signaling pathway	2	0.156	169
WP453	Inflammatory response pathway	2	0.156	408.75
WP4928	MAPK pathway in congenital thyroid cancer	2	0.156	381
WP474	Endochondral ossification	3	0.156	185.75
WP4808	Endochondral ossification with skeletal dysplasias	3	0.156	185.75
WP2795	Cardiac hypertrophic response	20	0.156	285
WP5122	Prostaglandin and leukotriene metabolism in senescence	20	0.156	290
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	30	0.156	317
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	2	0.155	229
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	3	0.155	447
WP1434	Osteopontin signaling	4	0.155	453.25
WP2880	Glucocorticoid receptor pathway	4	0.155	221.5
WP481	Insulin signaling	20	0.155	297
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	3	0.154	194.75
WP428	Wnt signaling	4	0.154	200.25
WP3601	Lipid particles composition	5	0.154	476.5
WP4018	Clear cell renal cell carcinoma pathways	5	0.154	232.25
WP5110	Familial hyperlipidemia type 3	5	0.154	449.75
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	20	0.154	316.5
WP4946	DNA repair pathways, full network	20	0.154	521
WP697	Estrogen metabolism	20	0.154	415.5
WP2447	Amyotrophic lateral sclerosis (ALS)	30	0.154	325.75
WP3298	Melatonin metabolism and effects	30	0.154	370.5
WP4629	Aerobic glycolysis	30	0.154	440.75
WP4925	Unfolded protein response	2	0.153	393.75
WP2064	Neural crest differentiation	3	0.153	200
WP4478	LTF danger signal response pathway	3	0.153	446.5
WP4540	Hippo signaling regulation pathways	4	0.153	218.75
WP4564	Neural crest cell migration during development	4	0.153	206
WP4919	Neuroinflammation	5	0.153	246.75
WP195	IL-1 signaling pathway	10	0.153	295.5
WP3599	Transcription factor regulation in adipogenesis	4	0.152	247.75
WP619	Type II interferon signaling (IFNG)	4	0.152	292.75
WP3299	let-7 inhibition of ES cell reprogramming	5	0.152	188.5
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	5	0.152	266.5
WP2289	Drug induction of bile acid pathway	10	0.152	344
WP2118	Arrhythmogenic right ventricular cardiomyopathy	20	0.152	311
WP2456	HIF1A and PPARG regulation of glycolysis	30	0.152	334
WP3591	Sleep regulation	30	0.152	298.5
WP4969	RAS and bradykinin pathways in COVID-19	3	0.151	313
WP395	IL-4 signaling pathway	4	0.151	228.5
WP3297	EV release from cardiac cells and their functional effects	5	0.151	494
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	5	0.151	245.5
WP4698	Vitamin D-sensitive calcium signaling in depression	5	0.151	217
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	10	0.151	276.25
WP3297	EV release from cardiac cells and their functional effects	10	0.151	308.5
WP2059	Alzheimer's disease and miRNA effects	20	0.151	302
WP2876	Pregnane X receptor pathway	20	0.151	431.75
WP702	Metapathway biotransformation Phase I and II	20	0.151	458
WP4249	Hedgehog signaling pathway	2	0.15	359.5
WP2447	Amyotrophic lateral sclerosis (ALS)	4	0.15	254.75
WP3892	Development of pulmonary dendritic cells and macrophage subsets	4	0.15	194.75
WP395	IL-4 signaling pathway	5	0.15	230.75
WP5111	Familial hyperlipidemia type 4	5	0.15	394.5
WP4204	Tumor suppressor activity of SMARCB1	10	0.15	282.25
WP4312	Rett syndrome causing genes	10	0.15	264.75
WP4494	Selective expression of chemokine receptors during T-cell polarization	2	0.149	410.75
WP34	Ovarian infertility	3	0.149	222.75
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	3	0.149	229.5
WP430	Statin inhibition of cholesterol production	3	0.149	426.5
WP43	Oxidation by cytochrome P450	5	0.149	347.75
WP5033	Genes associated with the development of rheumatoid arthritis	10	0.149	312
WP2272	Pathogenic Escherichia coli infection	20	0.149	308
WP1946	Cori cycle	30	0.149	404.75
WP2876	Pregnane X receptor pathway	30	0.149	433
WP702	Metapathway biotransformation Phase I and II	30	0.149	467
WP2324	AGE/RAGE pathway	2	0.148	189
WP2363	Gastric cancer network 2	3	0.148	228.5
WP5092	Interactions of natural killer cells in pancreatic cancer	3	0.148	248
WP2881	Estrogen receptor pathway	4	0.148	301.75
WP3599	Transcription factor regulation in adipogenesis	5	0.148	237.75
WP5122	Prostaglandin and leukotriene metabolism in senescence	10	0.148	249.25
WP3937	Microglia pathogen phagocytosis pathway	30	0.148	483.25
WP2858	Ectoderm differentiation	2	0.147	165.5
WP3892	Development of pulmonary dendritic cells and macrophage subsets	3	0.147	246.5
WP75	Toll-like receptor signaling pathway	3	0.147	245
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	4	0.147	205.5
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	5	0.147	219.5
WP3584	MECP2 and associated Rett syndrome	30	0.147	308
WP4838	Regucalcin in proximal tubule epithelial kidney cells	30	0.147	399
WP5103	Progeria-associated lipodystrophy	30	0.147	285.5
WP554	ACE inhibitor pathway	30	0.147	330.25
WP5044	Kynurenine pathway and links to cell senescence	2	0.146	400.75
WP5088	Prostaglandin signaling	2	0.146	392.25
WP4564	Neural crest cell migration during development	3	0.146	202.5
WP4655	Cytosolic DNA-sensing pathway	4	0.146	411.75
WP5110	Familial hyperlipidemia type 3	4	0.146	464.5
WP5049	Glycolysis in senescence	10	0.146	307.5
WP2447	Amyotrophic lateral sclerosis (ALS)	20	0.146	302
WP4558	Overview of interferons-mediated signaling pathway	20	0.146	403.5
WP496	Steroid biosynthesis	30	0.146	404.25
WP2516	ATM signaling pathway	3	0.145	235
WP2507	Nanomaterial induced apoptosis	5	0.145	268.5
WP4205	MET in type 1 papillary renal cell carcinoma	5	0.145	210
WP3935	Leptin-insulin signaling overlap	10	0.145	330.25
WP2456	HIF1A and PPARG regulation of glycolysis	20	0.145	344.75
WP4147	PTF1A related regulatory pathway	30	0.145	321.25
WP5122	Prostaglandin and leukotriene metabolism in senescence	30	0.145	310
WP4707	Aspirin and miRNAs	2	0.144	412.75
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	2	0.144	177.5
WP4565	Neural crest cell migration in cancer	4	0.144	211.25
WP3851	TLR4 signaling and tolerance	5	0.144	293.75
WP3407	FTO obesity variant mechanism	20	0.144	317.5
WP496	Steroid biosynthesis	20	0.144	424
WP5103	Progeria-associated lipodystrophy	20	0.144	285.5
WP286	IL-3 signaling pathway	2	0.143	196.25
WP4483	Relationship between inflammation, COX-2 and EGFR	2	0.143	404
WP129	Matrix metalloproteinases	3	0.143	429.25
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	3	0.143	276.25
WP2332	Interleukin-11 signaling pathway	4	0.143	230.75
WP2363	Gastric cancer network 2	20	0.143	282.75
WP3591	Sleep regulation	20	0.143	298.5
WP51	Regulation of actin cytoskeleton	20	0.143	322.75
WP5124	Alzheimer's disease	20	0.143	303
WP581	EPO receptor signaling	20	0.143	327.25
WP2363	Gastric cancer network 2	2	0.142	378.75
WP2865	IL1 and megakaryocytes in obesity	2	0.142	410.25
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	2	0.142	409.25
WP4493	Cells and molecules involved in local acute inflammatory response	3	0.142	440.75
WP231	TNF-alpha signaling pathway	4	0.142	243.75
WP3594	Circadian rhythm genes	4	0.142	234
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	4	0.142	452.25
WP2848	Pluripotent stem cell differentiation pathway	5	0.142	251
WP3630	NAD metabolism, sirtuins and aging	10	0.142	303.75
WP98	Prostaglandin synthesis and regulation	10	0.142	288.25
WP2059	Alzheimer's disease and miRNA effects	30	0.142	323
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	3	0.141	405.75
WP43	Oxidation by cytochrome P450	3	0.141	426.25
WP4481	Resistin as a regulator of inflammation	3	0.141	245.25
WP4149	White fat cell differentiation	4	0.141	246
WP558	Complement and coagulation cascades	5	0.141	319.25
WP2853	Endoderm differentiation	10	0.141	281.5
WP466	DNA replication	10	0.141	474.5
WP3931	Embryonic stem cell pluripotency pathways	20	0.141	339.5
WP3596	miR-517 relationship with ARCN1 and USP1	30	0.141	276.75
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	2	0.14	162
WP5110	Familial hyperlipidemia type 3	3	0.14	456.5
WP558	Complement and coagulation cascades	4	0.14	322
WP4312	Rett syndrome causing genes	5	0.14	259
WP4211	Transcriptional cascade regulating adipogenesis	10	0.14	286
WP5120	Inclusion body myositis	20	0.14	332.25
WP5124	Alzheimer's disease	30	0.14	327.5
WP1403	AMP-activated protein kinase (AMPK) signaling	3	0.139	204.25
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	3	0.139	195.5
WP4496	Signal transduction through IL1R	3	0.139	279.5
WP364	IL-6 signaling pathway	4	0.139	274.25
WP4495	IL-10 anti-inflammatory signaling pathway	4	0.139	310.75
WP2884	NRF2 pathway	5	0.139	288
WP2643	Nanoparticle-mediated activation of receptor signaling	10	0.139	282.75
WP4946	DNA repair pathways, full network	10	0.139	454.75
WP3596	miR-517 relationship with ARCN1 and USP1	2	0.138	421
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	2	0.138	402.25
WP69	T-cell receptor (TCR) signaling pathway	2	0.138	210.5
WP4018	Clear cell renal cell carcinoma pathways	3	0.138	212
WP4205	MET in type 1 papillary renal cell carcinoma	4	0.138	208.5
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	10	0.138	324.75
WP5036	Angiotensin II receptor type 1 pathway	10	0.138	310.5
WP3407	FTO obesity variant mechanism	30	0.138	312.25
WP3890	Nanomaterial-induced inflammasome activation	30	0.138	299.5
WP5120	Inclusion body myositis	30	0.138	327.75
WP4136	Fibrin complement receptor 3 signaling pathway	3	0.137	358.75
WP5108	Familial  hyperlipidemia type 1	3	0.137	463.5
WP2018	RANKL/RANK signaling pathway	4	0.137	218.75
WP299	Nuclear receptors in lipid metabolism and toxicity	4	0.137	303.75
WP3601	Lipid particles composition	4	0.137	468
WP5108	Familial  hyperlipidemia type 1	4	0.137	477
WP2447	Amyotrophic lateral sclerosis (ALS)	5	0.137	270
WP4223	Ras signaling	5	0.137	227
WP5120	Inclusion body myositis	10	0.137	343.75
WP2363	Gastric cancer network 2	30	0.137	300.25
WP2880	Glucocorticoid receptor pathway	3	0.136	222.5
WP428	Wnt signaling	3	0.136	182.25
WP4462	Platelet-mediated interactions with vascular and circulating cells	3	0.136	447.5
WP5111	Familial hyperlipidemia type 4	4	0.136	432.25
WP2332	Interleukin-11 signaling pathway	5	0.136	238.75
WP262	Ebstein-Barr virus LMP1 signaling	5	0.136	340.25
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	30	0.136	437.25
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	2	0.135	181
WP4565	Neural crest cell migration in cancer	3	0.135	206.5
WP3959	DNA IR-double strand breaks and cellular response via ATM	4	0.135	307.75
WP4919	Neuroinflammation	4	0.135	296.5
WP3591	Sleep regulation	10	0.135	272
WP5090	Complement system in neuronal development and plasticity	30	0.135	323
WP4141	PI3K/AKT/mTOR - VitD3 signaling	2	0.134	393.5
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	2	0.134	207
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	3	0.134	304.5
WP3851	TLR4 signaling and tolerance	4	0.134	359.25
WP4008	NO/cGMP/PKG mediated neuroprotection	5	0.134	262.5
WP5033	Genes associated with the development of rheumatoid arthritis	5	0.134	461.25
WP4239	Epithelial to mesenchymal transition in colorectal cancer	10	0.134	298.5
WP4538	Regulatory circuits of the STAT3 signaling pathway	20	0.134	329
WP4830	GDNF/RET signaling axis	20	0.134	397.25
WP4949	16p11.2 proximal deletion syndrome	30	0.134	286.5
WP2064	Neural crest differentiation	2	0.133	177
WP3893	Development and heterogeneity of the ILC family	2	0.133	401.5
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	3	0.133	291
WP304	Kit receptor signaling pathway	3	0.133	208
WP2884	NRF2 pathway	4	0.133	273.75
WP5033	Genes associated with the development of rheumatoid arthritis	4	0.133	469.5
WP185	Integrin-mediated cell adhesion	10	0.133	280.5
WP2272	Pathogenic Escherichia coli infection	10	0.133	300.75
WP4874	CAMKK2 pathway	10	0.133	272.5
WP4290	Metabolic reprogramming in colon cancer	20	0.133	465
WP129	Matrix metalloproteinases	2	0.132	421
WP2881	Estrogen receptor pathway	3	0.132	405.25
WP5122	Prostaglandin and leukotriene metabolism in senescence	4	0.132	225.75
WP4331	Neovascularisation processes	5	0.132	247
WP3584	MECP2 and associated Rett syndrome	20	0.132	300.5
WP1981	Thyroxine (thyroid hormone) production	30	0.132	507
WP53	ID signaling pathway	30	0.132	350.25
WP1539	Angiogenesis	2	0.131	388
WP2034	Leptin signaling pathway	2	0.131	194
WP474	Endochondral ossification	2	0.131	188.5
WP4808	Endochondral ossification with skeletal dysplasias	2	0.131	188.5
WP299	Nuclear receptors in lipid metabolism and toxicity	3	0.131	330
WP3601	Lipid particles composition	3	0.131	458.5
WP395	IL-4 signaling pathway	3	0.131	218.25
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	3	0.131	442
WP5053	Development of ureteric collection system	3	0.131	224
WP4223	Ras signaling	4	0.131	224
WP4239	Epithelial to mesenchymal transition in colorectal cancer	5	0.131	265
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	5	0.131	334.5
WP2806	Complement system	20	0.131	359
WP3656	Interleukin-1 induced activation of NF-kB	30	0.131	304
WP4286	Genotoxicity pathway	30	0.131	425.5
WP4891	COVID-19 adverse outcome pathway	2	0.13	414
WP2507	Nanomaterial induced apoptosis	3	0.13	435.75
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	4	0.13	262.25
WP4331	Neovascularisation processes	4	0.13	241
WP4698	Vitamin D-sensitive calcium signaling in depression	4	0.13	215.5
WP1434	Osteopontin signaling	5	0.13	459.25
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	5	0.13	235.75
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	5	0.13	385.5
WP5108	Familial  hyperlipidemia type 1	5	0.13	487
WP3942	PPAR signaling pathway	10	0.13	396.25
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	20	0.13	518
WP4947	Nitric oxide metabolism in cystic fibrosis	20	0.13	327.75
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	30	0.13	536.75
WP4969	RAS and bradykinin pathways in COVID-19	2	0.129	410.5
WP3286	Copper homeostasis	3	0.129	223.5
WP408	Oxidative stress response	3	0.129	218.75
WP437	EGF/EGFR signaling pathway	3	0.129	181.5
WP43	Oxidation by cytochrome P450	4	0.129	418
WP3927	BMP signaling in eyelid development	20	0.129	313.5
WP1424	Globo sphingolipid metabolism	30	0.129	337.75
WP35	G protein signaling pathways	30	0.129	359
WP2870	Extracellular vesicle-mediated signaling in recipient cells	2	0.128	380
WP2874	Liver X receptor pathway	3	0.128	459.5
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	4	0.128	461.5
WP5112	Familial hyperlipidemia type 5	5	0.128	487
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	10	0.128	285
WP2875	Constitutive androstane receptor pathway	20	0.128	396.25
WP5102	Familial partial lipodystrophy (FPLD)	20	0.128	297.25
WP554	ACE inhibitor pathway	20	0.128	322.25
WP4844	Influence of laminopathies on Wnt signaling	2	0.127	274.75
WP3982	miRNA regulation of p53 pathway in prostate cancer	3	0.127	439.75
WP4482	Vitamin D in inflammatory diseases	3	0.127	245.5
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	4	0.127	233.75
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	5	0.127	258.5
WP2637	Interleukin-1 (IL-1) structural pathway	10	0.127	265
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	10	0.127	305.25
WP4538	Regulatory circuits of the STAT3 signaling pathway	10	0.127	320.5
WP727	Monoamine transport	10	0.127	319.5
WP1992	Genes targeted by miRNAs in adipocytes	20	0.127	312
WP4558	Overview of interferons-mediated signaling pathway	30	0.127	410.75
WP2447	Amyotrophic lateral sclerosis (ALS)	3	0.126	331.25
WP4540	Hippo signaling regulation pathways	3	0.126	204
WP5112	Familial hyperlipidemia type 5	4	0.126	477
WP4211	Transcriptional cascade regulating adipogenesis	5	0.126	310.25
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	5	0.126	245
WP3890	Nanomaterial-induced inflammasome activation	10	0.126	322.75
WP698	Glucuronidation	30	0.126	497.75
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	3	0.125	452
WP4961	STING pathway in Kawasaki-like disease and COVID-19	4	0.125	323.5
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	10	0.125	291.5
WP3596	miR-517 relationship with ARCN1 and USP1	20	0.125	272
WP4963	p53 transcriptional gene network	30	0.125	477.5
WP289	Myometrial relaxation and contraction pathways	2	0.124	177
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	2	0.124	391.5
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	2	0.124	185.75
WP3594	Circadian rhythm genes	3	0.124	214
WP3599	Transcription factor regulation in adipogenesis	3	0.124	264.25
WP5111	Familial hyperlipidemia type 4	3	0.124	449.75
WP481	Insulin signaling	10	0.124	268
WP3298	Melatonin metabolism and effects	20	0.124	380
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	20	0.124	283.5
WP53	ID signaling pathway	20	0.124	375.25
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	2	0.123	394.25
WP364	IL-6 signaling pathway	3	0.123	295.75
WP272	Blood clotting cascade	4	0.123	455.5
WP2874	Liver X receptor pathway	4	0.123	472.5
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	4	0.123	473
WP1528	Physiological and pathological hypertrophy of the heart	5	0.123	256
WP35	G protein signaling pathways	5	0.123	282.25
WP3959	DNA IR-double strand breaks and cellular response via ATM	5	0.123	310.75
WP4823	Genes controlling nephrogenesis	5	0.123	295.5
WP2583	T cell receptor and co-stimulatory signaling	10	0.123	296.5
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	10	0.123	286.5
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	10	0.123	297.5
WP35	G protein signaling pathways	20	0.123	341
WP5114	Nucleotide excision repair in xeroderma pigmentosum	20	0.123	501.25
WP2806	Complement system	30	0.123	360
WP2037	Prolactin signaling pathway	2	0.122	168.25
WP3286	Copper homeostasis	2	0.122	250.5
WP4478	LTF danger signal response pathway	2	0.122	422.25
WP313	Hepatocyte growth factor receptor signaling	3	0.122	196.5
WP382	MAPK signaling pathway	3	0.122	190
WP3995	Prion disease pathway	3	0.122	210.25
WP619	Type II interferon signaling (IFNG)	3	0.122	386
WP3297	EV release from cardiac cells and their functional effects	4	0.122	483.25
WP2583	T cell receptor and co-stimulatory signaling	5	0.122	292.5
WP3929	Chemokine signaling pathway	5	0.122	255
WP2059	Alzheimer's disease and miRNA effects	10	0.122	301
WP5124	Alzheimer's disease	10	0.122	305.5
WP581	EPO receptor signaling	10	0.122	333.5
WP3613	Photodynamic therapy-induced unfolded protein response	20	0.122	388.75
WP4022	Pyrimidine metabolism	20	0.122	544
WP4357	NRF2-ARE regulation	20	0.122	297.25
WP197	Cholesterol biosynthesis pathway	30	0.122	518.5
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	30	0.122	287.5
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	3	0.121	339.25
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	4	0.121	227.75
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	4	0.121	440.25
WP496	Steroid biosynthesis	10	0.121	553
WP229	Irinotecan pathway	20	0.121	447.25
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	30	0.121	324
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	2	0.12	245
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	2	0.12	427.25
WP4747	Netrin-UNC5B signaling pathway	2	0.12	203
WP2853	Endoderm differentiation	5	0.12	248
WP3972	PDGFR-beta pathway	5	0.12	260
WP5122	Prostaglandin and leukotriene metabolism in senescence	5	0.12	241
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	10	0.12	291
WP170	Nuclear receptors	2	0.119	265.75
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	3	0.119	273.25
WP5033	Genes associated with the development of rheumatoid arthritis	3	0.119	455.5
WP5112	Familial hyperlipidemia type 5	3	0.119	463.5
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	5	0.119	233.5
WP4629	Aerobic glycolysis	20	0.119	464
WP4746	Thyroid hormones production and peripheral downstream signaling effects	20	0.119	359
WP5072	Modulators of TCR signaling and T cell activation	20	0.119	346.25
WP691	Tamoxifen metabolism	30	0.119	487
WP437	EGF/EGFR signaling pathway	2	0.118	165.25
WP5053	Development of ureteric collection system	2	0.118	236
WP2848	Pluripotent stem cell differentiation pathway	3	0.118	251.5
WP2870	Extracellular vesicle-mediated signaling in recipient cells	3	0.118	245.5
WP5122	Prostaglandin and leukotriene metabolism in senescence	3	0.118	244
WP2637	Interleukin-1 (IL-1) structural pathway	20	0.118	305.25
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	20	0.118	374.75
WP534	Glycolysis and gluconeogenesis	20	0.118	422
WP1449	Regulation of toll-like receptor signaling pathway	2	0.117	229.5
WP2516	ATM signaling pathway	2	0.117	292
WP34	Ovarian infertility	2	0.117	361.5
WP4136	Fibrin complement receptor 3 signaling pathway	2	0.117	411.5
WP3596	miR-517 relationship with ARCN1 and USP1	3	0.117	437
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	3	0.117	449.75
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	5	0.117	485
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	5	0.117	321.25
WP2806	Complement system	10	0.117	353
WP4585	Cancer immunotherapy by PD-1 blockade	10	0.117	321.5
WP3656	Interleukin-1 induced activation of NF-kB	20	0.117	317.25
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	20	0.117	296.5
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	30	0.117	302
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	30	0.117	304
WP4329	miRNAs involvement in the immune response in sepsis	2	0.116	406
WP4008	NO/cGMP/PKG mediated neuroprotection	4	0.116	270.25
WP2272	Pathogenic Escherichia coli infection	5	0.116	277.25
WP3596	miR-517 relationship with ARCN1 and USP1	5	0.116	263.5
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	5	0.116	282
WP4961	STING pathway in Kawasaki-like disease and COVID-19	5	0.116	284.25
WP3947	Serotonin and anxiety	10	0.116	291
WP1531	Vitamin D metabolism	30	0.116	349.5
WP2875	Constitutive androstane receptor pathway	30	0.116	421
WP314	Fas ligand pathway and stress induction of heat shock proteins	2	0.115	257.25
WP4241	Type 2 papillary renal cell carcinoma	2	0.115	382.75
WP428	Wnt signaling	2	0.115	185.25
WP430	Statin inhibition of cholesterol production	2	0.115	418.5
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	2	0.115	344.5
WP5092	Interactions of natural killer cells in pancreatic cancer	2	0.115	396.75
WP4205	MET in type 1 papillary renal cell carcinoma	3	0.115	198
WP4312	Rett syndrome causing genes	4	0.115	252
WP3591	Sleep regulation	5	0.115	275.25
WP5114	Nucleotide excision repair in xeroderma pigmentosum	10	0.115	447.5
WP4545	Oxysterols derived from cholesterol	30	0.115	449.75
WP4830	GDNF/RET signaling axis	30	0.115	379.25
WP4018	Clear cell renal cell carcinoma pathways	2	0.114	212
WP2332	Interleukin-11 signaling pathway	3	0.114	231.75
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	3	0.114	454
WP2583	T cell receptor and co-stimulatory signaling	4	0.114	302.75
WP3596	miR-517 relationship with ARCN1 and USP1	4	0.114	306
WP3972	PDGFR-beta pathway	4	0.114	268.25
WP98	Prostaglandin synthesis and regulation	4	0.114	270.25
WP4191	Caloric restriction and aging	5	0.114	352.75
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	20	0.114	287.25
WP4906	3q29 copy number variation syndrome	20	0.114	305.5
WP5090	Complement system in neuronal development and plasticity	20	0.114	326
WP5114	Nucleotide excision repair in xeroderma pigmentosum	30	0.114	517
WP43	Oxidation by cytochrome P450	2	0.113	418
WP4008	NO/cGMP/PKG mediated neuroprotection	3	0.113	286.5
WP3299	let-7 inhibition of ES cell reprogramming	4	0.113	210.25
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	4	0.113	354
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	4	0.113	275
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	5	0.113	282.25
WP322	Osteoblast signaling	30	0.113	360.5
WP3931	Embryonic stem cell pluripotency pathways	30	0.113	353.5
WP4482	Vitamin D in inflammatory diseases	2	0.112	399
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	3	0.112	257.75
WP2526	PDGF pathway	5	0.112	257.75
WP516	Hypertrophy model	5	0.112	269
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	10	0.112	420.5
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	10	0.112	371.75
WP322	Osteoblast signaling	20	0.112	351.5
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	30	0.112	376.5
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	2	0.111	400.25
WP4396	Nonalcoholic fatty liver disease	2	0.111	207
WP231	TNF-alpha signaling pathway	3	0.111	248.75
WP4495	IL-10 anti-inflammatory signaling pathway	3	0.111	438.5
WP2289	Drug induction of bile acid pathway	4	0.111	456.5
WP3942	PPAR signaling pathway	5	0.111	346
WP2197	Endothelin pathways	10	0.111	303.75
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	10	0.111	281.25
WP2846	PCSK9-mediated LDL receptor degradation	20	0.111	376.75
WP3408	Evolocumab mechanism to reduce LDL cholesterol	20	0.111	376.75
WP698	Glucuronidation	20	0.111	488.75
WP516	Hypertrophy model	30	0.111	287.5
WP2447	Amyotrophic lateral sclerosis (ALS)	2	0.11	405.5
WP3594	Circadian rhythm genes	2	0.11	190
WP75	Toll-like receptor signaling pathway	2	0.11	264.75
WP1434	Osteopontin signaling	3	0.11	454
WP4655	Cytosolic DNA-sensing pathway	3	0.11	446
WP4239	Epithelial to mesenchymal transition in colorectal cancer	4	0.11	247.5
WP4204	Tumor suppressor activity of SMARCB1	5	0.11	270.25
WP3947	Serotonin and anxiety	20	0.11	310
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	20	0.11	440.25
WP531	DNA mismatch repair	20	0.11	501.75
WP3613	Photodynamic therapy-induced unfolded protein response	30	0.11	393
WP2880	Glucocorticoid receptor pathway	2	0.109	244
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	2	0.109	410.25
WP35	G protein signaling pathways	4	0.109	285
WP4479	Supression of HMGB1 mediated inflammation by THBD	10	0.109	352.75
WP51	Regulation of actin cytoskeleton	10	0.109	319.5
WP1531	Vitamin D metabolism	20	0.109	360.25
WP4838	Regucalcin in proximal tubule epithelial kidney cells	20	0.109	408
WP3413	NOTCH1 regulation of endothelial cell calcification	30	0.109	359.5
WP357	Fatty acid biosynthesis	30	0.109	497.25
WP4919	Neuroinflammation	3	0.108	440.75
WP558	Complement and coagulation cascades	3	0.108	365.75
WP4561	Cell migration and invasion through p75NTR	4	0.108	227.5
WP4823	Genes controlling nephrogenesis	4	0.108	279
WP5124	Alzheimer's disease	4	0.108	246
WP4558	Overview of interferons-mediated signaling pathway	10	0.108	387
WP702	Metapathway biotransformation Phase I and II	10	0.108	416
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	20	0.108	349.5
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	20	0.108	318
WP2509	Nanoparticle triggered autophagic cell death	30	0.108	393
WP477	Cytoplasmic ribosomal proteins	30	0.108	606
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	2	0.107	420.5
WP408	Oxidative stress response	2	0.107	378.75
WP2018	RANKL/RANK signaling pathway	3	0.107	208
WP2289	Drug induction of bile acid pathway	3	0.107	455.75
WP3929	Chemokine signaling pathway	3	0.107	222
WP4698	Vitamin D-sensitive calcium signaling in depression	3	0.107	219
WP1528	Physiological and pathological hypertrophy of the heart	4	0.107	268
WP35	G protein signaling pathways	10	0.107	318.5
WP697	Estrogen metabolism	10	0.107	449.25
WP382	MAPK signaling pathway	2	0.106	163
WP5122	Prostaglandin and leukotriene metabolism in senescence	2	0.106	401.25
WP4016	DNA IR-damage and cellular response via ATR	5	0.106	315
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	5	0.106	281.25
WP4561	Cell migration and invasion through p75NTR	5	0.106	231.25
WP5109	Familial hyperlipidemia type 2	5	0.106	470.5
WP4906	3q29 copy number variation syndrome	10	0.106	273.25
WP4947	Nitric oxide metabolism in cystic fibrosis	10	0.106	349.75
WP5066	FOXA2 pathway	20	0.106	408
WP12	Osteoclast signaling	30	0.106	337.5
WP3947	Serotonin and anxiety	30	0.106	330
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	30	0.106	392.5
WP4496	Signal transduction through IL1R	2	0.105	401.5
WP4149	White fat cell differentiation	3	0.105	239.5
WP4223	Ras signaling	3	0.105	213.5
WP516	Hypertrophy model	4	0.105	295.25
WP2118	Arrhythmogenic right ventricular cardiomyopathy	10	0.105	309.75
WP1471	Target of rapamycin (TOR) signaling	30	0.105	334.5
WP4746	Thyroid hormones production and peripheral downstream signaling effects	30	0.105	359.75
WP299	Nuclear receptors in lipid metabolism and toxicity	2	0.104	409
WP313	Hepatocyte growth factor receptor signaling	2	0.104	319.5
WP3892	Development of pulmonary dendritic cells and macrophage subsets	2	0.104	405.5
WP395	IL-4 signaling pathway	2	0.104	247.75
WP3982	miRNA regulation of p53 pathway in prostate cancer	2	0.104	421.75
WP558	Complement and coagulation cascades	2	0.104	414.25
WP619	Type II interferon signaling (IFNG)	2	0.104	410.5
WP516	Hypertrophy model	3	0.104	406.25
WP2526	PDGF pathway	4	0.104	257.25
WP98	Prostaglandin synthesis and regulation	5	0.104	285.25
WP2876	Pregnane X receptor pathway	10	0.104	402.5
WP3931	Embryonic stem cell pluripotency pathways	10	0.104	314
WP4629	Aerobic glycolysis	10	0.104	528.5
WP53	ID signaling pathway	10	0.104	382.5
WP3890	Nanomaterial-induced inflammasome activation	20	0.104	305
WP4545	Oxysterols derived from cholesterol	20	0.104	420.75
WP1992	Genes targeted by miRNAs in adipocytes	30	0.104	316
WP1403	AMP-activated protein kinase (AMPK) signaling	2	0.103	222.25
WP2332	Interleukin-11 signaling pathway	2	0.103	253.25
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	3	0.103	282
WP2059	Alzheimer's disease and miRNA effects	4	0.103	245
WP262	Ebstein-Barr virus LMP1 signaling	4	0.103	425.5
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	4	0.103	276.75
WP3890	Nanomaterial-induced inflammasome activation	5	0.103	490.25
WP4746	Thyroid hormones production and peripheral downstream signaling effects	5	0.103	297.5
WP2795	Cardiac hypertrophic response	10	0.103	284.5
WP554	ACE inhibitor pathway	10	0.103	336.5
WP2646	Lidocaine metabolism	20	0.103	425.75
WP400	p38 MAPK signaling pathway	30	0.103	318.75
WP304	Kit receptor signaling pathway	2	0.102	205.25
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	2	0.102	398.5
WP2637	Interleukin-1 (IL-1) structural pathway	4	0.102	245
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	4	0.102	332.75
WP4217	Ebola virus pathway in host	4	0.102	248.25
WP702	Metapathway biotransformation Phase I and II	5	0.102	340
WP5072	Modulators of TCR signaling and T cell activation	10	0.102	334
WP3915	Angiopoietin-like protein 8 regulatory pathway	20	0.102	379
WP3995	Prion disease pathway	2	0.101	292.5
WP4239	Epithelial to mesenchymal transition in colorectal cancer	2	0.101	221
WP2884	NRF2 pathway	3	0.101	257.75
WP4239	Epithelial to mesenchymal transition in colorectal cancer	3	0.101	232
WP481	Insulin signaling	4	0.101	230.75
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	5	0.101	397.5
WP2637	Interleukin-1 (IL-1) structural pathway	5	0.101	248
WP272	Blood clotting cascade	5	0.101	435.5
WP3298	Melatonin metabolism and effects	10	0.101	371.5
WP5103	Progeria-associated lipodystrophy	10	0.101	294
WP1424	Globo sphingolipid metabolism	20	0.101	362.75
WP1946	Cori cycle	20	0.101	413.75
WP691	Tamoxifen metabolism	20	0.101	489.5
WP4148	Splicing factor NOVA regulated synaptic proteins	30	0.101	397.75
WP2507	Nanomaterial induced apoptosis	2	0.1	415.5
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	3	0.1	427.5
WP2853	Endoderm differentiation	4	0.1	246.5
WP3929	Chemokine signaling pathway	4	0.1	236
WP3942	PPAR signaling pathway	4	0.1	350.25
WP4016	DNA IR-damage and cellular response via ATR	4	0.1	322.5
WP4204	Tumor suppressor activity of SMARCB1	4	0.1	292
WP2806	Complement system	5	0.1	304
WP4524	Alternative pathway of fetal androgen synthesis	5	0.1	470
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	10	0.1	273.5
WP1981	Thyroxine (thyroid hormone) production	20	0.1	520
WP4756	Renin-angiotensin-aldosterone system (RAAS)	20	0.1	389
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	30	0.1	344.5
WP384	Apoptosis modulation by HSP70	30	0.1	378.5
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	2	0.099	397.25
WP3591	Sleep regulation	4	0.099	288.75
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	4	0.099	231.5
WP4357	NRF2-ARE regulation	10	0.099	305.25
WP1591	Heart development	20	0.099	324.75
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	20	0.099	345
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	20	0.099	295
WP384	Apoptosis modulation by HSP70	20	0.099	373.75
WP3937	Microglia pathogen phagocytosis pathway	20	0.099	487.75
WP716	Vitamin A and carotenoid metabolism	20	0.099	404.5
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	2	0.098	429.5
WP5110	Familial hyperlipidemia type 3	2	0.098	430.25
WP3297	EV release from cardiac cells and their functional effects	3	0.098	467
WP3851	TLR4 signaling and tolerance	3	0.098	429.25
WP3959	DNA IR-double strand breaks and cellular response via ATM	3	0.098	342.25
WP2806	Complement system	4	0.098	288.75
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	4	0.098	405
WP4949	16p11.2 proximal deletion syndrome	4	0.098	252.25
WP4830	GDNF/RET signaling axis	10	0.098	417.75
WP5102	Familial partial lipodystrophy (FPLD)	10	0.098	310
WP2509	Nanoparticle triggered autophagic cell death	20	0.098	363
WP2029	Cell differentiation - index	30	0.098	353.5
WP3927	BMP signaling in eyelid development	30	0.098	313.5
WP696	Benzo(a)pyrene metabolism	30	0.098	390.5
WP4698	Vitamin D-sensitive calcium signaling in depression	2	0.097	300.25
WP1528	Physiological and pathological hypertrophy of the heart	3	0.097	277
WP195	IL-1 signaling pathway	4	0.097	285.5
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	4	0.097	290
WP4217	Ebola virus pathway in host	5	0.097	268.5
WP4538	Regulatory circuits of the STAT3 signaling pathway	5	0.097	283.5
WP5124	Alzheimer's disease	5	0.097	276
WP1424	Globo sphingolipid metabolism	10	0.097	396.25
WP2456	HIF1A and PPARG regulation of glycolysis	10	0.097	344
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	10	0.097	341.5
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	10	0.097	347.25
WP4950	16p11.2 distal deletion syndrome	30	0.097	360
WP4481	Resistin as a regulator of inflammation	2	0.096	398.5
WP185	Integrin-mediated cell adhesion	3	0.096	233.25
WP4299	Lamin A-processing pathway	3	0.096	482.25
WP4906	3q29 copy number variation syndrome	3	0.096	247.75
WP4299	Lamin A-processing pathway	4	0.096	505.5
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	5	0.096	281.75
WP2059	Alzheimer's disease and miRNA effects	5	0.096	275
WP2289	Drug induction of bile acid pathway	5	0.096	416.75
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	5	0.096	446.25
WP3927	BMP signaling in eyelid development	10	0.096	309.75
WP4197	Immune response to tuberculosis	10	0.096	475
WP4657	22q11.2 copy number variation syndrome	10	0.096	321
WP186	Homologous recombination	20	0.096	405.25
WP3878	ATM signaling in development and disease	20	0.096	390.25
WP1541	Energy metabolism	30	0.096	360
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	2	0.095	415.75
WP4462	Platelet-mediated interactions with vascular and circulating cells	2	0.095	424
WP4540	Hippo signaling regulation pathways	2	0.095	198.5
WP4564	Neural crest cell migration during development	2	0.095	262.25
WP2637	Interleukin-1 (IL-1) structural pathway	3	0.095	224
WP3591	Sleep regulation	3	0.095	349.5
WP3942	PPAR signaling pathway	3	0.095	334.75
WP4016	DNA IR-damage and cellular response via ATR	3	0.095	323.5
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	3	0.095	240.5
WP5109	Familial hyperlipidemia type 2	3	0.095	458.75
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	4	0.095	476
WP195	IL-1 signaling pathway	5	0.095	295.75
WP4585	Cancer immunotherapy by PD-1 blockade	5	0.095	314.75
WP4949	16p11.2 proximal deletion syndrome	5	0.095	253.25
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	5	0.095	484.75
WP51	Regulation of actin cytoskeleton	5	0.095	268.75
WP357	Fatty acid biosynthesis	20	0.095	493
WP229	Irinotecan pathway	30	0.095	443.25
WP2637	Interleukin-1 (IL-1) structural pathway	30	0.095	336.5
WP3877	MYD88 distinct input-output pathway	30	0.095	376
WP5066	FOXA2 pathway	30	0.095	413.75
WP4655	Cytosolic DNA-sensing pathway	2	0.094	421.75
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	2	0.094	421
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	4	0.094	452.25
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	4	0.094	295.75
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	5	0.094	492.75
WP697	Estrogen metabolism	5	0.094	499.5
WP1604	Codeine and morphine metabolism	10	0.094	431
WP2509	Nanoparticle triggered autophagic cell death	10	0.094	325.75
WP3413	NOTCH1 regulation of endothelial cell calcification	20	0.094	344.25
WP733	Serotonin receptor 2 and STAT3 signaling	20	0.094	423
WP3915	Angiopoietin-like protein 8 regulatory pathway	30	0.094	375
WP4789	MED and pseudoachondroplasia genes	30	0.094	647
WP2853	Endoderm differentiation	2	0.093	200.75
WP2881	Estrogen receptor pathway	2	0.093	417.25
WP5108	Familial  hyperlipidemia type 1	2	0.093	435
WP2059	Alzheimer's disease and miRNA effects	3	0.093	234
WP4331	Neovascularisation processes	3	0.093	248
WP4823	Genes controlling nephrogenesis	3	0.093	301.25
WP5124	Alzheimer's disease	3	0.093	235
WP3630	NAD metabolism, sirtuins and aging	4	0.093	449
WP3947	Serotonin and anxiety	4	0.093	443.5
WP3584	MECP2 and associated Rett syndrome	5	0.093	274.5
WP3931	Embryonic stem cell pluripotency pathways	5	0.093	276.5
WP3584	MECP2 and associated Rett syndrome	10	0.093	311.5
WP3613	Photodynamic therapy-induced unfolded protein response	10	0.093	369.75
WP4746	Thyroid hormones production and peripheral downstream signaling effects	10	0.093	347.75
WP716	Vitamin A and carotenoid metabolism	10	0.093	393.25
WP12	Osteoclast signaling	20	0.093	345.5
WP1584	Type II diabetes mellitus	20	0.093	374.25
WP197	Cholesterol biosynthesis pathway	20	0.093	526.5
WP400	p38 MAPK signaling pathway	20	0.093	315.75
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	30	0.093	466
WP3878	ATM signaling in development and disease	30	0.093	381
WP4022	Pyrimidine metabolism	30	0.093	571.5
WP231	TNF-alpha signaling pathway	2	0.092	260.25
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	2	0.092	428
WP2583	T cell receptor and co-stimulatory signaling	3	0.092	379
WP4312	Rett syndrome causing genes	3	0.092	264.75
WP2643	Nanoparticle-mediated activation of receptor signaling	4	0.092	287
WP4211	Transcriptional cascade regulating adipogenesis	4	0.092	413
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	4	0.092	417.5
WP4657	22q11.2 copy number variation syndrome	5	0.092	265
WP1601	Fluoropyrimidine activity	10	0.092	408.75
WP4022	Pyrimidine metabolism	10	0.092	510
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	10	0.092	490.25
WP1995	Effects of nitric oxide	20	0.092	344
WP4008	NO/cGMP/PKG mediated neuroprotection	2	0.091	361
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	2	0.091	414.75
WP5063	FOXP3 in COVID-19	2	0.091	422
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	3	0.091	413.25
WP4191	Caloric restriction and aging	4	0.091	448.5
WP3943	Robo4 and VEGF signaling pathways crosstalk	5	0.091	471.25
WP4290	Metabolic reprogramming in colon cancer	10	0.091	437
WP4286	Genotoxicity pathway	20	0.091	374.5
WP2023	Cell differentiation - expanded index	30	0.091	371
WP2038	Microtubule cytoskeleton regulation	30	0.091	324
WP4906	3q29 copy number variation syndrome	30	0.091	319
WP3959	DNA IR-double strand breaks and cellular response via ATM	2	0.09	401.5
WP4191	Caloric restriction and aging	3	0.09	451.75
WP400	p38 MAPK signaling pathway	10	0.09	284.5
WP2406	Cardiac progenitor differentiation	20	0.09	328.5
WP5064	7-oxo-C and 7-beta-HC pathways	20	0.09	448
WP1591	Heart development	30	0.09	322.75
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	30	0.09	372.75
WP23	B cell receptor signaling pathway	2	0.089	206
WP3601	Lipid particles composition	2	0.089	434
WP4149	White fat cell differentiation	2	0.089	293.75
WP4561	Cell migration and invasion through p75NTR	3	0.089	248.25
WP4538	Regulatory circuits of the STAT3 signaling pathway	4	0.089	290.75
WP4906	3q29 copy number variation syndrome	4	0.089	258
WP1544	MicroRNAs in cardiomyocyte hypertrophy	5	0.089	257
WP185	Integrin-mediated cell adhesion	5	0.089	262.75
WP3630	NAD metabolism, sirtuins and aging	5	0.089	411.75
WP3947	Serotonin and anxiety	5	0.089	345.25
WP691	Tamoxifen metabolism	5	0.089	504.5
WP1992	Genes targeted by miRNAs in adipocytes	10	0.089	319
WP3937	Microglia pathogen phagocytosis pathway	10	0.089	442
WP4147	PTF1A related regulatory pathway	20	0.089	347.75
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	3	0.088	459.75
WP1544	MicroRNAs in cardiomyocyte hypertrophy	4	0.088	242.5
WP4746	Thyroid hormones production and peripheral downstream signaling effects	4	0.088	294
WP2118	Arrhythmogenic right ventricular cardiomyopathy	5	0.088	278.75
WP2643	Nanoparticle-mediated activation of receptor signaling	5	0.088	277.25
WP2876	Pregnane X receptor pathway	5	0.088	378.75
WP4146	Macrophage markers	5	0.088	494.25
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	5	0.088	355.75
WP1981	Thyroxine (thyroid hormone) production	10	0.088	563.75
WP4963	p53 transcriptional gene network	20	0.088	429
WP186	Homologous recombination	30	0.088	380.75
WP4342	Vitamins A and D - action mechanisms	2	0.087	441.5
WP2853	Endoderm differentiation	3	0.087	216.75
WP3972	PDGFR-beta pathway	3	0.087	299.25
WP4211	Transcriptional cascade regulating adipogenesis	3	0.087	447.75
WP98	Prostaglandin synthesis and regulation	3	0.087	293.5
WP185	Integrin-mediated cell adhesion	4	0.087	259
WP3890	Nanomaterial-induced inflammasome activation	4	0.087	476
WP4585	Cancer immunotherapy by PD-1 blockade	4	0.087	362.25
WP4657	22q11.2 copy number variation syndrome	4	0.087	248.75
WP51	Regulation of actin cytoskeleton	4	0.087	255.5
WP4299	Lamin A-processing pathway	5	0.087	520
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	5	0.087	324.5
WP481	Insulin signaling	5	0.087	249
WP4906	3q29 copy number variation syndrome	5	0.087	262.75
WP4313	Ferroptosis	10	0.087	321.25
WP4752	Base excision repair	10	0.087	425
WP4657	22q11.2 copy number variation syndrome	20	0.087	360
WP4947	Nitric oxide metabolism in cystic fibrosis	30	0.087	331
WP2018	RANKL/RANK signaling pathway	2	0.086	236.5
WP3972	PDGFR-beta pathway	2	0.086	407
WP4312	Rett syndrome causing genes	2	0.086	391.5
WP4561	Cell migration and invasion through p75NTR	2	0.086	400
WP4657	22q11.2 copy number variation syndrome	3	0.086	239
WP51	Regulation of actin cytoskeleton	3	0.086	243.25
WP1424	Globo sphingolipid metabolism	4	0.086	493.75
WP3915	Angiopoietin-like protein 8 regulatory pathway	4	0.086	282.75
WP4352	Ciliary landscape	10	0.086	428.25
WP3670	Interactions between LOXL4 and oxidative stress pathway	20	0.086	344.5
WP716	Vitamin A and carotenoid metabolism	30	0.086	413.5
WP2583	T cell receptor and co-stimulatory signaling	2	0.085	410.5
WP262	Ebstein-Barr virus LMP1 signaling	2	0.085	422.25
WP3851	TLR4 signaling and tolerance	2	0.085	417
WP3929	Chemokine signaling pathway	2	0.085	194
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	2	0.085	426
WP4493	Cells and molecules involved in local acute inflammatory response	2	0.085	422
WP5109	Familial hyperlipidemia type 2	2	0.085	433.75
WP5111	Familial hyperlipidemia type 4	2	0.085	426
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	3	0.085	286
WP2272	Pathogenic Escherichia coli infection	3	0.085	297.75
WP4963	p53 transcriptional gene network	4	0.085	287.5
WP5109	Familial hyperlipidemia type 2	4	0.085	470.25
WP697	Estrogen metabolism	4	0.085	489.5
WP702	Metapathway biotransformation Phase I and II	4	0.085	336.25
WP1604	Codeine and morphine metabolism	5	0.085	486
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	10	0.085	304
WP2826	Cocaine metabolism	20	0.085	604.5
WP4565	Neural crest cell migration in cancer	2	0.084	267
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	4	0.084	273.25
WP1424	Globo sphingolipid metabolism	5	0.084	507.5
WP3413	NOTCH1 regulation of endothelial cell calcification	5	0.084	325.25
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	5	0.084	282.25
WP5102	Familial partial lipodystrophy (FPLD)	5	0.084	297.25
WP531	DNA mismatch repair	10	0.084	500.25
WP2038	Microtubule cytoskeleton regulation	20	0.084	330.25
WP2276	Glial cell differentiation	30	0.084	635.5
WP2406	Cardiac progenitor differentiation	30	0.084	334.5
WP5064	7-oxo-C and 7-beta-HC pathways	30	0.084	458
WP3599	Transcription factor regulation in adipogenesis	2	0.083	403
WP364	IL-6 signaling pathway	2	0.083	396
WP4223	Ras signaling	2	0.083	190
WP272	Blood clotting cascade	3	0.083	452
WP3915	Angiopoietin-like protein 8 regulatory pathway	3	0.083	250
WP4830	GDNF/RET signaling axis	4	0.083	484
WP727	Monoamine transport	4	0.083	339
WP3915	Angiopoietin-like protein 8 regulatory pathway	10	0.083	358.25
WP3945	TYROBP causal network in microglia	10	0.083	394
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	20	0.083	360.75
WP4873	Peroxiredoxin 2 induced ovarian failure	20	0.083	398
WP696	Benzo(a)pyrene metabolism	20	0.083	399.5
WP3967	miR-509-3p alteration of YAP1/ECM axis	30	0.083	349.25
WP2848	Pluripotent stem cell differentiation pathway	2	0.082	362.75
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	2	0.082	440.5
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	4	0.082	447.25
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	5	0.082	286.5
WP466	DNA replication	5	0.082	474.5
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	5	0.082	277.75
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	10	0.082	446.75
WP3413	NOTCH1 regulation of endothelial cell calcification	10	0.082	337.25
WP534	Glycolysis and gluconeogenesis	10	0.082	414
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	20	0.082	469.25
WP1528	Physiological and pathological hypertrophy of the heart	2	0.081	409
WP4204	Tumor suppressor activity of SMARCB1	2	0.081	403.25
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	2	0.081	401.75
WP5112	Familial hyperlipidemia type 5	2	0.081	435
WP4961	STING pathway in Kawasaki-like disease and COVID-19	3	0.081	442.5
WP3931	Embryonic stem cell pluripotency pathways	4	0.081	269
WP554	ACE inhibitor pathway	4	0.081	468.75
WP4342	Vitamins A and D - action mechanisms	5	0.081	496.75
WP581	EPO receptor signaling	5	0.081	343.5
WP384	Apoptosis modulation by HSP70	10	0.081	368
WP5066	FOXA2 pathway	10	0.081	401.75
WP3877	MYD88 distinct input-output pathway	20	0.081	359.25
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	20	0.081	331
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	20	0.081	414
WP4752	Base excision repair	20	0.081	455.5
WP4753	Nucleotide excision repair	20	0.081	515.75
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	30	0.081	364
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	30	0.081	441.75
WP1434	Osteopontin signaling	2	0.08	428
WP4205	MET in type 1 papillary renal cell carcinoma	2	0.08	228
WP4919	Neuroinflammation	2	0.08	425.25
WP195	IL-1 signaling pathway	3	0.08	287
WP3584	MECP2 and associated Rett syndrome	3	0.08	243.5
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	3	0.08	453.5
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	4	0.08	262
WP4342	Vitamins A and D - action mechanisms	4	0.08	487.5
WP5036	Angiotensin II receptor type 1 pathway	4	0.08	305
WP2197	Endothelin pathways	5	0.08	299.75
WP4148	Splicing factor NOVA regulated synaptic proteins	5	0.08	336.75
WP186	Homologous recombination	10	0.08	483
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	10	0.08	316
WP3407	FTO obesity variant mechanism	10	0.08	328.5
WP357	Fatty acid biosynthesis	10	0.08	507.5
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	10	0.08	282.5
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	30	0.08	358
WP3299	let-7 inhibition of ES cell reprogramming	2	0.079	407.5
WP5124	Alzheimer's disease	2	0.079	206.5
WP516	Hypertrophy model	2	0.079	413.25
WP322	Osteoblast signaling	3	0.079	455
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	3	0.079	411.25
WP4342	Vitamins A and D - action mechanisms	3	0.079	472
WP481	Insulin signaling	3	0.079	209.5
WP697	Estrogen metabolism	3	0.079	468.5
WP4524	Alternative pathway of fetal androgen synthesis	4	0.079	477.5
WP5049	Glycolysis in senescence	4	0.079	449
WP4197	Immune response to tuberculosis	5	0.079	489.75
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	5	0.079	267.25
WP1591	Heart development	10	0.079	308
WP1995	Effects of nitric oxide	10	0.079	364.5
WP3656	Interleukin-1 induced activation of NF-kB	10	0.079	318.75
WP4148	Splicing factor NOVA regulated synaptic proteins	10	0.079	388.5
WP3945	TYROBP causal network in microglia	30	0.079	418
WP4016	DNA IR-damage and cellular response via ATR	2	0.078	398.75
WP4331	Neovascularisation processes	2	0.078	305.5
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	2	0.078	435.5
WP3299	let-7 inhibition of ES cell reprogramming	3	0.078	281.25
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	3	0.078	299.5
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	3	0.078	463.5
WP702	Metapathway biotransformation Phase I and II	3	0.078	334.5
WP2272	Pathogenic Escherichia coli infection	4	0.078	279.5
WP1992	Genes targeted by miRNAs in adipocytes	5	0.078	379.75
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	5	0.078	272
WP5049	Glycolysis in senescence	5	0.078	408.75
WP229	Irinotecan pathway	10	0.078	455
WP322	Osteoblast signaling	10	0.078	375.25
WP3878	ATM signaling in development and disease	10	0.078	370.25
WP4756	Renin-angiotensin-aldosterone system (RAAS)	10	0.078	381.5
WP4148	Splicing factor NOVA regulated synaptic proteins	20	0.078	396.25
WP4949	16p11.2 proximal deletion syndrome	2	0.077	293.5
WP262	Ebstein-Barr virus LMP1 signaling	3	0.077	448.75
WP581	EPO receptor signaling	4	0.077	412
WP4357	NRF2-ARE regulation	5	0.077	291
WP5036	Angiotensin II receptor type 1 pathway	5	0.077	317
WP2875	Constitutive androstane receptor pathway	10	0.077	373.5
WP3853	ERK pathway in Huntington's disease	10	0.077	408.25
WP4753	Nucleotide excision repair	10	0.077	476
WP691	Tamoxifen metabolism	10	0.077	500.75
WP1471	Target of rapamycin (TOR) signaling	20	0.077	359
WP1541	Energy metabolism	20	0.077	368.75
WP2112	IL-17 signaling pathway	20	0.077	377.25
WP2542	Sulindac metabolic pathway	20	0.077	619.5
WP1584	Type II diabetes mellitus	30	0.077	368.25
WP1995	Effects of nitric oxide	30	0.077	348
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	2	0.076	385
WP2289	Drug induction of bile acid pathway	2	0.076	429.5
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	2	0.076	413.75
WP35	G protein signaling pathways	3	0.076	265.75
WP4217	Ebola virus pathway in host	3	0.076	238
WP4949	16p11.2 proximal deletion syndrome	3	0.076	253.5
WP1604	Codeine and morphine metabolism	4	0.076	475
WP3935	Leptin-insulin signaling overlap	4	0.076	445.5
WP3943	Robo4 and VEGF signaling pathways crosstalk	4	0.076	466.75
WP384	Apoptosis modulation by HSP70	5	0.076	457.5
WP554	ACE inhibitor pathway	5	0.076	483
WP4286	Genotoxicity pathway	10	0.076	314.75
WP465	Tryptophan metabolism	10	0.076	432.25
WP4932	7q11.23 copy number variation syndrome	10	0.076	359
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	20	0.076	367
WP3	Transcriptional activation by NRF2 in response to phytochemicals	30	0.076	352.25
WP4562	Canonical NF-kB pathway	30	0.076	378.5
WP4873	Peroxiredoxin 2 induced ovarian failure	30	0.076	396.5
WP35	G protein signaling pathways	2	0.075	374.75
WP2879	Farnesoid X receptor pathway	3	0.075	462
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	3	0.075	333.5
WP3927	BMP signaling in eyelid development	3	0.075	442.5
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	3	0.075	446
WP5066	FOXA2 pathway	3	0.075	454.25
WP4146	Macrophage markers	4	0.075	482
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	4	0.075	254.5
WP4874	CAMKK2 pathway	4	0.075	261.25
WP5066	FOXA2 pathway	4	0.075	465.75
WP536	Calcium regulation in cardiac cells	5	0.075	300.75
WP2826	Cocaine metabolism	10	0.075	575.75
WP536	Calcium regulation in cardiac cells	10	0.075	388.5
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	20	0.075	412.5
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	30	0.075	400.5
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	30	0.075	379.5
WP2059	Alzheimer's disease and miRNA effects	2	0.074	207
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	2	0.074	435.75
WP5033	Genes associated with the development of rheumatoid arthritis	2	0.074	430.75
WP1544	MicroRNAs in cardiomyocyte hypertrophy	3	0.074	235
WP3890	Nanomaterial-induced inflammasome activation	3	0.074	465.5
WP4204	Tumor suppressor activity of SMARCB1	3	0.074	295.75
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	4	0.074	280
WP466	DNA replication	4	0.074	472.5
WP3407	FTO obesity variant mechanism	5	0.074	464.75
WP3944	Serotonin and anxiety-related events	5	0.074	393
WP197	Cholesterol biosynthesis pathway	10	0.074	560.75
WP4545	Oxysterols derived from cholesterol	10	0.074	398.5
WP58	Monoamine GPCRs	20	0.074	621
WP4657	22q11.2 copy number variation syndrome	30	0.074	375.5
WP272	Blood clotting cascade	2	0.073	429.5
WP3938	miR-222 in exercise-induced cardiac growth	2	0.073	446.5
WP2526	PDGF pathway	3	0.073	254.5
WP3927	BMP signaling in eyelid development	4	0.073	389.5
WP400	p38 MAPK signaling pathway	4	0.073	263.5
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	10	0.073	556.5
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	20	0.073	461
WP4722	Glycerolipids and glycerophospholipids	30	0.073	400.25
WP4823	Genes controlling nephrogenesis	2	0.072	389.5
WP5036	Angiotensin II receptor type 1 pathway	2	0.072	415
WP51	Regulation of actin cytoskeleton	2	0.072	222.5
WP4585	Cancer immunotherapy by PD-1 blockade	3	0.072	423
WP2118	Arrhythmogenic right ventricular cardiomyopathy	4	0.072	273.25
WP3927	BMP signaling in eyelid development	5	0.072	313.75
WP4313	Ferroptosis	5	0.072	307.25
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	5	0.072	325.5
WP5072	Modulators of TCR signaling and T cell activation	5	0.072	299.5
WP2276	Glial cell differentiation	20	0.072	624
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	20	0.072	357.5
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	30	0.072	325.5
WP2874	Liver X receptor pathway	2	0.071	434.5
WP2884	NRF2 pathway	2	0.071	277.5
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	2	0.071	374.75
WP4906	3q29 copy number variation syndrome	2	0.071	381.5
WP2846	PCSK9-mediated LDL receptor degradation	3	0.071	481.25
WP3408	Evolocumab mechanism to reduce LDL cholesterol	3	0.071	481.25
WP5036	Angiotensin II receptor type 1 pathway	3	0.071	386.25
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	4	0.071	471.5
WP2509	Nanoparticle triggered autophagic cell death	4	0.071	375
WP2876	Pregnane X receptor pathway	4	0.071	417.75
WP4197	Immune response to tuberculosis	4	0.071	480
WP5102	Familial partial lipodystrophy (FPLD)	4	0.071	327
WP691	Tamoxifen metabolism	4	0.071	492
WP3915	Angiopoietin-like protein 8 regulatory pathway	5	0.071	301.25
WP4830	GDNF/RET signaling axis	5	0.071	498
WP3	Transcriptional activation by NRF2 in response to phytochemicals	10	0.071	358.25
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	10	0.071	302
WP4838	Regucalcin in proximal tubule epithelial kidney cells	10	0.071	395.5
WP2023	Cell differentiation - expanded index	20	0.071	386.5
WP2112	IL-17 signaling pathway	30	0.071	385.75
WP4753	Nucleotide excision repair	30	0.071	535.5
WP4746	Thyroid hormones production and peripheral downstream signaling effects	2	0.07	377
WP3630	NAD metabolism, sirtuins and aging	3	0.07	453
WP3947	Serotonin and anxiety	3	0.07	441.5
WP4746	Thyroid hormones production and peripheral downstream signaling effects	3	0.07	283
WP3584	MECP2 and associated Rett syndrome	4	0.07	270
WP4313	Ferroptosis	4	0.07	309.5
WP4947	Nitric oxide metabolism in cystic fibrosis	4	0.07	490.5
WP2875	Constitutive androstane receptor pathway	5	0.07	338.75
WP4629	Aerobic glycolysis	5	0.07	512
WP4946	DNA repair pathways, full network	5	0.07	391.5
WP4947	Nitric oxide metabolism in cystic fibrosis	5	0.07	503.25
WP2879	Farnesoid X receptor pathway	10	0.07	403.5
WP2029	Cell differentiation - index	20	0.07	369.75
WP3967	miR-509-3p alteration of YAP1/ECM axis	20	0.07	358.25
WP4752	Base excision repair	30	0.07	466
WP4756	Renin-angiotensin-aldosterone system (RAAS)	30	0.07	405.5
WP4191	Caloric restriction and aging	2	0.069	429.5
WP4495	IL-10 anti-inflammatory signaling pathway	2	0.069	419.5
WP702	Metapathway biotransformation Phase I and II	2	0.069	391.5
WP2806	Complement system	3	0.069	293
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	3	0.069	469.5
WP4545	Oxysterols derived from cholesterol	3	0.069	438.5
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	4	0.069	469.5
WP4760	PKC-gamma calcium signaling pathway in ataxia	4	0.069	474.5
WP5103	Progeria-associated lipodystrophy	5	0.069	280
WP696	Benzo(a)pyrene metabolism	5	0.069	509.25
WP1531	Vitamin D metabolism	10	0.069	391.5
WP2596	Gastric acid production	20	0.069	613
WP2855	Dopaminergic neurogenesis	20	0.069	372
WP477	Cytoplasmic ribosomal proteins	20	0.069	590
WP2637	Interleukin-1 (IL-1) structural pathway	2	0.068	257.25
WP3297	EV release from cardiac cells and their functional effects	2	0.068	436.5
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	2	0.068	410.5
WP3942	PPAR signaling pathway	2	0.068	406
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	2	0.068	385.25
WP2118	Arrhythmogenic right ventricular cardiomyopathy	3	0.068	257.75
WP2643	Nanoparticle-mediated activation of receptor signaling	3	0.068	287.25
WP691	Tamoxifen metabolism	3	0.068	472
WP2456	HIF1A and PPARG regulation of glycolysis	4	0.068	483.5
WP5120	Inclusion body myositis	4	0.068	477
WP1591	Heart development	5	0.068	276
WP400	p38 MAPK signaling pathway	5	0.068	274.25
WP4963	p53 transcriptional gene network	5	0.068	298.25
WP5066	FOXA2 pathway	5	0.068	450.75
WP727	Monoamine transport	5	0.068	313.75
WP410	Exercise-induced circadian regulation	10	0.068	443
WP5090	Complement system in neuronal development and plasticity	10	0.068	325
WP4313	Ferroptosis	20	0.068	347.75
WP4321	Thermogenesis	20	0.068	400
WP400	p38 MAPK signaling pathway	2	0.067	391.5
WP3943	Robo4 and VEGF signaling pathways crosstalk	3	0.067	458.25
WP5103	Progeria-associated lipodystrophy	3	0.067	418.5
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	4	0.067	318.75
WP534	Glycolysis and gluconeogenesis	4	0.067	451
WP229	Irinotecan pathway	5	0.067	499.75
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	5	0.067	475.25
WP4286	Genotoxicity pathway	5	0.067	287
WP698	Glucuronidation	5	0.067	511.5
WP3877	MYD88 distinct input-output pathway	10	0.067	342.5
WP733	Serotonin receptor 2 and STAT3 signaling	10	0.067	570.75
WP4723	Omega-3 / omega-6 fatty acid synthesis	20	0.067	483.5
WP536	Calcium regulation in cardiac cells	20	0.067	445
WP2855	Dopaminergic neurogenesis	30	0.067	379.75
WP3965	Lipid metabolism pathway	30	0.067	381.25
WP195	IL-1 signaling pathway	2	0.066	393.5
WP2272	Pathogenic Escherichia coli infection	2	0.066	398.25
WP4545	Oxysterols derived from cholesterol	2	0.066	421
WP4657	22q11.2 copy number variation syndrome	2	0.066	223.25
WP400	p38 MAPK signaling pathway	3	0.066	283.75
WP4286	Genotoxicity pathway	3	0.066	257.75
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	4	0.066	480
WP4545	Oxysterols derived from cholesterol	5	0.066	388.75
WP4752	Base excision repair	5	0.066	479
WP4874	CAMKK2 pathway	5	0.066	267.5
WP1946	Cori cycle	10	0.066	400
WP2406	Cardiac progenitor differentiation	10	0.066	326.5
WP167	Eicosanoid synthesis	20	0.066	374
WP4853	Linoleic acid metabolism affected by coronavirus infection	20	0.066	625.5
WP2525	Trans-sulfuration and one-carbon metabolism	30	0.066	414.5
WP3670	Interactions between LOXL4 and oxidative stress pathway	30	0.066	357
WP3943	Robo4 and VEGF signaling pathways crosstalk	2	0.065	433.5
WP1992	Genes targeted by miRNAs in adipocytes	4	0.065	464.5
WP3407	FTO obesity variant mechanism	4	0.065	473
WP4545	Oxysterols derived from cholesterol	4	0.065	436.75
WP4479	Supression of HMGB1 mediated inflammation by THBD	5	0.065	494
WP4760	PKC-gamma calcium signaling pathway in ataxia	5	0.065	481.25
WP716	Vitamin A and carotenoid metabolism	5	0.065	363.5
WP167	Eicosanoid synthesis	10	0.065	347
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	10	0.065	294.75
WP1601	Fluoropyrimidine activity	20	0.065	441
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	20	0.065	367
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	20	0.065	509
WP465	Tryptophan metabolism	20	0.065	448
WP4950	16p11.2 distal deletion syndrome	20	0.065	365.5
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	2	0.064	412.5
WP4299	Lamin A-processing pathway	2	0.064	449.5
WP5103	Progeria-associated lipodystrophy	2	0.064	416
WP3935	Leptin-insulin signaling overlap	3	0.064	444.75
WP4538	Regulatory circuits of the STAT3 signaling pathway	3	0.064	269.5
WP5102	Familial partial lipodystrophy (FPLD)	3	0.064	350.5
WP1995	Effects of nitric oxide	4	0.064	485.25
WP229	Irinotecan pathway	4	0.064	489
WP322	Osteoblast signaling	4	0.064	468.25
WP4286	Genotoxicity pathway	4	0.064	261
WP4946	DNA repair pathways, full network	4	0.064	410.25
WP4321	Thermogenesis	5	0.064	294.25
WP4352	Ciliary landscape	5	0.064	340
WP5120	Inclusion body myositis	5	0.064	487
WP2038	Microtubule cytoskeleton regulation	10	0.064	325.75
WP2112	IL-17 signaling pathway	10	0.064	365.5
WP4220	Neurotransmitter disorders	10	0.064	575
WP4789	MED and pseudoachondroplasia genes	20	0.064	630
WP4932	7q11.23 copy number variation syndrome	20	0.064	395
WP3527	Pre-implantation embryo	30	0.064	358.25
WP5102	Familial partial lipodystrophy (FPLD)	2	0.063	410
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	3	0.063	453
WP4313	Ferroptosis	3	0.063	344.75
WP4963	p53 transcriptional gene network	3	0.063	282.5
WP4357	NRF2-ARE regulation	4	0.063	284.75
WP465	Tryptophan metabolism	4	0.063	467
WP4814	Somatic sex determination	4	0.063	489
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	4	0.063	484.25
WP5090	Complement system in neuronal development and plasticity	4	0.063	271.25
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	5	0.063	470.25
WP2509	Nanoparticle triggered autophagic cell death	5	0.063	354.25
WP2536	Colchicine metabolic pathway	5	0.063	524.5
WP2816	Felbamate metabolism	5	0.063	524.5
WP3	Transcriptional activation by NRF2 in response to phytochemicals	5	0.063	362.5
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	5	0.063	278
WP3670	Interactions between LOXL4 and oxidative stress pathway	10	0.063	346.75
WP4963	p53 transcriptional gene network	10	0.063	358.5
WP4174	Metabolism of tetrahydrocannabinol (THC)	20	0.063	604.5
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	30	0.063	351
WP4313	Ferroptosis	30	0.063	355
WP4723	Omega-3 / omega-6 fatty acid synthesis	30	0.063	480.25
WP1544	MicroRNAs in cardiomyocyte hypertrophy	2	0.062	233.5
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	2	0.062	211
WP3584	MECP2 and associated Rett syndrome	2	0.062	302.5
WP3931	Embryonic stem cell pluripotency pathways	3	0.062	244
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	3	0.062	446
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	3	0.062	266.25
WP581	EPO receptor signaling	3	0.062	429.5
WP4629	Aerobic glycolysis	4	0.062	497
WP186	Homologous recombination	5	0.062	507.75
WP3935	Leptin-insulin signaling overlap	5	0.062	339.5
WP4814	Somatic sex determination	5	0.062	502.5
WP496	Steroid biosynthesis	5	0.062	515.5
WP5114	Nucleotide excision repair in xeroderma pigmentosum	5	0.062	434.75
WP661	Glucose homeostasis	5	0.062	528.5
WP3527	Pre-implantation embryo	10	0.062	335
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	10	0.062	355.25
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	10	0.062	435
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	10	0.062	367.25
WP3	Transcriptional activation by NRF2 in response to phytochemicals	20	0.062	353.25
WP4562	Canonical NF-kB pathway	20	0.062	372.75
WP678	Arachidonate epoxygenase / epoxide hydrolase	20	0.062	560.25
WP4211	Transcriptional cascade regulating adipogenesis	2	0.061	426.25
WP4585	Cancer immunotherapy by PD-1 blockade	2	0.061	415
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	2	0.061	426
WP481	Insulin signaling	2	0.061	198.5
WP98	Prostaglandin synthesis and regulation	2	0.061	385.25
WP1424	Globo sphingolipid metabolism	3	0.061	474.75
WP1995	Effects of nitric oxide	3	0.061	467
WP2536	Colchicine metabolic pathway	3	0.061	484.5
WP2816	Felbamate metabolism	3	0.061	484.5
WP3944	Serotonin and anxiety-related events	3	0.061	448.5
WP536	Calcium regulation in cardiac cells	3	0.061	267.75
WP727	Monoamine transport	3	0.061	436.5
WP1591	Heart development	4	0.061	272.75
WP3413	NOTCH1 regulation of endothelial cell calcification	4	0.061	386.25
WP3613	Photodynamic therapy-induced unfolded protein response	4	0.061	412.5
WP4148	Splicing factor NOVA regulated synaptic proteins	4	0.061	375.5
WP4932	7q11.23 copy number variation syndrome	4	0.061	288.5
WP3613	Photodynamic therapy-induced unfolded protein response	5	0.061	364.75
WP4558	Overview of interferons-mediated signaling pathway	5	0.061	440.5
WP4875	Disruption of postsynaptic signaling by CNV	5	0.061	408.5
WP1471	Target of rapamycin (TOR) signaling	10	0.061	346.5
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	10	0.061	350
WP2879	Farnesoid X receptor pathway	20	0.061	413
WP3915	Angiopoietin-like protein 8 regulatory pathway	2	0.06	231.75
WP4217	Ebola virus pathway in host	2	0.06	224
WP4313	Ferroptosis	2	0.06	404
WP4947	Nitric oxide metabolism in cystic fibrosis	2	0.06	438.75
WP5050	TCA cycle in senescence	2	0.06	440
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	3	0.06	233.5
WP3613	Photodynamic therapy-induced unfolded protein response	3	0.06	442.25
WP3967	miR-509-3p alteration of YAP1/ECM axis	3	0.06	451.75
WP4524	Alternative pathway of fetal androgen synthesis	3	0.06	465.5
WP2879	Farnesoid X receptor pathway	4	0.06	481.25
WP4558	Overview of interferons-mediated signaling pathway	4	0.06	460.75
WP4586	Metabolism of alpha-linolenic acid	4	0.06	473
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	4	0.06	336.5
WP53	ID signaling pathway	4	0.06	466.75
WP536	Calcium regulation in cardiac cells	4	0.06	291.5
WP696	Benzo(a)pyrene metabolism	4	0.06	499.5
WP2456	HIF1A and PPARG regulation of glycolysis	5	0.06	497.5
WP2879	Farnesoid X receptor pathway	5	0.06	477.5
WP4586	Metabolism of alpha-linolenic acid	10	0.06	359
WP4724	Omega-9 fatty acid synthesis	10	0.06	506.25
WP4549	Fragile X syndrome	20	0.06	419.5
WP4586	Metabolism of alpha-linolenic acid	20	0.06	388
WP4787	Osteoblast differentiation and related diseases	20	0.06	420.25
WP167	Eicosanoid synthesis	30	0.06	400.75
WP185	Integrin-mediated cell adhesion	2	0.059	240.25
WP2526	PDGF pathway	2	0.059	383
WP4286	Genotoxicity pathway	2	0.059	337.5
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	2	0.059	285.5
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	3	0.059	262
WP4321	Thermogenesis	3	0.059	257
WP4830	GDNF/RET signaling axis	3	0.059	469.25
WP4947	Nitric oxide metabolism in cystic fibrosis	3	0.059	471.75
WP534	Glycolysis and gluconeogenesis	3	0.059	448.75
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	4	0.059	461.25
WP2875	Constitutive androstane receptor pathway	4	0.059	369.5
WP384	Apoptosis modulation by HSP70	4	0.059	465.25
WP1995	Effects of nitric oxide	5	0.059	497.75
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	5	0.059	332.5
WP465	Tryptophan metabolism	5	0.059	467.5
WP47	Hedgehog signaling pathway Netpath	5	0.059	505
WP5090	Complement system in neuronal development and plasticity	5	0.059	282
WP404	Nucleotide metabolism	10	0.059	563
WP4259	Disorders of folate metabolism and transport	10	0.059	558.5
WP4950	16p11.2 distal deletion syndrome	10	0.059	374
WP3527	Pre-implantation embryo	20	0.059	360
WP410	Exercise-induced circadian regulation	20	0.059	488.5
WP4787	Osteoblast differentiation and related diseases	30	0.059	427
WP4932	7q11.23 copy number variation syndrome	30	0.059	419.5
WP3890	Nanomaterial-induced inflammasome activation	2	0.058	437
WP3413	NOTCH1 regulation of endothelial cell calcification	3	0.058	437.75
WP186	Homologous recombination	4	0.058	493.5
WP496	Steroid biosynthesis	4	0.058	501.5
WP3656	Interleukin-1 induced activation of NF-kB	5	0.058	472.25
WP4586	Metabolism of alpha-linolenic acid	5	0.058	477.5
WP53	ID signaling pathway	5	0.058	453.75
WP534	Glycolysis and gluconeogenesis	5	0.058	421.25
WP3944	Serotonin and anxiety-related events	10	0.058	322.25
WP4147	PTF1A related regulatory pathway	10	0.058	372.5
WP4562	Canonical NF-kB pathway	10	0.058	447.25
WP4584	Biomarkers for pyrimidine metabolism disorders	10	0.058	559
WP3874	Canonical and non-canonical TGF-B signaling	20	0.058	369.75
WP4760	PKC-gamma calcium signaling pathway in ataxia	20	0.058	403.5
WP5061	Fatty acid transporters	20	0.058	603.5
WP2846	PCSK9-mediated LDL receptor degradation	2	0.057	449.25
WP3408	Evolocumab mechanism to reduce LDL cholesterol	2	0.057	449.25
WP4352	Ciliary landscape	2	0.057	312.25
WP581	EPO receptor signaling	2	0.057	422.5
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	3	0.057	466.5
WP4357	NRF2-ARE regulation	3	0.057	296.25
WP5090	Complement system in neuronal development and plasticity	3	0.057	262
WP167	Eicosanoid synthesis	4	0.057	409.25
WP2029	Cell differentiation - index	4	0.057	480.75
WP3	Transcriptional activation by NRF2 in response to phytochemicals	4	0.057	407.25
WP3878	ATM signaling in development and disease	4	0.057	360.5
WP2023	Cell differentiation - expanded index	5	0.057	409.5
WP2029	Cell differentiation - index	5	0.057	483
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	5	0.057	516.5
WP2023	Cell differentiation - expanded index	10	0.057	376.5
WP2029	Cell differentiation - index	10	0.057	390.75
WP2846	PCSK9-mediated LDL receptor degradation	10	0.057	561.5
WP3408	Evolocumab mechanism to reduce LDL cholesterol	10	0.057	561.5
WP4760	PKC-gamma calcium signaling pathway in ataxia	10	0.057	367.5
WP698	Glucuronidation	10	0.057	527.25
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	20	0.057	360
WP4030	SCFA and skeletal muscle substrate metabolism	20	0.057	426.25
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	30	0.057	446.5
WP4875	Disruption of postsynaptic signaling by CNV	30	0.057	431.5
WP3413	NOTCH1 regulation of endothelial cell calcification	2	0.056	421
WP554	ACE inhibitor pathway	2	0.056	431
WP167	Eicosanoid synthesis	3	0.056	445.75
WP2876	Pregnane X receptor pathway	3	0.056	439
WP4146	Macrophage markers	3	0.056	470.25
WP4197	Immune response to tuberculosis	3	0.056	470.25
WP3944	Serotonin and anxiety-related events	4	0.056	448.5
WP4352	Ciliary landscape	4	0.056	322
WP5072	Modulators of TCR signaling and T cell activation	4	0.056	298.5
WP5103	Progeria-associated lipodystrophy	4	0.056	301.75
WP5114	Nucleotide excision repair in xeroderma pigmentosum	4	0.056	453
WP206	Fatty acid omega-oxidation	5	0.056	511.75
WP322	Osteoblast signaling	5	0.056	467
WP3937	Microglia pathogen phagocytosis pathway	5	0.056	445
WP3945	TYROBP causal network in microglia	5	0.056	348.5
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	5	0.056	475.25
WP4787	Osteoblast differentiation and related diseases	5	0.056	311.5
WP4873	Peroxiredoxin 2 induced ovarian failure	5	0.056	506.25
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	5	0.056	497.25
WP4932	7q11.23 copy number variation syndrome	5	0.056	303.5
WP1584	Type II diabetes mellitus	10	0.056	382.25
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	10	0.056	550.75
WP4321	Thermogenesis	10	0.056	363.5
WP2525	Trans-sulfuration and one-carbon metabolism	20	0.056	425
WP3853	ERK pathway in Huntington's disease	20	0.056	430.5
WP3965	Lipid metabolism pathway	20	0.056	382.25
WP465	Tryptophan metabolism	30	0.056	465.75
WP2118	Arrhythmogenic right ventricular cardiomyopathy	2	0.055	292.5
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	2	0.055	404.5
WP1604	Codeine and morphine metabolism	3	0.055	466.5
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	3	0.055	406.5
WP554	ACE inhibitor pathway	3	0.055	461.25
WP2795	Cardiac hypertrophic response	4	0.055	272.5
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	4	0.055	483
WP4917	Proximal tubule transport	4	0.055	446.25
WP661	Glucose homeostasis	4	0.055	512
WP1601	Fluoropyrimidine activity	5	0.055	451.25
WP3298	Melatonin metabolism and effects	5	0.055	338.5
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	5	0.055	265.5
WP4912	SARS coronavirus and innate immunity	5	0.055	506
WP206	Fatty acid omega-oxidation	10	0.055	542
WP4875	Disruption of postsynaptic signaling by CNV	20	0.055	432.75
WP4549	Fragile X syndrome	30	0.055	434
WP4760	PKC-gamma calcium signaling pathway in ataxia	30	0.055	406.75
WP3300	Dual hijack model of Vif in HIV infection	2	0.054	442
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	2	0.054	425.75
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	2	0.054	415
WP2646	Lidocaine metabolism	3	0.054	483
WP696	Benzo(a)pyrene metabolism	3	0.054	476
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	5	0.054	478
WP1531	Vitamin D metabolism	5	0.054	500
WP1541	Energy metabolism	10	0.054	354
WP3965	Lipid metabolism pathway	10	0.054	380.5
WP696	Benzo(a)pyrene metabolism	10	0.054	463.5
WP2879	Farnesoid X receptor pathway	30	0.054	422.5
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	30	0.054	372
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	30	0.054	477.25
WP678	Arachidonate epoxygenase / epoxide hydrolase	30	0.054	551.25
WP3931	Embryonic stem cell pluripotency pathways	2	0.053	253
WP4875	Disruption of postsynaptic signaling by CNV	2	0.053	431.5
WP4963	p53 transcriptional gene network	2	0.053	366.25
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	3	0.053	465.5
WP1992	Genes targeted by miRNAs in adipocytes	3	0.053	454
WP2023	Cell differentiation - expanded index	3	0.053	451.5
WP3	Transcriptional activation by NRF2 in response to phytochemicals	3	0.053	438
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	4	0.053	500.5
WP4537	Hippo-Yap signaling pathway	4	0.053	480.75
WP4584	Biomarkers for pyrimidine metabolism disorders	4	0.053	500.5
WP716	Vitamin A and carotenoid metabolism	4	0.053	404.5
WP4537	Hippo-Yap signaling pathway	5	0.053	478
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	5	0.053	495.75
WP531	DNA mismatch repair	5	0.053	501.25
WP12	Osteoclast signaling	10	0.053	346.5
WP4787	Osteoblast differentiation and related diseases	10	0.053	374.5
WP4912	SARS coronavirus and innate immunity	10	0.053	493
WP585	Interferon type I signaling pathways	10	0.053	364.25
WP4352	Ciliary landscape	20	0.053	493
WP1455	Serotonin transporter activity	30	0.053	378
WP2646	Lidocaine metabolism	30	0.053	408.75
WP3853	ERK pathway in Huntington's disease	30	0.053	447.25
WP1591	Heart development	2	0.052	389
WP2406	Cardiac progenitor differentiation	2	0.052	364.25
WP2643	Nanoparticle-mediated activation of receptor signaling	2	0.052	410.25
WP322	Osteoblast signaling	2	0.052	432.25
WP3927	BMP signaling in eyelid development	2	0.052	420.5
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	2	0.052	421
WP4538	Regulatory circuits of the STAT3 signaling pathway	2	0.052	334
WP4558	Overview of interferons-mediated signaling pathway	2	0.052	427.5
WP2855	Dopaminergic neurogenesis	3	0.052	455
WP4874	CAMKK2 pathway	3	0.052	262
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	4	0.052	273.5
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	4	0.052	390.5
WP4562	Canonical NF-kB pathway	4	0.052	492
WP5050	TCA cycle in senescence	4	0.052	482
WP531	DNA mismatch repair	4	0.052	492.25
WP734	Serotonin receptor 4/6/7 and NR3C signaling	4	0.052	471.5
WP3527	Pre-implantation embryo	5	0.052	305.25
WP4584	Biomarkers for pyrimidine metabolism disorders	5	0.052	517.5
WP2855	Dopaminergic neurogenesis	10	0.052	369.5
WP3967	miR-509-3p alteration of YAP1/ECM axis	10	0.052	351.5
WP5061	Fatty acid transporters	10	0.052	573.5
WP5101	Congenital generalized lipodystrophy (CGL)	10	0.052	349.75
WP4352	Ciliary landscape	30	0.052	518
WP2806	Complement system	2	0.051	391.5
WP2855	Dopaminergic neurogenesis	2	0.051	427.5
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	2	0.051	411.75
WP3591	Sleep regulation	2	0.051	416
WP4197	Immune response to tuberculosis	2	0.051	435
WP2509	Nanoparticle triggered autophagic cell death	3	0.051	441.75
WP384	Apoptosis modulation by HSP70	3	0.051	460
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	3	0.051	428
WP4814	Somatic sex determination	3	0.051	471.5
WP5072	Modulators of TCR signaling and T cell activation	3	0.051	290.5
WP5120	Inclusion body myositis	3	0.051	467.75
WP716	Vitamin A and carotenoid metabolism	3	0.051	441.25
WP2536	Colchicine metabolic pathway	4	0.051	508.5
WP2816	Felbamate metabolism	4	0.051	508.5
WP2855	Dopaminergic neurogenesis	4	0.051	448.5
WP3298	Melatonin metabolism and effects	4	0.051	354
WP4549	Fragile X syndrome	4	0.051	283.75
WP698	Glucuronidation	4	0.051	497
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	5	0.051	513
WP4290	Metabolic reprogramming in colon cancer	5	0.051	478.75
WP4549	Fragile X syndrome	5	0.051	295.5
WP325	Triacylglyceride synthesis	20	0.051	473
WP4259	Disorders of folate metabolism and transport	20	0.051	481
WP47	Hedgehog signaling pathway Netpath	20	0.051	451.5
WP4724	Omega-9 fatty acid synthesis	20	0.051	449
WP5101	Congenital generalized lipodystrophy (CGL)	20	0.051	369.75
WP2513	Nanoparticle triggered regulated necrosis	30	0.051	397
WP325	Triacylglyceride synthesis	30	0.051	487.5
WP3938	miR-222 in exercise-induced cardiac growth	30	0.051	402.5
WP4321	Thermogenesis	30	0.051	402.5
WP47	Hedgehog signaling pathway Netpath	30	0.051	446
WP1995	Effects of nitric oxide	2	0.05	437.25
WP4148	Splicing factor NOVA regulated synaptic proteins	2	0.05	421
WP4524	Alternative pathway of fetal androgen synthesis	2	0.05	437
WP4874	CAMKK2 pathway	2	0.05	391.5
WP5066	FOXA2 pathway	2	0.05	433
WP1591	Heart development	3	0.05	274.25
WP268	Notch signaling	3	0.05	442.25
WP3298	Melatonin metabolism and effects	3	0.05	410.25
WP4148	Splicing factor NOVA regulated synaptic proteins	3	0.05	413.75
WP4586	Metabolism of alpha-linolenic acid	3	0.05	462.75
WP5049	Glycolysis in senescence	3	0.05	455
WP2197	Endothelin pathways	4	0.05	305.5
WP4290	Metabolic reprogramming in colon cancer	4	0.05	472.5
WP4321	Thermogenesis	4	0.05	286.25
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	4	0.05	478.5
WP4756	Renin-angiotensin-aldosterone system (RAAS)	4	0.05	355
WP4971	Phosphoinositides metabolism	4	0.05	448.5
WP585	Interferon type I signaling pathways	4	0.05	326.75
WP2035	Follicle stimulating hormone (FSH) signaling pathway	5	0.05	413
WP734	Serotonin receptor 4/6/7 and NR3C signaling	5	0.05	479.75
WP4873	Peroxiredoxin 2 induced ovarian failure	10	0.05	437.5
WP2366	Butyrate-induced histone acetylation	20	0.05	434.5
WP3634	Insulin signaling in adipocytes (normal condition)	20	0.05	446.5
WP3635	Insulin signaling in adipocytes (diabetic condition)	20	0.05	446.5
WP4389	Bile acids synthesis and enterohepatic circulation	20	0.05	448.75
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	20	0.05	383
WP5052	Nephrogenesis	20	0.05	529.25
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	30	0.05	514
WP536	Calcium regulation in cardiac cells	30	0.05	467
WP384	Apoptosis modulation by HSP70	2	0.049	431.5
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	2	0.049	415.5
WP4787	Osteoblast differentiation and related diseases	2	0.049	302.5
WP697	Estrogen metabolism	2	0.049	441.5
WP4352	Ciliary landscape	3	0.049	308.5
WP4549	Fragile X syndrome	3	0.049	264.75
WP4724	Omega-9 fatty acid synthesis	3	0.049	476
WP53	ID signaling pathway	3	0.049	457.25
WP12	Osteoclast signaling	4	0.049	462.75
WP1541	Energy metabolism	4	0.049	310.5
WP2023	Cell differentiation - expanded index	4	0.049	449.25
WP3670	Interactions between LOXL4 and oxidative stress pathway	4	0.049	451
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	4	0.049	354.25
WP4752	Base excision repair	4	0.049	473.5
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	4	0.049	483.75
WP2795	Cardiac hypertrophic response	5	0.049	279
WP3878	ATM signaling in development and disease	5	0.049	347.5
WP3967	miR-509-3p alteration of YAP1/ECM axis	5	0.049	402.5
WP4756	Renin-angiotensin-aldosterone system (RAAS)	5	0.049	333
WP4875	Disruption of postsynaptic signaling by CNV	10	0.049	410
WP5117	Cohesin complex - Cornelia de Lange syndrome	10	0.049	398.5
WP3945	TYROBP causal network in microglia	20	0.049	429.75
WP2846	PCSK9-mediated LDL receptor degradation	30	0.049	392.5
WP3408	Evolocumab mechanism to reduce LDL cholesterol	30	0.049	392.5
WP410	Exercise-induced circadian regulation	30	0.049	493
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	2	0.048	428.75
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	2	0.048	452
WP4961	STING pathway in Kawasaki-like disease and COVID-19	2	0.048	423.25
WP5072	Modulators of TCR signaling and T cell activation	2	0.048	394
WP534	Glycolysis and gluconeogenesis	2	0.048	426.5
WP2456	HIF1A and PPARG regulation of glycolysis	3	0.048	467
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	3	0.048	386
WP3527	Pre-implantation embryo	3	0.048	311.5
WP4760	PKC-gamma calcium signaling pathway in ataxia	3	0.048	460
WP1601	Fluoropyrimidine activity	4	0.048	455.5
WP2406	Cardiac progenitor differentiation	4	0.048	297.75
WP2846	PCSK9-mediated LDL receptor degradation	4	0.048	504
WP3408	Evolocumab mechanism to reduce LDL cholesterol	4	0.048	504
WP4479	Supression of HMGB1 mediated inflammation by THBD	4	0.048	482.25
WP4842	Mammalian disorder of sexual development	4	0.048	458.75
WP4942	15q13.3 copy number variation syndrome	4	0.048	460.25
WP1981	Thyroxine (thyroid hormone) production	5	0.048	519
WP4753	Nucleotide excision repair	5	0.048	490.25
WP2646	Lidocaine metabolism	10	0.048	572.75
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	10	0.048	359.25
WP4549	Fragile X syndrome	10	0.048	378
WP5050	TCA cycle in senescence	10	0.048	334
WP58	Monoamine GPCRs	10	0.048	583.25
WP206	Fatty acid omega-oxidation	20	0.048	484.5
WP2513	Nanoparticle triggered regulated necrosis	20	0.048	395.5
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	20	0.048	391.25
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	30	0.048	393.75
WP1471	Target of rapamycin (TOR) signaling	3	0.047	450
WP2795	Cardiac hypertrophic response	3	0.047	263
WP2826	Cocaine metabolism	3	0.047	484.5
WP2875	Constitutive androstane receptor pathway	3	0.047	406.5
WP3945	TYROBP causal network in microglia	3	0.047	409.25
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	3	0.047	443
WP466	DNA replication	3	0.047	463.75
WP1946	Cori cycle	4	0.047	474.5
WP3877	MYD88 distinct input-output pathway	4	0.047	449.5
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	4	0.047	500.5
WP4753	Nucleotide excision repair	4	0.047	485
WP4873	Peroxiredoxin 2 induced ovarian failure	4	0.047	491
WP5064	7-oxo-C and 7-beta-HC pathways	4	0.047	482
WP1541	Energy metabolism	5	0.047	305.25
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	5	0.047	343.25
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	5	0.047	350
WP2525	Trans-sulfuration and one-carbon metabolism	10	0.047	392.5
WP2596	Gastric acid production	10	0.047	575.25
WP268	Notch signaling	10	0.047	393
WP3874	Canonical and non-canonical TGF-B signaling	10	0.047	350.25
WP3963	Mevalonate pathway	10	0.047	573.25
WP47	Hedgehog signaling pathway Netpath	10	0.047	459.75
WP5064	7-oxo-C and 7-beta-HC pathways	10	0.047	450.75
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	10	0.047	542.75
WP4758	Nephrotic syndrome	30	0.047	440.5
WP5101	Congenital generalized lipodystrophy (CGL)	30	0.047	375.5
WP3935	Leptin-insulin signaling overlap	2	0.046	425.5
WP4830	GDNF/RET signaling axis	2	0.046	438
WP5090	Complement system in neuronal development and plasticity	2	0.046	287.5
WP53	ID signaling pathway	2	0.046	435.25
WP1584	Type II diabetes mellitus	3	0.046	447.75
WP206	Fatty acid omega-oxidation	3	0.046	476
WP3878	ATM signaling in development and disease	3	0.046	416.75
WP4629	Aerobic glycolysis	3	0.046	477
WP4875	Disruption of postsynaptic signaling by CNV	3	0.046	453.25
WP4932	7q11.23 copy number variation syndrome	3	0.046	279
WP4950	16p11.2 distal deletion syndrome	3	0.046	441.75
WP733	Serotonin receptor 2 and STAT3 signaling	3	0.046	484.75
WP4912	SARS coronavirus and innate immunity	4	0.046	490.5
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	4	0.046	498.5
WP12	Osteoclast signaling	5	0.046	457.75
WP1584	Type II diabetes mellitus	5	0.046	383
WP383	Striated muscle contraction pathway	5	0.046	474
WP4147	PTF1A related regulatory pathway	5	0.046	490.5
WP4722	Glycerolipids and glycerophospholipids	20	0.046	412.25
WP1601	Fluoropyrimidine activity	30	0.046	450.5
WP2542	Sulindac metabolic pathway	30	0.046	624.75
WP4724	Omega-9 fatty acid synthesis	30	0.046	462.25
WP4971	Phosphoinositides metabolism	30	0.046	438.75
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	2	0.045	436
WP2875	Constitutive androstane receptor pathway	2	0.045	414
WP4950	16p11.2 distal deletion syndrome	2	0.045	423.25
WP536	Calcium regulation in cardiac cells	2	0.045	285
WP733	Serotonin receptor 2 and STAT3 signaling	2	0.045	449.5
WP1541	Energy metabolism	3	0.045	305.25
WP229	Irinotecan pathway	3	0.045	466.5
WP3407	FTO obesity variant mechanism	3	0.045	462
WP4479	Supression of HMGB1 mediated inflammation by THBD	3	0.045	466.5
WP465	Tryptophan metabolism	3	0.045	457.25
WP4946	DNA repair pathways, full network	3	0.045	421.25
WP661	Glucose homeostasis	3	0.045	487.5
WP206	Fatty acid omega-oxidation	4	0.045	499.5
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	4	0.045	465.75
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	4	0.045	349.25
WP3937	Microglia pathogen phagocytosis pathway	4	0.045	465.5
WP4259	Disorders of folate metabolism and transport	5	0.045	517.5
WP4389	Bile acids synthesis and enterohepatic circulation	5	0.045	496.5
WP4723	Omega-3 / omega-6 fatty acid synthesis	5	0.045	516
WP5050	TCA cycle in senescence	5	0.045	496.5
WP2359	Parkin-ubiquitin proteasomal system pathway	10	0.045	488.75
WP1455	Serotonin transporter activity	20	0.045	372.5
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	20	0.045	436
WP4751	HIPK2 in kidney fibrosis	20	0.045	625.5
WP288	Nod-like receptor (NLR) signaling pathway	30	0.045	465.75
WP3580	Methionine de novo and salvage pathway	30	0.045	473.75
WP4942	15q13.3 copy number variation syndrome	30	0.045	372.25
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	3	0.044	487.75
WP4756	Renin-angiotensin-aldosterone system (RAAS)	3	0.044	392.25
WP5064	7-oxo-C and 7-beta-HC pathways	3	0.044	463.25
WP1981	Thyroxine (thyroid hormone) production	4	0.044	504
WP410	Exercise-induced circadian regulation	4	0.044	456.5
WP47	Hedgehog signaling pathway Netpath	4	0.044	493
WP4787	Osteoblast differentiation and related diseases	4	0.044	288.25
WP4875	Disruption of postsynaptic signaling by CNV	4	0.044	435
WP2406	Cardiac progenitor differentiation	5	0.044	307.5
WP4842	Mammalian disorder of sexual development	5	0.044	465.25
WP4971	Phosphoinositides metabolism	5	0.044	446.5
WP5064	7-oxo-C and 7-beta-HC pathways	5	0.044	491
WP4389	Bile acids synthesis and enterohepatic circulation	10	0.044	430.5
WP4723	Omega-3 / omega-6 fatty acid synthesis	10	0.044	561
WP2895	Differentiation of white and brown adipocyte	20	0.044	409.75
WP3996	Ethanol effects on histone modifications	20	0.044	396.75
WP2113	Type III interferon signaling	30	0.044	539.75
WP2596	Gastric acid production	30	0.044	531.5
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	30	0.044	393.5
WP3944	Serotonin and anxiety-related events	30	0.044	392.75
WP524	G13 signaling pathway	30	0.044	433.5
WP1601	Fluoropyrimidine activity	2	0.043	431
WP2826	Cocaine metabolism	2	0.043	452
WP466	DNA replication	2	0.043	435
WP496	Steroid biosynthesis	2	0.043	446.75
WP186	Homologous recombination	3	0.043	473.5
WP1946	Cori cycle	3	0.043	465.5
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	3	0.043	457.75
WP3670	Interactions between LOXL4 and oxidative stress pathway	3	0.043	451.5
WP47	Hedgehog signaling pathway Netpath	3	0.043	475.75
WP496	Steroid biosynthesis	3	0.043	481
WP3527	Pre-implantation embryo	4	0.043	302.5
WP3656	Interleukin-1 induced activation of NF-kB	4	0.043	469.75
WP3853	ERK pathway in Huntington's disease	4	0.043	478.25
WP4022	Pyrimidine metabolism	4	0.043	487.75
WP4838	Regucalcin in proximal tubule epithelial kidney cells	4	0.043	442.75
WP143	Fatty acid beta-oxidation	5	0.043	511.5
WP4942	15q13.3 copy number variation syndrome	5	0.043	406.5
WP5061	Fatty acid transporters	5	0.043	521.5
WP1455	Serotonin transporter activity	10	0.043	400.5
WP2035	Follicle stimulating hormone (FSH) signaling pathway	10	0.043	383.25
WP3580	Methionine de novo and salvage pathway	10	0.043	478.75
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	10	0.043	378.5
WP4942	15q13.3 copy number variation syndrome	10	0.043	346.5
WP2113	Type III interferon signaling	20	0.043	527
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	20	0.043	380.5
WP2436	Dopamine metabolism	30	0.043	426
WP5117	Cohesin complex - Cornelia de Lange syndrome	30	0.043	409.5
WP2646	Lidocaine metabolism	2	0.042	450
WP2876	Pregnane X receptor pathway	2	0.042	424.75
WP3527	Pre-implantation embryo	2	0.042	385.25
WP4146	Macrophage markers	2	0.042	442.25
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	2	0.042	425.5
WP4357	NRF2-ARE regulation	2	0.042	409.5
WP465	Tryptophan metabolism	2	0.042	432.5
WP4946	DNA repair pathways, full network	2	0.042	418.25
WP5120	Inclusion body myositis	2	0.042	438.75
WP12	Osteoclast signaling	3	0.042	458.25
WP2197	Endothelin pathways	3	0.042	405.75
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	3	0.042	446
WP383	Striated muscle contraction pathway	3	0.042	464.75
WP4174	Metabolism of tetrahydrocannabinol (THC)	3	0.042	484.5
WP4537	Hippo-Yap signaling pathway	3	0.042	468.75
WP4917	Proximal tubule transport	3	0.042	451.5
WP734	Serotonin receptor 4/6/7 and NR3C signaling	3	0.042	466.5
WP2826	Cocaine metabolism	4	0.042	508.5
WP3945	TYROBP causal network in microglia	4	0.042	376.75
WP3967	miR-509-3p alteration of YAP1/ECM axis	4	0.042	444
WP4758	Nephrotic syndrome	4	0.042	331.25
WP733	Serotonin receptor 2 and STAT3 signaling	4	0.042	505.5
WP4758	Nephrotic syndrome	5	0.042	363.25
WP4838	Regucalcin in proximal tubule epithelial kidney cells	5	0.042	447.25
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	10	0.042	560.5
WP206	Fatty acid omega-oxidation	30	0.042	488.25
WP4842	Mammalian disorder of sexual development	30	0.042	480.25
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	30	0.042	416
WP2795	Cardiac hypertrophic response	2	0.041	303.5
WP3630	NAD metabolism, sirtuins and aging	2	0.041	427.75
WP4758	Nephrotic syndrome	2	0.041	416
WP4971	Phosphoinositides metabolism	2	0.041	434
WP2035	Follicle stimulating hormone (FSH) signaling pathway	3	0.041	445.5
WP357	Fatty acid biosynthesis	3	0.041	475.75
WP3877	MYD88 distinct input-output pathway	3	0.041	451.5
WP4558	Overview of interferons-mediated signaling pathway	3	0.041	459.75
WP4723	Omega-3 / omega-6 fatty acid synthesis	3	0.041	480.5
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	3	0.041	411.25
WP4787	Osteoblast differentiation and related diseases	3	0.041	281.75
WP4873	Peroxiredoxin 2 induced ovarian failure	3	0.041	475.75
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	3	0.041	470.5
WP1531	Vitamin D metabolism	4	0.041	489.25
WP197	Cholesterol biosynthesis pathway	4	0.041	505.5
WP357	Fatty acid biosynthesis	4	0.041	494.5
WP197	Cholesterol biosynthesis pathway	5	0.041	521
WP2038	Microtubule cytoskeleton regulation	5	0.041	286.25
WP268	Notch signaling	5	0.041	352
WP4022	Pyrimidine metabolism	5	0.041	501
WP410	Exercise-induced circadian regulation	5	0.041	466
WP4724	Omega-9 fatty acid synthesis	5	0.041	508.75
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	5	0.041	318.75
WP4917	Proximal tubule transport	5	0.041	429.25
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	5	0.041	513.75
WP143	Fatty acid beta-oxidation	10	0.041	534.25
WP2513	Nanoparticle triggered regulated necrosis	10	0.041	402.25
WP4324	Mitochondrial complex I assembly model OXPHOS system	10	0.041	585
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	10	0.041	371.5
WP5031	Biotin metabolism, including IEMs	10	0.041	583.5
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	20	0.041	380.5
WP4814	Somatic sex determination	20	0.041	455.75
WP268	Notch signaling	30	0.041	428.75
WP3874	Canonical and non-canonical TGF-B signaling	30	0.041	374.25
WP167	Eicosanoid synthesis	2	0.04	424
WP2456	HIF1A and PPARG regulation of glycolysis	2	0.04	439.75
WP2536	Colchicine metabolic pathway	2	0.04	452
WP2816	Felbamate metabolism	2	0.04	452
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	2	0.04	431.75
WP4940	15q11.2 copy number variation syndrome	2	0.04	452.5
WP661	Glucose homeostasis	2	0.04	453.5
WP2029	Cell differentiation - index	3	0.04	466.5
WP3938	miR-222 in exercise-induced cardiac growth	3	0.04	479
WP3965	Lipid metabolism pathway	3	0.04	460
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	3	0.04	461.75
WP4842	Mammalian disorder of sexual development	3	0.04	459.25
WP585	Interferon type I signaling pathways	3	0.04	328.25
WP698	Glucuronidation	3	0.04	477.25
WP1471	Target of rapamycin (TOR) signaling	4	0.04	431.25
WP1584	Type II diabetes mellitus	4	0.04	440.75
WP268	Notch signaling	4	0.04	411.5
WP4724	Omega-9 fatty acid synthesis	4	0.04	495.5
WP1471	Target of rapamycin (TOR) signaling	5	0.04	400.75
WP167	Eicosanoid synthesis	5	0.04	354
WP3853	ERK pathway in Huntington's disease	5	0.04	487
WP3874	Canonical and non-canonical TGF-B signaling	5	0.04	473.5
WP2436	Dopamine metabolism	10	0.04	425
WP3938	miR-222 in exercise-induced cardiac growth	10	0.04	551.5
WP4537	Hippo-Yap signaling pathway	10	0.04	407.25
WP4853	Linoleic acid metabolism affected by coronavirus infection	10	0.04	587.5
WP3580	Methionine de novo and salvage pathway	20	0.04	451.25
WP4324	Mitochondrial complex I assembly model OXPHOS system	20	0.04	626.5
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	20	0.04	426.75
WP4586	Metabolism of alpha-linolenic acid	30	0.04	424
WP4752	Base excision repair	2	0.039	438.25
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	2	0.039	414.5
WP727	Monoamine transport	2	0.039	417.5
WP1531	Vitamin D metabolism	3	0.039	471.75
WP1601	Fluoropyrimidine activity	3	0.039	456.25
WP3656	Interleukin-1 induced activation of NF-kB	3	0.039	463.5
WP4290	Metabolic reprogramming in colon cancer	3	0.039	461.25
WP531	DNA mismatch repair	3	0.039	476.25
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	4	0.039	364
WP4861	Endoplasmic reticulum stress response in coronavirus infection	4	0.039	354
WP1455	Serotonin transporter activity	5	0.039	494.5
WP1946	Cori cycle	5	0.039	484.25
WP3670	Interactions between LOXL4 and oxidative stress pathway	5	0.039	398
WP4220	Neurotransmitter disorders	5	0.039	524.5
WP4269	Ethanol metabolism production of ROS by CYP2E1	5	0.039	496
WP4562	Canonical NF-kB pathway	5	0.039	506.5
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	10	0.039	412.75
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	10	0.039	368.25
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	10	0.039	582
WP2035	Follicle stimulating hormone (FSH) signaling pathway	20	0.039	401.5
WP2436	Dopamine metabolism	20	0.039	417.5
WP3938	miR-222 in exercise-induced cardiac growth	20	0.039	396.75
WP3944	Serotonin and anxiety-related events	20	0.039	373.75
WP4584	Biomarkers for pyrimidine metabolism disorders	20	0.039	501.25
WP383	Striated muscle contraction pathway	30	0.039	440
WP5052	Nephrogenesis	30	0.039	546
WP585	Interferon type I signaling pathways	30	0.039	404
WP186	Homologous recombination	2	0.038	443.25
WP2023	Cell differentiation - expanded index	2	0.038	429.5
WP2361	Gastric cancer network 1	2	0.038	440.75
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	2	0.038	377.25
WP3878	ATM signaling in development and disease	2	0.038	412.5
WP4290	Metabolic reprogramming in colon cancer	2	0.038	436.5
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	2	0.038	420.5
WP4753	Nucleotide excision repair	2	0.038	441.5
WP585	Interferon type I signaling pathways	2	0.038	398.75
WP691	Tamoxifen metabolism	2	0.038	441.5
WP696	Benzo(a)pyrene metabolism	2	0.038	445
WP4562	Canonical NF-kB pathway	3	0.038	474
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	3	0.038	463.25
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	3	0.038	469.5
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	3	0.038	478.5
WP2525	Trans-sulfuration and one-carbon metabolism	4	0.038	461.75
WP3965	Lipid metabolism pathway	4	0.038	472.25
WP4723	Omega-3 / omega-6 fatty acid synthesis	4	0.038	502.5
WP5101	Congenital generalized lipodystrophy (CGL)	4	0.038	461.25
WP3877	MYD88 distinct input-output pathway	5	0.038	408.25
WP4962	Airway smooth muscle cell contraction	5	0.038	500.75
WP585	Interferon type I signaling pathways	5	0.038	318
WP1603	Nicotine effect on chromaffin cells	10	0.038	575.75
WP2113	Type III interferon signaling	10	0.038	570
WP4842	Mammalian disorder of sexual development	10	0.038	409
WP4942	15q13.3 copy number variation syndrome	20	0.038	378.25
WP5117	Cohesin complex - Cornelia de Lange syndrome	20	0.038	417.75
WP2911	miRNA targets in ECM and membrane receptors	30	0.038	494.25
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	30	0.038	481.75
WP404	Nucleotide metabolism	30	0.038	548.75
WP4259	Disorders of folate metabolism and transport	30	0.038	465.75
WP58	Monoamine GPCRs	30	0.038	637.5
WP1471	Target of rapamycin (TOR) signaling	2	0.037	428
WP3	Transcriptional activation by NRF2 in response to phytochemicals	2	0.037	424
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	2	0.037	437.5
WP4321	Thermogenesis	2	0.037	273.25
WP5049	Glycolysis in senescence	2	0.037	427.5
WP531	DNA mismatch repair	2	0.037	444
WP197	Cholesterol biosynthesis pathway	3	0.037	484
WP2361	Gastric cancer network 1	3	0.037	472.25
WP4950	16p11.2 distal deletion syndrome	4	0.037	416.25
WP4950	16p11.2 distal deletion syndrome	5	0.037	363.5
WP5101	Congenital generalized lipodystrophy (CGL)	5	0.037	418.5
WP2276	Glial cell differentiation	10	0.037	585
WP2542	Sulindac metabolic pathway	10	0.037	580.5
WP325	Triacylglyceride synthesis	10	0.037	547.5
WP383	Striated muscle contraction pathway	10	0.037	397.25
WP4789	MED and pseudoachondroplasia genes	10	0.037	590
WP4861	Endoplasmic reticulum stress response in coronavirus infection	10	0.037	394
WP5052	Nephrogenesis	10	0.037	535.25
WP550	Biogenic amine synthesis	10	0.037	561.5
WP704	Methylation pathways	10	0.037	557
WP268	Notch signaling	20	0.037	423.75
WP4758	Nephrotic syndrome	20	0.037	416.5
WP4912	SARS coronavirus and innate immunity	20	0.037	501.5
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	20	0.037	622.5
WP2035	Follicle stimulating hormone (FSH) signaling pathway	30	0.037	408.75
WP4269	Ethanol metabolism production of ROS by CYP2E1	30	0.037	400.75
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	30	0.037	440.25
WP3947	Serotonin and anxiety	2	0.036	427.5
WP734	Serotonin receptor 4/6/7 and NR3C signaling	2	0.036	437
WP4389	Bile acids synthesis and enterohepatic circulation	3	0.036	470.25
WP4942	15q13.3 copy number variation syndrome	3	0.036	458
WP2361	Gastric cancer network 1	4	0.036	488
WP3679	Cell-type dependent selectivity of CCK2R signaling	4	0.036	483
WP4147	PTF1A related regulatory pathway	4	0.036	488
WP183	Proteasome degradation	5	0.036	454.75
WP2846	PCSK9-mediated LDL receptor degradation	5	0.036	519
WP2855	Dopaminergic neurogenesis	5	0.036	422.25
WP3408	Evolocumab mechanism to reduce LDL cholesterol	5	0.036	519
WP3585	Cytosine methylation	5	0.036	527.75
WP4758	Nephrotic syndrome	10	0.036	378
WP477	Cytoplasmic ribosomal proteins	10	0.036	567.5
WP4814	Somatic sex determination	10	0.036	447.5
WP5038	Mitochondrial immune response to SARS-CoV-2	10	0.036	385.75
WP524	G13 signaling pathway	10	0.036	404.5
WP4923	Autophagy	20	0.036	434.5
WP585	Interferon type I signaling pathways	20	0.036	400
WP2525	Trans-sulfuration and one-carbon metabolism	2	0.035	433
WP383	Striated muscle contraction pathway	2	0.035	436.5
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	2	0.035	444.5
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	2	0.035	440.25
WP5114	Nucleotide excision repair in xeroderma pigmentosum	2	0.035	429.5
WP4861	Endoplasmic reticulum stress response in coronavirus infection	3	0.035	424.75
WP5117	Cohesin complex - Cornelia de Lange syndrome	3	0.035	460
WP4259	Disorders of folate metabolism and transport	4	0.035	503
WP4389	Bile acids synthesis and enterohepatic circulation	4	0.035	489
WP524	G13 signaling pathway	4	0.035	442.5
WP2112	IL-17 signaling pathway	5	0.035	416.75
WP3300	Dual hijack model of Vif in HIV infection	10	0.035	345
WP3634	Insulin signaling in adipocytes (normal condition)	10	0.035	548.5
WP3635	Insulin signaling in adipocytes (diabetic condition)	10	0.035	548.5
WP143	Fatty acid beta-oxidation	20	0.035	538
WP183	Proteasome degradation	20	0.035	441.75
WP383	Striated muscle contraction pathway	20	0.035	436.5
WP404	Nucleotide metabolism	20	0.035	546.5
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	20	0.035	510
WP4842	Mammalian disorder of sexual development	20	0.035	452.5
WP4971	Phosphoinositides metabolism	20	0.035	442.25
WP2895	Differentiation of white and brown adipocyte	30	0.035	409.5
WP4814	Somatic sex determination	30	0.035	485.75
WP561	Heme biosynthesis	30	0.035	633.25
WP1584	Type II diabetes mellitus	2	0.034	427.5
WP2197	Endothelin pathways	2	0.034	415.5
WP2879	Farnesoid X receptor pathway	2	0.034	439
WP3613	Photodynamic therapy-induced unfolded protein response	2	0.034	422
WP4549	Fragile X syndrome	2	0.034	290.5
WP4838	Regucalcin in proximal tubule epithelial kidney cells	2	0.034	427.75
WP4842	Mammalian disorder of sexual development	2	0.034	427.5
WP524	G13 signaling pathway	2	0.034	432.75
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	3	0.034	463
WP3874	Canonical and non-canonical TGF-B signaling	3	0.034	462
WP2112	IL-17 signaling pathway	4	0.034	450.25
WP4688	Serine metabolism	4	0.034	505.75
WP704	Methylation pathways	4	0.034	501.5
WP2113	Type III interferon signaling	5	0.034	520.25
WP2513	Nanoparticle triggered regulated necrosis	5	0.034	491.25
WP325	Triacylglyceride synthesis	5	0.034	512
WP3679	Cell-type dependent selectivity of CCK2R signaling	5	0.034	498.75
WP5117	Cohesin complex - Cornelia de Lange syndrome	5	0.034	475
WP4722	Glycerolipids and glycerophospholipids	10	0.034	432.25
WP2359	Parkin-ubiquitin proteasomal system pathway	20	0.034	514
WP4571	Urea cycle and related diseases	30	0.034	642
WP4846	SARS-CoV-2 and COVID-19 pathway	30	0.034	413.75
WP4853	Linoleic acid metabolism affected by coronavirus infection	30	0.034	641.5
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	30	0.034	449
WP4962	Airway smooth muscle cell contraction	30	0.034	401
WP206	Fatty acid omega-oxidation	2	0.033	445.5
WP2112	IL-17 signaling pathway	2	0.033	430
WP268	Notch signaling	2	0.033	425.25
WP3298	Melatonin metabolism and effects	2	0.033	414.75
WP3945	TYROBP causal network in microglia	2	0.033	418
WP716	Vitamin A and carotenoid metabolism	2	0.033	426
WP1981	Thyroxine (thyroid hormone) production	3	0.033	480.5
WP2406	Cardiac progenitor differentiation	3	0.033	296.75
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	3	0.033	430
WP4838	Regucalcin in proximal tubule epithelial kidney cells	3	0.033	454
WP4971	Phosphoinositides metabolism	3	0.033	456.75
WP5031	Biotin metabolism, including IEMs	3	0.033	487.75
WP5114	Nucleotide excision repair in xeroderma pigmentosum	3	0.033	455.75
WP2035	Follicle stimulating hormone (FSH) signaling pathway	4	0.033	433.25
WP2513	Nanoparticle triggered regulated necrosis	4	0.033	479.5
WP2646	Lidocaine metabolism	4	0.033	507
WP383	Striated muscle contraction pathway	4	0.033	464.25
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	4	0.033	503
WP455	GPCRs, class A rhodopsin-like	4	0.033	415
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	4	0.033	359
WP5061	Fatty acid transporters	4	0.033	506
WP357	Fatty acid biosynthesis	5	0.033	507
WP550	Biogenic amine synthesis	5	0.033	516.5
WP699	Aflatoxin B1 metabolism	5	0.033	516.5
WP733	Serotonin receptor 2 and STAT3 signaling	5	0.033	521.5
WP183	Proteasome degradation	10	0.033	409
WP2911	miRNA targets in ECM and membrane receptors	10	0.033	448.25
WP4688	Serine metabolism	10	0.033	569.5
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	10	0.033	580.5
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	10	0.033	544.5
WP3963	Mevalonate pathway	20	0.033	560.75
WP4962	Airway smooth muscle cell contraction	20	0.033	426.5
WP5050	TCA cycle in senescence	20	0.033	366.75
WP704	Methylation pathways	20	0.033	455
WP3845	Canonical and non-canonical Notch signaling	30	0.033	465
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	30	0.033	367
WP2029	Cell differentiation - index	2	0.032	438
WP2359	Parkin-ubiquitin proteasomal system pathway	2	0.032	442.5
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	2	0.032	446.75
WP4479	Supression of HMGB1 mediated inflammation by THBD	2	0.032	436.75
WP4932	7q11.23 copy number variation syndrome	2	0.032	308.25
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	3	0.032	478.5
WP5050	TCA cycle in senescence	3	0.032	469
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	5	0.032	456.75
WP3580	Methionine de novo and salvage pathway	5	0.032	510.5
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	5	0.032	506.25
WP1495	Glycine metabolism	10	0.032	586.25
WP3585	Cytosine methylation	10	0.032	579
WP3674	Tgif disruption of Shh signaling	10	0.032	398.25
WP4971	Phosphoinositides metabolism	10	0.032	417.75
WP2361	Gastric cancer network 1	20	0.032	469
WP2911	miRNA targets in ECM and membrane receptors	20	0.032	471
WP4861	Endoplasmic reticulum stress response in coronavirus infection	20	0.032	453.5
WP1604	Codeine and morphine metabolism	2	0.031	437.25
WP3967	miR-509-3p alteration of YAP1/ECM axis	2	0.031	427.25
WP4174	Metabolism of tetrahydrocannabinol (THC)	2	0.031	452
WP4803	Ciliopathies	2	0.031	436.25
WP4804	Cholesterol biosynthesis with skeletal dysplasias	2	0.031	453.75
WP4814	Somatic sex determination	2	0.031	440
WP2112	IL-17 signaling pathway	3	0.031	456.5
WP4752	Base excision repair	3	0.031	466
WP143	Fatty acid beta-oxidation	4	0.031	495.5
WP1455	Serotonin transporter activity	4	0.031	482.75
WP2113	Type III interferon signaling	4	0.031	505.5
WP404	Nucleotide metabolism	4	0.031	504
WP4225	Pyrimidine metabolism and related diseases	4	0.031	500.5
WP4962	Airway smooth muscle cell contraction	4	0.031	489.5
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	4	0.031	509.75
WP699	Aflatoxin B1 metabolism	4	0.031	504
WP4722	Glycerolipids and glycerophospholipids	5	0.031	509
WP3925	Amino acid metabolism	10	0.031	451
WP4751	HIPK2 in kidney fibrosis	10	0.031	585.5
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	10	0.031	357.75
WP4917	Proximal tubule transport	10	0.031	424.75
WP4923	Autophagy	10	0.031	436.75
WP561	Heme biosynthesis	10	0.031	583.5
WP690	Polyol pathway	10	0.031	587
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	20	0.031	463.5
WP3925	Amino acid metabolism	20	0.031	516.5
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	20	0.031	440.75
WP1603	Nicotine effect on chromaffin cells	30	0.031	479.25
WP2361	Gastric cancer network 1	30	0.031	456.5
WP3634	Insulin signaling in adipocytes (normal condition)	30	0.031	441
WP3635	Insulin signaling in adipocytes (diabetic condition)	30	0.031	441
WP3644	NAD+ metabolism	30	0.031	464.25
WP3996	Ethanol effects on histone modifications	30	0.031	393.75
WP4923	Autophagy	30	0.031	422
WP500	Glycogen synthesis and degradation	30	0.031	487
WP1424	Globo sphingolipid metabolism	2	0.03	447.75
WP2253	Pilocytic astrocytoma	2	0.03	452.25
WP4562	Canonical NF-kB pathway	2	0.03	442.5
WP4917	Proximal tubule transport	2	0.03	429.5
WP1495	Glycine metabolism	3	0.03	489
WP2525	Trans-sulfuration and one-carbon metabolism	3	0.03	459.5
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	3	0.03	458.5
WP410	Exercise-induced circadian regulation	3	0.03	456
WP4147	PTF1A related regulatory pathway	3	0.03	471.5
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	3	0.03	443.25
WP4584	Biomarkers for pyrimidine metabolism disorders	3	0.03	478.5
WP100	Glutathione metabolism	4	0.03	497
WP3634	Insulin signaling in adipocytes (normal condition)	4	0.03	495.75
WP3635	Insulin signaling in adipocytes (diabetic condition)	4	0.03	495.75
WP4595	Urea cycle and associated pathways	4	0.03	484.5
WP500	Glycogen synthesis and degradation	4	0.03	482
WP58	Monoamine GPCRs	4	0.03	511.5
WP3634	Insulin signaling in adipocytes (normal condition)	5	0.03	511
WP3635	Insulin signaling in adipocytes (diabetic condition)	5	0.03	511
WP3971	OSX and miRNAs in tooth development	5	0.03	497.25
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	5	0.03	497
WP5052	Nephrogenesis	5	0.03	511
WP524	G13 signaling pathway	5	0.03	411.75
WP2361	Gastric cancer network 1	10	0.03	442.25
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	10	0.03	510
WP3958	GPR40 pathway	10	0.03	565.75
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	10	0.03	416
WP500	Glycogen synthesis and degradation	10	0.03	431
WP678	Arachidonate epoxygenase / epoxide hydrolase	10	0.03	570.5
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	20	0.03	469.25
WP183	Proteasome degradation	30	0.03	473.25
WP2366	Butyrate-induced histone acetylation	30	0.03	412
WP4912	SARS coronavirus and innate immunity	30	0.03	523.25
WP117	GPCRs, other	2	0.029	436
WP229	Irinotecan pathway	2	0.029	442.5
WP2366	Butyrate-induced histone acetylation	2	0.029	450.25
WP4537	Hippo-Yap signaling pathway	2	0.029	440
WP4756	Renin-angiotensin-aldosterone system (RAAS)	2	0.029	410.25
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	2	0.029	438.5
WP4873	Peroxiredoxin 2 induced ovarian failure	2	0.029	444.5
WP143	Fatty acid beta-oxidation	3	0.029	476
WP3853	ERK pathway in Huntington's disease	3	0.029	465.5
WP4030	SCFA and skeletal muscle substrate metabolism	3	0.029	479
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	3	0.029	481
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	4	0.029	491.25
WP3958	GPR40 pathway	4	0.029	503.5
WP5117	Cohesin complex - Cornelia de Lange syndrome	4	0.029	469
WP3965	Lipid metabolism pathway	5	0.029	452.25
WP4861	Endoplasmic reticulum stress response in coronavirus infection	5	0.029	351.75
WP58	Monoamine GPCRs	5	0.029	528.5
WP4174	Metabolism of tetrahydrocannabinol (THC)	10	0.029	575.75
WP455	GPCRs, class A rhodopsin-like	10	0.029	460.25
WP4571	Urea cycle and related diseases	10	0.029	583.5
WP4962	Airway smooth muscle cell contraction	10	0.029	430
WP734	Serotonin receptor 4/6/7 and NR3C signaling	10	0.029	406.5
WP3891	Benzene metabolism	20	0.029	440.75
WP4537	Hippo-Yap signaling pathway	20	0.029	410.25
WP4537	Hippo-Yap signaling pathway	30	0.029	400.25
WP4595	Urea cycle and associated pathways	30	0.029	435.25
WP2035	Follicle stimulating hormone (FSH) signaling pathway	2	0.028	425.75
WP3656	Interleukin-1 induced activation of NF-kB	2	0.028	435.75
WP4022	Pyrimidine metabolism	2	0.028	441.5
WP4629	Aerobic glycolysis	2	0.028	445
WP47	Hedgehog signaling pathway Netpath	2	0.028	444.75
WP4760	PKC-gamma calcium signaling pathway in ataxia	2	0.028	441
WP4269	Ethanol metabolism production of ROS by CYP2E1	3	0.028	471
WP4758	Nephrotic syndrome	3	0.028	418.25
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	3	0.028	442.5
WP5061	Fatty acid transporters	3	0.028	483.5
WP3585	Cytosine methylation	4	0.028	509.5
WP100	Glutathione metabolism	5	0.028	514
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	5	0.028	413.25
WP2491	Diclofenac metabolic pathway	10	0.028	587.5
WP3595	mir-124 predicted interactions with cell cycle and differentiation	10	0.028	582.5
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	10	0.028	536.5
WP3674	Tgif disruption of Shh signaling	20	0.028	412.5
WP4220	Neurotransmitter disorders	20	0.028	609.5
WP5038	Mitochondrial immune response to SARS-CoV-2	20	0.028	409.75
WP4030	SCFA and skeletal muscle substrate metabolism	30	0.028	398.75
WP1455	Serotonin transporter activity	2	0.027	440.25
WP2542	Sulindac metabolic pathway	2	0.027	452
WP3674	Tgif disruption of Shh signaling	2	0.027	444.5
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	2	0.027	422.25
WP4584	Biomarkers for pyrimidine metabolism disorders	2	0.027	448.25
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	2	0.027	440
WP5117	Cohesin complex - Cornelia de Lange syndrome	2	0.027	434.5
WP2038	Microtubule cytoskeleton regulation	3	0.027	293
WP2366	Butyrate-induced histone acetylation	3	0.027	481
WP4753	Nucleotide excision repair	3	0.027	471.75
WP4853	Linoleic acid metabolism affected by coronavirus infection	3	0.027	488
WP4912	SARS coronavirus and innate immunity	3	0.027	477.5
WP4940	15q11.2 copy number variation syndrome	3	0.027	486
WP699	Aflatoxin B1 metabolism	3	0.027	480.5
WP2038	Microtubule cytoskeleton regulation	4	0.027	288.75
WP325	Triacylglyceride synthesis	4	0.027	498
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	4	0.027	491.5
WP4220	Neurotransmitter disorders	4	0.027	507.5
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	4	0.027	500.5
WP5031	Biotin metabolism, including IEMs	4	0.027	513
WP561	Heme biosynthesis	4	0.027	511.5
WP2525	Trans-sulfuration and one-carbon metabolism	5	0.027	450
WP2646	Lidocaine metabolism	5	0.027	521.25
WP2826	Cocaine metabolism	5	0.027	524.5
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	5	0.027	517
WP704	Methylation pathways	5	0.027	516.5
WP26	S1P receptor signal transduction	10	0.027	419.5
WP3996	Ethanol effects on histone modifications	10	0.027	372.75
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	10	0.027	424
WP699	Aflatoxin B1 metabolism	10	0.027	561.5
WP4688	Serine metabolism	20	0.027	600.75
WP500	Glycogen synthesis and degradation	20	0.027	470.5
WP4174	Metabolism of tetrahydrocannabinol (THC)	30	0.027	445
WP704	Methylation pathways	30	0.027	461
WP734	Serotonin receptor 4/6/7 and NR3C signaling	30	0.027	423.5
WP1531	Vitamin D metabolism	2	0.026	440.75
WP1946	Cori cycle	2	0.026	437.25
WP1981	Thyroxine (thyroid hormone) production	2	0.026	448.75
WP2509	Nanoparticle triggered autophagic cell death	2	0.026	421
WP4030	SCFA and skeletal muscle substrate metabolism	2	0.026	450
WP4225	Pyrimidine metabolism and related diseases	2	0.026	447.5
WP4751	HIPK2 in kidney fibrosis	2	0.026	453.5
WP698	Glucuronidation	2	0.026	446.5
WP2542	Sulindac metabolic pathway	3	0.026	486
WP3937	Microglia pathogen phagocytosis pathway	3	0.026	459.5
WP1495	Glycine metabolism	4	0.026	513.5
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	4	0.026	508
WP3595	mir-124 predicted interactions with cell cycle and differentiation	5	0.026	529
WP411	mRNA processing	5	0.026	496.5
WP4533	Transcription co-factors SKI and SKIL protein partners	5	0.026	500
WP521	Amino acid conjugation of benzoic acid	5	0.026	533
WP561	Heme biosynthesis	5	0.026	529
WP2333	Trans-sulfuration pathway	10	0.026	562.25
WP3679	Cell-type dependent selectivity of CCK2R signaling	10	0.026	403.75
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	20	0.026	498.75
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	20	0.026	606.5
WP4595	Urea cycle and associated pathways	20	0.026	409.5
WP524	G13 signaling pathway	20	0.026	438.25
WP4389	Bile acids synthesis and enterohepatic circulation	30	0.026	464.5
WP5038	Mitochondrial immune response to SARS-CoV-2	30	0.026	417.5
WP3845	Canonical and non-canonical Notch signaling	2	0.025	433.25
WP3853	ERK pathway in Huntington's disease	2	0.025	434.5
WP3877	MYD88 distinct input-output pathway	2	0.025	426.5
WP3937	Microglia pathogen phagocytosis pathway	2	0.025	435.25
WP4147	PTF1A related regulatory pathway	2	0.025	441
WP4220	Neurotransmitter disorders	2	0.025	452
WP4586	Metabolism of alpha-linolenic acid	2	0.025	434.25
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	3	0.025	479.75
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	3	0.025	482
WP183	Proteasome degradation	4	0.025	466.5
WP2911	miRNA targets in ECM and membrane receptors	4	0.025	472
WP4174	Metabolism of tetrahydrocannabinol (THC)	4	0.025	508.5
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	4	0.025	431.75
WP1603	Nicotine effect on chromaffin cells	5	0.025	527
WP4688	Serine metabolism	5	0.025	521.5
WP3924	Hfe effect on hepcidin production	10	0.025	543
WP4269	Ethanol metabolism production of ROS by CYP2E1	10	0.025	415.75
WP2333	Trans-sulfuration pathway	20	0.025	510.25
WP4940	15q11.2 copy number variation syndrome	20	0.025	605.5
WP734	Serotonin receptor 4/6/7 and NR3C signaling	20	0.025	407.75
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	30	0.025	519.25
WP4324	Mitochondrial complex I assembly model OXPHOS system	30	0.025	642
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	30	0.025	475.5
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	30	0.025	407.25
WP1603	Nicotine effect on chromaffin cells	2	0.024	451.5
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	2	0.024	433.5
WP2038	Microtubule cytoskeleton regulation	2	0.024	397.25
WP2369	Histone modifications	2	0.024	446.5
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	2	0.024	421.75
WP3874	Canonical and non-canonical TGF-B signaling	2	0.024	433.5
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	2	0.024	440.25
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	2	0.024	445
WP4861	Endoplasmic reticulum stress response in coronavirus infection	2	0.024	416.5
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	2	0.024	452.5
WP3634	Insulin signaling in adipocytes (normal condition)	3	0.024	474
WP3635	Insulin signaling in adipocytes (diabetic condition)	3	0.024	474
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	3	0.024	488
WP4595	Urea cycle and associated pathways	3	0.024	466.75
WP5101	Congenital generalized lipodystrophy (CGL)	3	0.024	453.75
WP704	Methylation pathways	3	0.024	481
WP3934	Leptin and adiponectin	4	0.024	506.25
WP411	mRNA processing	4	0.024	491.5
WP4269	Ethanol metabolism production of ROS by CYP2E1	4	0.024	486.25
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	4	0.024	408.75
WP4905	1q21.1 copy number variation syndrome	4	0.024	493.75
WP550	Biogenic amine synthesis	4	0.024	502.5
WP2895	Differentiation of white and brown adipocyte	5	0.024	428.5
WP3845	Canonical and non-canonical Notch signaling	5	0.024	456.5
WP3938	miR-222 in exercise-induced cardiac growth	5	0.024	515.5
WP4222	Phosphodiesterases in neuronal function	5	0.024	398.5
WP4853	Linoleic acid metabolism affected by coronavirus infection	5	0.024	529
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	5	0.024	514.25
WP5031	Biotin metabolism, including IEMs	5	0.024	529.5
WP2253	Pilocytic astrocytoma	10	0.024	578
WP3845	Canonical and non-canonical Notch signaling	10	0.024	424.5
WP3891	Benzene metabolism	10	0.024	561
WP4582	Cancer immunotherapy by CTLA4 blockade	10	0.024	444.5
WP100	Glutathione metabolism	20	0.024	503.5
WP26	S1P receptor signal transduction	20	0.024	443.25
WP3585	Cytosine methylation	20	0.024	606.5
WP3924	Hfe effect on hepcidin production	20	0.024	440
WP3891	Benzene metabolism	30	0.024	458.25
WP3963	Mevalonate pathway	30	0.024	539
WP5061	Fatty acid transporters	30	0.024	593
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	30	0.024	498.5
WP12	Osteoclast signaling	2	0.023	431.25
WP183	Proteasome degradation	2	0.023	429.75
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	2	0.023	433
WP3407	FTO obesity variant mechanism	2	0.023	436
WP3944	Serotonin and anxiety-related events	2	0.023	429.5
WP411	mRNA processing	2	0.023	444.5
WP4259	Disorders of folate metabolism and transport	2	0.023	448.5
WP4688	Serine metabolism	2	0.023	449.5
WP704	Methylation pathways	2	0.023	448
WP3585	Cytosine methylation	3	0.023	486
WP3963	Mevalonate pathway	3	0.023	485
WP4022	Pyrimidine metabolism	3	0.023	472
WP411	mRNA processing	3	0.023	473.75
WP4225	Pyrimidine metabolism and related diseases	3	0.023	478
WP4803	Ciliopathies	3	0.023	466.5
WP2533	Glycerophospholipid biosynthetic pathway	4	0.023	504
WP3845	Canonical and non-canonical Notch signaling	4	0.023	464.5
WP391	Mitochondrial gene expression	4	0.023	493
WP3930	EDA signaling in hair follicle development	4	0.023	499.5
WP3938	miR-222 in exercise-induced cardiac growth	4	0.023	502.5
WP3971	OSX and miRNAs in tooth development	4	0.023	490.25
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	4	0.023	491.5
WP106	Alanine and aspartate metabolism	5	0.023	524.5
WP117	GPCRs, other	5	0.023	450.25
WP2359	Parkin-ubiquitin proteasomal system pathway	5	0.023	506.5
WP2361	Gastric cancer network 1	5	0.023	499.5
WP391	Mitochondrial gene expression	5	0.023	502.5
WP3925	Amino acid metabolism	5	0.023	442
WP3958	GPR40 pathway	5	0.023	518.75
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	5	0.023	514.5
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	5	0.023	477.25
WP391	Mitochondrial gene expression	10	0.023	487.25
WP3971	OSX and miRNAs in tooth development	10	0.023	479
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	10	0.023	548
WP3958	GPR40 pathway	20	0.023	465
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	20	0.023	412.75
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	20	0.023	617
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	30	0.023	466.5
WP4220	Neurotransmitter disorders	30	0.023	507
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	30	0.023	534
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	30	0.023	485
WP197	Cholesterol biosynthesis pathway	2	0.022	450.25
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	2	0.022	448
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	2	0.022	448
WP4912	SARS coronavirus and innate immunity	2	0.022	442.75
WP1455	Serotonin transporter activity	3	0.022	467.75
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	3	0.022	487.5
WP2369	Histone modifications	3	0.022	478.5
WP2513	Nanoparticle triggered regulated necrosis	3	0.022	468.5
WP2636	Common pathways underlying drug addiction	3	0.022	453
WP2895	Differentiation of white and brown adipocyte	3	0.022	457
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	3	0.022	469
WP3934	Leptin and adiponectin	3	0.022	483.5
WP4566	Translation inhibitors in chronically activated PDGFRA cells	3	0.022	426
WP4688	Serine metabolism	3	0.022	484
WP4751	HIPK2 in kidney fibrosis	3	0.022	488
WP4804	Cholesterol biosynthesis with skeletal dysplasias	3	0.022	487.5
WP500	Glycogen synthesis and degradation	3	0.022	465.75
WP2436	Dopamine metabolism	4	0.022	490
WP3580	Methionine de novo and salvage pathway	4	0.022	495
WP4236	Krebs cycle disorders	4	0.022	514.5
WP4803	Ciliopathies	4	0.022	473.5
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	4	0.022	473.5
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	4	0.022	510
WP5038	Mitochondrial immune response to SARS-CoV-2	4	0.022	471.5
WP521	Amino acid conjugation of benzoic acid	4	0.022	514.5
WP2267	Synaptic vesicle pathway	5	0.022	489.5
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	5	0.022	506.5
WP404	Nucleotide metabolism	5	0.022	517
WP4225	Pyrimidine metabolism and related diseases	5	0.022	516.5
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	5	0.022	503.75
WP3644	NAD+ metabolism	10	0.022	556.5
WP4595	Urea cycle and associated pathways	10	0.022	400.25
WP241	One-carbon metabolism	20	0.022	460
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	20	0.022	451.25
WP4224	Purine metabolism and related disorders	20	0.022	458.25
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	20	0.022	471
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	20	0.022	620.5
WP550	Biogenic amine synthesis	20	0.022	545.75
WP699	Aflatoxin B1 metabolism	20	0.022	484
WP2636	Common pathways underlying drug addiction	30	0.022	456.5
WP4584	Biomarkers for pyrimidine metabolism disorders	30	0.022	499
WP1495	Glycine metabolism	2	0.021	454.25
WP1541	Energy metabolism	2	0.021	401.25
WP1992	Genes targeted by miRNAs in adipocytes	2	0.021	431.5
WP2267	Synaptic vesicle pathway	2	0.021	440
WP2513	Nanoparticle triggered regulated necrosis	2	0.021	437
WP3925	Amino acid metabolism	2	0.021	422
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	2	0.021	426
WP100	Glutathione metabolism	3	0.021	480.5
WP117	GPCRs, other	3	0.021	460
WP391	Mitochondrial gene expression	3	0.021	470.5
WP3971	OSX and miRNAs in tooth development	3	0.021	473.5
WP4220	Neurotransmitter disorders	3	0.021	486
WP455	GPCRs, class A rhodopsin-like	3	0.021	443
WP550	Biogenic amine synthesis	3	0.021	481
WP2895	Differentiation of white and brown adipocyte	4	0.021	464.5
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	4	0.021	489
WP501	GPCRs, class C metabotropic glutamate, pheromone	4	0.021	504
WP1495	Glycine metabolism	5	0.021	530.5
WP3674	Tgif disruption of Shh signaling	5	0.021	509.5
WP4595	Urea cycle and associated pathways	5	0.021	493.5
WP477	Cytoplasmic ribosomal proteins	5	0.021	519.5
WP500	Glycogen synthesis and degradation	5	0.021	491.25
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	5	0.021	512
WP1423	Ganglio sphingolipid metabolism	10	0.021	574
WP1600	Nicotine metabolism in liver cells	10	0.021	581.5
WP4157	GABA metabolism (aka GHB)	10	0.021	590.5
WP4236	Krebs cycle disorders	10	0.021	590
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	10	0.021	516.75
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	10	0.021	418.5
WP4269	Ethanol metabolism production of ROS by CYP2E1	20	0.021	416.5
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	20	0.021	412.5
WP22	IL-9 signaling pathway	30	0.021	435.5
WP2359	Parkin-ubiquitin proteasomal system pathway	30	0.021	532.25
WP4224	Purine metabolism and related disorders	30	0.021	466.5
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	30	0.021	457.5
WP4917	Proximal tubule transport	30	0.021	477.25
WP3633	Caffeine and theobromine metabolism	2	0.02	453
WP3634	Insulin signaling in adipocytes (normal condition)	2	0.02	446.5
WP3635	Insulin signaling in adipocytes (diabetic condition)	2	0.02	446.5
WP3644	NAD+ metabolism	2	0.02	448.5
WP391	Mitochondrial gene expression	2	0.02	444.5
WP455	GPCRs, class A rhodopsin-like	2	0.02	422
WP2436	Dopamine metabolism	3	0.02	472
WP3595	mir-124 predicted interactions with cell cycle and differentiation	3	0.02	486
WP3925	Amino acid metabolism	3	0.02	450
WP3996	Ethanol effects on histone modifications	3	0.02	433.75
WP4317	Mitochondrial fatty acid synthesis pathway	3	0.02	488.75
WP4905	1q21.1 copy number variation syndrome	3	0.02	476
WP4962	Airway smooth muscle cell contraction	3	0.02	471
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	3	0.02	487.5
WP22	IL-9 signaling pathway	4	0.02	484.75
WP2333	Trans-sulfuration pathway	4	0.02	505
WP2640	Aripiprazole metabolic pathway	4	0.02	514.5
WP3874	Canonical and non-canonical TGF-B signaling	4	0.02	465.5
WP4533	Transcription co-factors SKI and SKIL protein partners	4	0.02	493.5
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	4	0.02	489.75
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	4	0.02	464
WP4923	Autophagy	4	0.02	492
WP2276	Glial cell differentiation	5	0.02	528.5
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	5	0.02	508.25
WP4174	Metabolism of tetrahydrocannabinol (THC)	5	0.02	524.5
WP678	Arachidonate epoxygenase / epoxide hydrolase	5	0.02	522.25
WP2895	Differentiation of white and brown adipocyte	10	0.02	380.25
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	10	0.02	452
WP1603	Nicotine effect on chromaffin cells	20	0.02	615.5
WP3595	mir-124 predicted interactions with cell cycle and differentiation	20	0.02	620
WP3644	NAD+ metabolism	20	0.02	469.5
WP3679	Cell-type dependent selectivity of CCK2R signaling	20	0.02	427
WP391	Mitochondrial gene expression	20	0.02	498.5
WP3971	OSX and miRNAs in tooth development	20	0.02	479
WP4818	Conversion of angiotensinogen to angiotensin II	20	0.02	621.5
WP4846	SARS-CoV-2 and COVID-19 pathway	20	0.02	414.25
WP4917	Proximal tubule transport	20	0.02	464
WP561	Heme biosynthesis	20	0.02	622.75
WP241	One-carbon metabolism	30	0.02	460
WP26	S1P receptor signal transduction	30	0.02	443.75
WP3674	Tgif disruption of Shh signaling	30	0.02	428.75
WP4788	Autosomal recessive osteopetrosis pathways	30	0.02	453
WP2007	Iron metabolism in placenta	2	0.019	448.5
WP404	Nucleotide metabolism	2	0.019	448.5
WP4595	Urea cycle and associated pathways	2	0.019	435.75
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	2	0.019	433
WP500	Glycogen synthesis and degradation	2	0.019	438.25
WP5064	7-oxo-C and 7-beta-HC pathways	2	0.019	439.25
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	2	0.019	452.5
WP699	Aflatoxin B1 metabolism	2	0.019	448.5
WP325	Triacylglyceride synthesis	3	0.019	474.75
WP4222	Phosphodiesterases in neuronal function	3	0.019	454
WP4259	Disorders of folate metabolism and transport	3	0.019	482
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	3	0.019	472.25
WP1602	Nicotine effect on dopaminergic neurons	4	0.019	505
WP2359	Parkin-ubiquitin proteasomal system pathway	4	0.019	490.25
WP2366	Butyrate-induced histone acetylation	4	0.019	507
WP2596	Gastric acid production	4	0.019	507
WP26	S1P receptor signal transduction	4	0.019	483.25
WP288	Nod-like receptor (NLR) signaling pathway	4	0.019	494.75
WP3996	Ethanol effects on histone modifications	4	0.019	372
WP4324	Mitochondrial complex I assembly model OXPHOS system	4	0.019	511.25
WP1425	Bone morphogenic protein (BMP) signaling and regulation	5	0.019	520
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	5	0.019	394.5
WP4923	Autophagy	5	0.019	500.25
WP22	IL-9 signaling pathway	10	0.019	428.5
WP288	Nod-like receptor (NLR) signaling pathway	10	0.019	520.25
WP4225	Pyrimidine metabolism and related diseases	10	0.019	556.5
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	20	0.019	447.75
WP288	Nod-like receptor (NLR) signaling pathway	20	0.019	462.25
WP3845	Canonical and non-canonical Notch signaling	20	0.019	451.25
WP1423	Ganglio sphingolipid metabolism	30	0.019	486
WP2333	Trans-sulfuration pathway	30	0.019	522.25
WP4582	Cancer immunotherapy by CTLA4 blockade	30	0.019	463.25
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	30	0.019	605
WP5031	Biotin metabolism, including IEMs	30	0.019	632.5
WP5050	TCA cycle in senescence	30	0.019	394.25
WP3670	Interactions between LOXL4 and oxidative stress pathway	2	0.018	426.5
WP3965	Lipid metabolism pathway	2	0.018	434
WP4269	Ethanol metabolism production of ROS by CYP2E1	2	0.018	441.5
WP4723	Omega-3 / omega-6 fatty acid synthesis	2	0.018	449.5
WP4724	Omega-9 fatty acid synthesis	2	0.018	446.5
WP561	Heme biosynthesis	2	0.018	453
WP26	S1P receptor signal transduction	3	0.018	467
WP3679	Cell-type dependent selectivity of CCK2R signaling	3	0.018	466.5
WP404	Nucleotide metabolism	3	0.018	481.25
WP4224	Purine metabolism and related disorders	3	0.018	479
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	3	0.018	475
WP561	Heme biosynthesis	3	0.018	487.5
WP117	GPCRs, other	4	0.018	466.5
WP241	One-carbon metabolism	4	0.018	484.5
WP2889	Oxytocin signaling	4	0.018	513
WP3925	Amino acid metabolism	4	0.018	435.25
WP4400	FABP4 in ovarian cancer	4	0.018	514.5
WP4566	Translation inhibitors in chronically activated PDGFRA cells	4	0.018	418.25
WP4582	Cancer immunotherapy by CTLA4 blockade	4	0.018	480.75
WP4722	Glycerolipids and glycerophospholipids	4	0.018	499.25
WP477	Cytoplasmic ribosomal proteins	4	0.018	504.75
WP4789	MED and pseudoachondroplasia genes	4	0.018	513.5
WP1600	Nicotine metabolism in liver cells	5	0.018	528.5
WP2333	Trans-sulfuration pathway	5	0.018	520
WP2436	Dopamine metabolism	5	0.018	502.5
WP2491	Diclofenac metabolic pathway	5	0.018	530
WP2636	Common pathways underlying drug addiction	5	0.018	401.75
WP288	Nod-like receptor (NLR) signaling pathway	5	0.018	507.75
WP3930	EDA signaling in hair follicle development	5	0.018	513.75
WP3934	Leptin and adiponectin	5	0.018	524.5
WP4324	Mitochondrial complex I assembly model OXPHOS system	5	0.018	530.5
WP4751	HIPK2 in kidney fibrosis	5	0.018	529.5
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	5	0.018	516.5
WP690	Polyol pathway	5	0.018	530
WP244	Alpha 6 beta 4 signaling pathway	10	0.018	422.75
WP3858	Toll-like receptor signaling related to MyD88	10	0.018	419
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	20	0.018	625.5
WP22	IL-9 signaling pathway	20	0.018	433.5
WP438	Non-homologous end joining	30	0.018	534
WP4566	Translation inhibitors in chronically activated PDGFRA cells	30	0.018	474
WP4861	Endoplasmic reticulum stress response in coronavirus infection	30	0.018	475
WP357	Fatty acid biosynthesis	2	0.017	445.25
WP3595	mir-124 predicted interactions with cell cycle and differentiation	2	0.017	453
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	2	0.017	454.5
WP4236	Krebs cycle disorders	2	0.017	455
WP4905	1q21.1 copy number variation syndrome	2	0.017	443.5
WP4923	Autophagy	2	0.017	443.25
WP4942	15q13.3 copy number variation syndrome	2	0.017	431.5
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	2	0.017	446.5
WP2640	Aripiprazole metabolic pathway	3	0.017	489
WP3845	Canonical and non-canonical Notch signaling	3	0.017	462
WP4536	Genes related to primary cilium development (based on CRISPR)	3	0.017	484.5
WP521	Amino acid conjugation of benzoic acid	3	0.017	490
WP524	G13 signaling pathway	3	0.017	453.5
WP2267	Synaptic vesicle pathway	4	0.017	483.25
WP24	Peptide GPCRs	4	0.017	465.25
WP2636	Common pathways underlying drug addiction	4	0.017	438.25
WP4222	Phosphodiesterases in neuronal function	4	0.017	440.75
WP4804	Cholesterol biosynthesis with skeletal dysplasias	4	0.017	510.75
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	4	0.017	498.5
WP5052	Nephrogenesis	4	0.017	495.5
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	4	0.017	501
WP2369	Histone modifications	5	0.017	512.25
WP244	Alpha 6 beta 4 signaling pathway	5	0.017	414
WP2542	Sulindac metabolic pathway	5	0.017	526.5
WP2911	miRNA targets in ECM and membrane receptors	5	0.017	485.25
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	5	0.017	498
WP455	GPCRs, class A rhodopsin-like	5	0.017	426
WP4803	Ciliopathies	5	0.017	477
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	5	0.017	528
WP4922	Mitochondrial complex IV assembly	5	0.017	528.5
WP501	GPCRs, class C metabotropic glutamate, pheromone	5	0.017	515.5
WP5038	Mitochondrial immune response to SARS-CoV-2	5	0.017	470.5
WP24	Peptide GPCRs	10	0.017	444.5
WP2636	Common pathways underlying drug addiction	10	0.017	397.5
WP4030	SCFA and skeletal muscle substrate metabolism	10	0.017	568.5
WP4224	Purine metabolism and related disorders	10	0.017	465.75
WP4846	SARS-CoV-2 and COVID-19 pathway	10	0.017	442.75
WP4905	1q21.1 copy number variation syndrome	10	0.017	445
WP3934	Leptin and adiponectin	20	0.017	605.5
WP4566	Translation inhibitors in chronically activated PDGFRA cells	20	0.017	459
WP3934	Leptin and adiponectin	30	0.017	522
WP4288	MTHFR deficiency	30	0.017	455.5
WP4940	15q11.2 copy number variation syndrome	30	0.017	442.5
WP3585	Cytosine methylation	2	0.016	453
WP3891	Benzene metabolism	2	0.016	449.5
WP3934	Leptin and adiponectin	2	0.016	450.5
WP5031	Biotin metabolism, including IEMs	2	0.016	453.5
WP244	Alpha 6 beta 4 signaling pathway	3	0.016	440.5
WP2889	Oxytocin signaling	3	0.016	489
WP2911	miRNA targets in ECM and membrane receptors	3	0.016	461.75
WP4656	Joubert syndrome	3	0.016	469.25
WP4789	MED and pseudoachondroplasia genes	3	0.016	488
WP501	GPCRs, class C metabotropic glutamate, pheromone	3	0.016	481.75
WP5052	Nephrogenesis	3	0.016	476
WP107	Translation factors	4	0.016	496
WP3963	Mevalonate pathway	4	0.016	507.5
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	4	0.016	513.25
WP4922	Mitochondrial complex IV assembly	4	0.016	509.5
WP678	Arachidonate epoxygenase / epoxide hydrolase	4	0.016	505.5
WP2640	Aripiprazole metabolic pathway	5	0.016	532
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	5	0.016	516
WP3644	NAD+ metabolism	5	0.016	515
WP3963	Mevalonate pathway	5	0.016	525.5
WP4236	Krebs cycle disorders	5	0.016	532
WP3930	EDA signaling in hair follicle development	10	0.016	555.75
WP3940	One-carbon metabolism and related pathways	10	0.016	401.75
WP2253	Pilocytic astrocytoma	20	0.016	509.25
WP2636	Common pathways underlying drug addiction	20	0.016	446.25
WP2943	Hypoxia-mediated EMT and stemness	20	0.016	622.5
WP4571	Urea cycle and related diseases	20	0.016	625
WP4922	Mitochondrial complex IV assembly	20	0.016	620.5
WP143	Fatty acid beta-oxidation	30	0.016	560.25
WP2253	Pilocytic astrocytoma	30	0.016	469.75
WP391	Mitochondrial gene expression	30	0.016	513
WP3924	Hfe effect on hepcidin production	30	0.016	456.5
WP4533	Transcription co-factors SKI and SKIL protein partners	30	0.016	456.5
WP2889	Oxytocin signaling	2	0.015	454
WP334	GPCRs, class B secretin-like	2	0.015	449.5
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	2	0.015	441.5
WP3971	OSX and miRNAs in tooth development	2	0.015	442.5
WP410	Exercise-induced circadian regulation	2	0.015	433.5
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	2	0.015	449.5
WP4785	Somitogenesis in the context of spondylocostal dysostosis	2	0.015	452.75
WP4788	Autosomal recessive osteopetrosis pathways	2	0.015	445
WP4904	LDLRAD4 and what we know about it	2	0.015	451.5
WP58	Monoamine GPCRs	2	0.015	453
WP1603	Nicotine effect on chromaffin cells	3	0.015	486
WP183	Proteasome degradation	3	0.015	460
WP2113	Type III interferon signaling	3	0.015	484.75
WP2267	Synaptic vesicle pathway	3	0.015	467.75
WP2359	Parkin-ubiquitin proteasomal system pathway	3	0.015	472
WP3633	Caffeine and theobromine metabolism	3	0.015	487.5
WP3858	Toll-like receptor signaling related to MyD88	3	0.015	460.5
WP3869	Cannabinoid receptor signaling	3	0.015	469
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	3	0.015	476.25
WP4236	Krebs cycle disorders	3	0.015	489.25
WP4400	FABP4 in ovarian cancer	3	0.015	489
WP4533	Transcription co-factors SKI and SKIL protein partners	3	0.015	474.5
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	3	0.015	463.5
WP4923	Autophagy	3	0.015	474.25
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	3	0.015	477
WP58	Monoamine GPCRs	3	0.015	487.5
WP1422	Sphingolipid pathway	4	0.015	500.5
WP1425	Bone morphogenic protein (BMP) signaling and regulation	4	0.015	506.5
WP334	GPCRs, class B secretin-like	4	0.015	504.5
WP3595	mir-124 predicted interactions with cell cycle and differentiation	4	0.015	509.5
WP4751	HIPK2 in kidney fibrosis	4	0.015	513
WP4846	SARS-CoV-2 and COVID-19 pathway	4	0.015	490.5
WP4872	MAP3K1 role in promoting and blocking gonadal determination	4	0.015	488.25
WP623	Oxidative phosphorylation	4	0.015	507.75
WP78	TCA cycle (aka Krebs or citric acid cycle)	4	0.015	512
WP1422	Sphingolipid pathway	5	0.015	515.25
WP26	S1P receptor signal transduction	5	0.015	491.75
WP3300	Dual hijack model of Vif in HIV infection	5	0.015	497.5
WP368	Mitochondrial long chain fatty acid beta-oxidation	5	0.015	523.25
WP3858	Toll-like receptor signaling related to MyD88	5	0.015	466.25
WP4157	GABA metabolism (aka GHB)	5	0.015	531.5
WP4566	Translation inhibitors in chronically activated PDGFRA cells	5	0.015	385.25
WP4571	Urea cycle and related diseases	5	0.015	528
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	5	0.015	464.75
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	5	0.015	529
WP117	GPCRs, other	10	0.015	443.5
WP2366	Butyrate-induced histone acetylation	10	0.015	570.25
WP411	mRNA processing	10	0.015	497
WP4788	Autosomal recessive osteopetrosis pathways	10	0.015	544.25
WP3858	Toll-like receptor signaling related to MyD88	20	0.015	460.75
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	20	0.015	463
WP4804	Cholesterol biosynthesis with skeletal dysplasias	20	0.015	617
WP3925	Amino acid metabolism	30	0.015	551
WP3958	GPR40 pathway	30	0.015	478.5
WP3971	OSX and miRNAs in tooth development	30	0.015	484.25
WP143	Fatty acid beta-oxidation	2	0.014	445.5
WP2333	Trans-sulfuration pathway	2	0.014	450.5
WP2636	Common pathways underlying drug addiction	2	0.014	433
WP2943	Hypoxia-mediated EMT and stemness	2	0.014	453.5
WP3676	BDNF-TrkB signaling	2	0.014	439.75
WP3679	Cell-type dependent selectivity of CCK2R signaling	2	0.014	444
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	2	0.014	442.5
WP4389	Bile acids synthesis and enterohepatic circulation	2	0.014	442.5
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	2	0.014	444.5
WP4962	Airway smooth muscle cell contraction	2	0.014	442.25
WP5037	Riboflavin and CoQ disorders	2	0.014	453.5
WP3644	NAD+ metabolism	3	0.014	479.75
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	3	0.014	473.5
WP3940	One-carbon metabolism and related pathways	3	0.014	438.5
WP4722	Glycerolipids and glycerophospholipids	3	0.014	476
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	3	0.014	479
WP1600	Nicotine metabolism in liver cells	4	0.014	509
WP2369	Histone modifications	4	0.014	500
WP2491	Diclofenac metabolic pathway	4	0.014	512
WP2542	Sulindac metabolic pathway	4	0.014	509.5
WP3644	NAD+ metabolism	4	0.014	502.5
WP3924	Hfe effect on hepcidin production	4	0.014	497.5
WP3940	One-carbon metabolism and related pathways	4	0.014	388.5
WP4571	Urea cycle and related diseases	4	0.014	511.5
WP4853	Linoleic acid metabolism affected by coronavirus infection	4	0.014	513
WP107	Translation factors	5	0.014	509.5
WP134	Pentose phosphate metabolism	5	0.014	534
WP3996	Ethanol effects on histone modifications	5	0.014	361.25
WP4224	Purine metabolism and related disorders	5	0.014	510.75
WP4400	FABP4 in ovarian cancer	5	0.014	532.25
WP4789	MED and pseudoachondroplasia genes	5	0.014	530.5
WP4846	SARS-CoV-2 and COVID-19 pathway	5	0.014	505
WP106	Alanine and aspartate metabolism	10	0.014	578.5
WP1589	Folate-alcohol and cancer pathway hypotheses	10	0.014	554.75
WP241	One-carbon metabolism	10	0.014	421
WP3934	Leptin and adiponectin	10	0.014	574
WP4222	Phosphodiesterases in neuronal function	10	0.014	448.25
WP4533	Transcription co-factors SKI and SKIL protein partners	10	0.014	474.25
WP4566	Translation inhibitors in chronically activated PDGFRA cells	10	0.014	412.25
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	10	0.014	579
WP3875	ATR signaling	20	0.014	626.25
WP4297	Thiamine metabolic pathways	20	0.014	613
WP244	Alpha 6 beta 4 signaling pathway	30	0.014	467.25
WP334	GPCRs, class B secretin-like	30	0.014	518
WP3595	mir-124 predicted interactions with cell cycle and differentiation	30	0.014	530.25
WP3858	Toll-like receptor signaling related to MyD88	30	0.014	472
WP699	Aflatoxin B1 metabolism	30	0.014	482
WP107	Translation factors	2	0.013	445
WP1422	Sphingolipid pathway	2	0.013	449.5
WP244	Alpha 6 beta 4 signaling pathway	2	0.013	426
WP2640	Aripiprazole metabolic pathway	2	0.013	455
WP4566	Translation inhibitors in chronically activated PDGFRA cells	2	0.013	419.75
WP477	Cytoplasmic ribosomal proteins	2	0.013	450
WP4792	Purine metabolism	2	0.013	451
WP4853	Linoleic acid metabolism affected by coronavirus infection	2	0.013	454.5
WP5061	Fatty acid transporters	2	0.013	450.5
WP1425	Bone morphogenic protein (BMP) signaling and regulation	3	0.013	483
WP1600	Nicotine metabolism in liver cells	3	0.013	487.5
WP2276	Glial cell differentiation	3	0.013	488
WP2491	Diclofenac metabolic pathway	3	0.013	487.5
WP3871	Valproic acid pathway	3	0.013	486.5
WP3930	EDA signaling in hair follicle development	3	0.013	480
WP678	Arachidonate epoxygenase / epoxide hydrolase	3	0.013	484
WP106	Alanine and aspartate metabolism	4	0.013	509
WP2276	Glial cell differentiation	4	0.013	511.75
WP3871	Valproic acid pathway	4	0.013	509.75
WP4030	SCFA and skeletal muscle substrate metabolism	4	0.013	503
WP4224	Purine metabolism and related disorders	4	0.013	495.5
WP4288	MTHFR deficiency	4	0.013	483
WP4317	Mitochondrial fatty acid synthesis pathway	4	0.013	514.5
WP1589	Folate-alcohol and cancer pathway hypotheses	5	0.013	518.5
WP1602	Nicotine effect on dopaminergic neurons	5	0.013	520
WP24	Peptide GPCRs	5	0.013	473
WP2485	NAD biosynthesis II (from tryptophan)	5	0.013	533.5
WP2596	Gastric acid production	5	0.013	522.75
WP3871	Valproic acid pathway	5	0.013	528.25
WP4921	Mitochondrial complex III assembly	5	0.013	533
WP501	GPCRs, class C metabotropic glutamate, pheromone	10	0.013	567.5
WP4533	Transcription co-factors SKI and SKIL protein partners	20	0.013	463
WP455	GPCRs, class A rhodopsin-like	20	0.013	532.75
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	20	0.013	453.5
WP5031	Biotin metabolism, including IEMs	20	0.013	622
WP3300	Dual hijack model of Vif in HIV infection	30	0.013	453
WP3585	Cytosine methylation	30	0.013	544
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	30	0.013	436.5
WP325	Triacylglyceride synthesis	2	0.012	444.5
WP3869	Cannabinoid receptor signaling	2	0.012	442.5
WP3996	Ethanol effects on histone modifications	2	0.012	417.5
WP4656	Joubert syndrome	2	0.012	442.75
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	2	0.012	455
WP5052	Nephrogenesis	2	0.012	444.5
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	2	0.012	445
WP550	Biogenic amine synthesis	2	0.012	449
WP1422	Sphingolipid pathway	3	0.012	480.5
WP2253	Pilocytic astrocytoma	3	0.012	484.5
WP2333	Trans-sulfuration pathway	3	0.012	484
WP2943	Hypoxia-mediated EMT and stemness	3	0.012	487
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	3	0.012	489.25
WP334	GPCRs, class B secretin-like	3	0.012	483
WP3924	Hfe effect on hepcidin production	3	0.012	476
WP3958	GPR40 pathway	3	0.012	485.25
WP4324	Mitochondrial complex I assembly model OXPHOS system	3	0.012	488.25
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	3	0.012	488
WP4922	Mitochondrial complex IV assembly	3	0.012	486.75
WP5038	Mitochondrial immune response to SARS-CoV-2	3	0.012	463.75
WP134	Pentose phosphate metabolism	4	0.012	515.5
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	4	0.012	494.75
WP3300	Dual hijack model of Vif in HIV infection	4	0.012	491.5
WP3858	Toll-like receptor signaling related to MyD88	4	0.012	470
WP334	GPCRs, class B secretin-like	5	0.012	517.5
WP4536	Genes related to primary cilium development (based on CRISPR)	5	0.012	515
WP4725	Sphingolipid metabolism overview	5	0.012	513.5
WP4726	Sphingolipid metabolism: integrated pathway	5	0.012	513.5
WP4905	1q21.1 copy number variation syndrome	5	0.012	499.5
WP2267	Synaptic vesicle pathway	10	0.012	491.5
WP3655	Hypothetical craniofacial development pathway	10	0.012	576.5
WP4288	MTHFR deficiency	10	0.012	428
WP4785	Somitogenesis in the context of spondylocostal dysostosis	10	0.012	579.75
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	10	0.012	575
WP692	Sulfation biotransformation reaction	10	0.012	580.5
WP106	Alanine and aspartate metabolism	20	0.012	614.75
WP1422	Sphingolipid pathway	20	0.012	507.5
WP1589	Folate-alcohol and cancer pathway hypotheses	20	0.012	479.5
WP2267	Synaptic vesicle pathway	20	0.012	530.5
WP2854	Gene regulatory network modelling somitogenesis	20	0.012	510.5
WP3930	EDA signaling in hair follicle development	20	0.012	499.5
WP4225	Pyrimidine metabolism and related diseases	20	0.012	502.75
WP100	Glutathione metabolism	30	0.012	515.25
WP3875	ATR signaling	30	0.012	640.25
WP4157	GABA metabolism (aka GHB)	30	0.012	647.5
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	30	0.012	444.75
WP4804	Cholesterol biosynthesis with skeletal dysplasias	30	0.012	494
WP4905	1q21.1 copy number variation syndrome	30	0.012	460.75
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	30	0.012	637
WP550	Biogenic amine synthesis	30	0.012	543
WP134	Pentose phosphate metabolism	2	0.011	455.5
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	2	0.011	454
WP241	One-carbon metabolism	2	0.011	438.5
WP2485	NAD biosynthesis II (from tryptophan)	2	0.011	455.25
WP2895	Differentiation of white and brown adipocyte	2	0.011	433.5
WP2911	miRNA targets in ECM and membrane receptors	2	0.011	436
WP3580	Methionine de novo and salvage pathway	2	0.011	445
WP4536	Genes related to primary cilium development (based on CRISPR)	2	0.011	450.5
WP4789	MED and pseudoachondroplasia genes	2	0.011	454
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	2	0.011	452
WP4921	Mitochondrial complex III assembly	2	0.011	455.5
WP5089	Kinin-Kallikrein pathway	2	0.011	452.5
WP521	Amino acid conjugation of benzoic acid	2	0.011	455
WP106	Alanine and aspartate metabolism	3	0.011	486
WP134	Pentose phosphate metabolism	3	0.011	491
WP3580	Methionine de novo and salvage pathway	3	0.011	478.5
WP368	Mitochondrial long chain fatty acid beta-oxidation	3	0.011	484.5
WP422	MAPK cascade	3	0.011	466.25
WP4582	Cancer immunotherapy by CTLA4 blockade	3	0.011	467.75
WP1603	Nicotine effect on chromaffin cells	4	0.011	509
WP2485	NAD biosynthesis II (from tryptophan)	4	0.011	515.75
WP4228	Vitamin B6-dependent and responsive disorders	4	0.011	515.5
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	4	0.011	513.75
WP22	IL-9 signaling pathway	5	0.011	497.25
WP2889	Oxytocin signaling	5	0.011	530.5
WP3924	Hfe effect on hepcidin production	5	0.011	511
WP3940	One-carbon metabolism and related pathways	5	0.011	375.75
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	5	0.011	531.25
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	5	0.011	527
WP4904	LDLRAD4 and what we know about it	5	0.011	520.5
WP100	Glutathione metabolism	10	0.011	556.5
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	10	0.011	546.5
WP4150	Wnt signaling in kidney disease	10	0.011	481.25
WP4583	Biomarkers for urea cycle disorders	10	0.011	579
WP4725	Sphingolipid metabolism overview	10	0.011	530.25
WP4726	Sphingolipid metabolism: integrated pathway	10	0.011	530.25
WP4803	Ciliopathies	10	0.011	487
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	10	0.011	555.5
WP1495	Glycine metabolism	20	0.011	627.25
WP334	GPCRs, class B secretin-like	20	0.011	499.75
WP3633	Caffeine and theobromine metabolism	20	0.011	626.5
WP3655	Hypothetical craniofacial development pathway	20	0.011	599
WP3940	One-carbon metabolism and related pathways	20	0.011	428.5
WP4222	Phosphodiesterases in neuronal function	20	0.011	512.5
WP4583	Biomarkers for urea cycle disorders	20	0.011	616.75
WP4788	Autosomal recessive osteopetrosis pathways	20	0.011	430
WP4905	1q21.1 copy number variation syndrome	20	0.011	445.5
WP501	GPCRs, class C metabotropic glutamate, pheromone	20	0.011	518.75
WP106	Alanine and aspartate metabolism	30	0.011	574.75
WP1589	Folate-alcohol and cancer pathway hypotheses	30	0.011	480.75
WP2826	Cocaine metabolism	30	0.011	412.25
WP3655	Hypothetical craniofacial development pathway	30	0.011	522.75
WP4785	Somitogenesis in the context of spondylocostal dysostosis	30	0.011	514.5
WP2113	Type III interferon signaling	2	0.01	449.5
WP2276	Glial cell differentiation	2	0.01	453.5
WP2371	Parkinson's disease pathway	2	0.01	441.5
WP2436	Dopamine metabolism	2	0.01	441.5
WP4317	Mitochondrial fatty acid synthesis pathway	2	0.01	455
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	2	0.01	444.25
WP694	Arylamine metabolism	2	0.01	452.5
WP241	One-carbon metabolism	3	0.01	469.5
WP4228	Vitamin B6-dependent and responsive disorders	3	0.01	489.5
WP4571	Urea cycle and related diseases	3	0.01	487.5
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	3	0.01	482
WP623	Oxidative phosphorylation	3	0.01	486
WP78	TCA cycle (aka Krebs or citric acid cycle)	3	0.01	488.5
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	4	0.01	504
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	4	0.01	515.5
WP368	Mitochondrial long chain fatty acid beta-oxidation	4	0.01	507.25
WP3933	Kennedy pathway from sphingolipids	4	0.01	506
WP4157	GABA metabolism (aka GHB)	4	0.01	514.5
WP4656	Joubert syndrome	4	0.01	485.5
WP4725	Sphingolipid metabolism overview	4	0.01	499.25
WP4726	Sphingolipid metabolism: integrated pathway	4	0.01	499.25
WP4940	15q11.2 copy number variation syndrome	4	0.01	508
WP1423	Ganglio sphingolipid metabolism	5	0.01	521.5
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	5	0.01	524.5
WP241	One-carbon metabolism	5	0.01	486
WP2533	Glycerophospholipid biosynthetic pathway	5	0.01	517.5
WP422	MAPK cascade	5	0.01	487
WP4788	Autosomal recessive osteopetrosis pathways	5	0.01	511.5
WP107	Translation factors	10	0.01	528.5
WP2369	Histone modifications	10	0.01	529
WP1423	Ganglio sphingolipid metabolism	20	0.01	488.5
WP2007	Iron metabolism in placenta	20	0.01	509.75
WP2371	Parkinson's disease pathway	20	0.01	521.75
WP2491	Diclofenac metabolic pathway	20	0.01	628
WP3871	Valproic acid pathway	20	0.01	619.5
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	20	0.01	627.25
WP4582	Cancer immunotherapy by CTLA4 blockade	20	0.01	449.25
WP528	Acetylcholine synthesis	20	0.01	502.25
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	30	0.01	463
WP2491	Diclofenac metabolic pathway	30	0.01	646
WP455	GPCRs, class A rhodopsin-like	30	0.01	568.5
WP690	Polyol pathway	30	0.01	645.5
WP100	Glutathione metabolism	2	0.009	446.5
WP1423	Ganglio sphingolipid metabolism	2	0.009	452
WP24	Peptide GPCRs	2	0.009	431.25
WP2596	Gastric acid production	2	0.009	451.75
WP288	Nod-like receptor (NLR) signaling pathway	2	0.009	446.5
WP3924	Hfe effect on hepcidin production	2	0.009	445.5
WP3940	One-carbon metabolism and related pathways	2	0.009	423.5
WP3963	Mevalonate pathway	2	0.009	452.25
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	2	0.009	450.5
WP4150	Wnt signaling in kidney disease	2	0.009	442.5
WP4222	Phosphodiesterases in neuronal function	2	0.009	433
WP4288	MTHFR deficiency	2	0.009	437.75
WP4400	FABP4 in ovarian cancer	2	0.009	455
WP4504	Cysteine and methionine catabolism	2	0.009	449.25
WP4521	Glycosylation and related congenital defects	2	0.009	453
WP4722	Glycerolipids and glycerophospholipids	2	0.009	447.25
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	2	0.009	453.5
WP5038	Mitochondrial immune response to SARS-CoV-2	2	0.009	432.5
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	2	0.009	449
WP692	Sulfation biotransformation reaction	2	0.009	453
WP1602	Nicotine effect on dopaminergic neurons	3	0.009	484
WP2533	Glycerophospholipid biosynthetic pathway	3	0.009	482
WP288	Nod-like receptor (NLR) signaling pathway	3	0.009	478.5
WP3300	Dual hijack model of Vif in HIV infection	3	0.009	474
WP3891	Benzene metabolism	3	0.009	482
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	3	0.009	489.25
WP477	Cytoplasmic ribosomal proteins	3	0.009	482
WP3674	Tgif disruption of Shh signaling	4	0.009	492
WP4150	Wnt signaling in kidney disease	4	0.009	488
WP4536	Genes related to primary cilium development (based on CRISPR)	4	0.009	504
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	4	0.009	499.5
WP3875	ATR signaling	5	0.009	529.5
WP4228	Vitamin B6-dependent and responsive disorders	5	0.009	533.5
WP4582	Cancer immunotherapy by CTLA4 blockade	5	0.009	498
WP4872	MAP3K1 role in promoting and blocking gonadal determination	5	0.009	502.5
WP2007	Iron metabolism in placenta	10	0.009	564.25
WP334	GPCRs, class B secretin-like	10	0.009	559
WP2290	RalA downstream regulated genes	20	0.009	612.25
WP3300	Dual hijack model of Vif in HIV infection	20	0.009	405.75
WP78	TCA cycle (aka Krebs or citric acid cycle)	20	0.009	628.5
WP2007	Iron metabolism in placenta	30	0.009	513.25
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	30	0.009	458.5
WP3930	EDA signaling in hair follicle development	30	0.009	516
WP4236	Krebs cycle disorders	30	0.009	648
WP4297	Thiamine metabolic pathways	30	0.009	537.5
WP4751	HIPK2 in kidney fibrosis	30	0.009	642
WP4922	Mitochondrial complex IV assembly	30	0.009	633
WP501	GPCRs, class C metabotropic glutamate, pheromone	30	0.009	528.25
WP106	Alanine and aspartate metabolism	2	0.008	452.5
WP1425	Bone morphogenic protein (BMP) signaling and regulation	2	0.008	450.25
WP22	IL-9 signaling pathway	2	0.008	439.75
WP26	S1P receptor signal transduction	2	0.008	440
WP4194	Hormonal control of pubertal growth spurt	2	0.008	454.5
WP4224	Purine metabolism and related disorders	2	0.008	444.5
WP4228	Vitamin B6-dependent and responsive disorders	2	0.008	455
WP4571	Urea cycle and related diseases	2	0.008	453
WP4725	Sphingolipid metabolism overview	2	0.008	447.75
WP4726	Sphingolipid metabolism: integrated pathway	2	0.008	447.75
WP4922	Mitochondrial complex IV assembly	2	0.008	453
WP4927	COVID-19, thrombosis and anticoagulation	2	0.008	452.5
WP501	GPCRs, class C metabotropic glutamate, pheromone	2	0.008	449.75
WP5101	Congenital generalized lipodystrophy (CGL)	2	0.008	431.75
WP107	Translation factors	3	0.008	478.75
WP2485	NAD biosynthesis II (from tryptophan)	3	0.008	490.75
WP2596	Gastric acid production	3	0.008	484.5
WP4194	Hormonal control of pubertal growth spurt	3	0.008	488
WP4788	Autosomal recessive osteopetrosis pathways	3	0.008	475.5
WP4921	Mitochondrial complex III assembly	3	0.008	490.75
WP5037	Riboflavin and CoQ disorders	3	0.008	488
WP244	Alpha 6 beta 4 signaling pathway	4	0.008	439.25
WP3676	BDNF-TrkB signaling	4	0.008	481.75
WP3875	ATR signaling	4	0.008	513
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	4	0.008	514
WP497	Urea cycle and metabolism of amino groups	4	0.008	504
WP528	Acetylcholine synthesis	4	0.008	501.25
WP2253	Pilocytic astrocytoma	5	0.008	523.25
WP2371	Parkinson's disease pathway	5	0.008	499.25
WP3869	Cannabinoid receptor signaling	5	0.008	501.5
WP3891	Benzene metabolism	5	0.008	516.25
WP4288	MTHFR deficiency	5	0.008	482.25
WP1422	Sphingolipid pathway	10	0.008	549
WP1425	Bone morphogenic protein (BMP) signaling and regulation	10	0.008	569.5
WP2290	RalA downstream regulated genes	10	0.008	574
WP2371	Parkinson's disease pathway	10	0.008	497.75
WP3529	Zinc homeostasis	10	0.008	578.25
WP4271	Vitamin B12 disorders	10	0.008	579
WP438	Non-homologous end joining	10	0.008	578
WP4922	Mitochondrial complex IV assembly	10	0.008	581.5
WP80	Nucleotide GPCRs	10	0.008	583.5
WP1425	Bone morphogenic protein (BMP) signaling and regulation	20	0.008	571.5
WP1600	Nicotine metabolism in liver cells	20	0.008	617.5
WP244	Alpha 6 beta 4 signaling pathway	20	0.008	455.25
WP4288	MTHFR deficiency	20	0.008	462.75
WP4504	Cysteine and methionine catabolism	20	0.008	503.5
WP4784	Proteoglycan biosynthesis	20	0.008	563.75
WP4785	Somitogenesis in the context of spondylocostal dysostosis	20	0.008	619.25
WP4904	LDLRAD4 and what we know about it	20	0.008	507.5
WP690	Polyol pathway	20	0.008	626.5
WP2533	Glycerophospholipid biosynthetic pathway	30	0.008	541.5
WP2943	Hypoxia-mediated EMT and stemness	30	0.008	638
WP111	Electron transport chain: OXPHOS system in mitochondria	2	0.007	449
WP1600	Nicotine metabolism in liver cells	2	0.007	453.5
WP1602	Nicotine effect on dopaminergic neurons	2	0.007	452
WP3655	Hypothetical craniofacial development pathway	2	0.007	450.5
WP3875	ATR signaling	2	0.007	453
WP3958	GPR40 pathway	2	0.007	450.5
WP4157	GABA metabolism (aka GHB)	2	0.007	454.75
WP4324	Mitochondrial complex I assembly model OXPHOS system	2	0.007	454.25
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	2	0.007	454
WP5030	Ethylmalonic encephalopathy	2	0.007	455
WP690	Polyol pathway	2	0.007	454
WP78	TCA cycle (aka Krebs or citric acid cycle)	2	0.007	454
WP24	Peptide GPCRs	3	0.007	460.5
WP4271	Vitamin B12 disorders	3	0.007	486
WP4288	MTHFR deficiency	3	0.007	466.5
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	3	0.007	488.5
WP4872	MAP3K1 role in promoting and blocking gonadal determination	3	0.007	471.5
WP5074	Kallmann syndrome	3	0.007	475
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	3	0.007	487
WP111	Electron transport chain: OXPHOS system in mitochondria	4	0.007	500.75
WP1423	Ganglio sphingolipid metabolism	4	0.007	504.5
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	4	0.007	512.75
WP4788	Autosomal recessive osteopetrosis pathways	4	0.007	494
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	4	0.007	508
WP4921	Mitochondrial complex III assembly	4	0.007	515.5
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	5	0.007	533.5
WP3676	BDNF-TrkB signaling	5	0.007	495.25
WP4150	Wnt signaling in kidney disease	5	0.007	493.5
WP4317	Mitochondrial fatty acid synthesis pathway	5	0.007	532.5
WP623	Oxidative phosphorylation	5	0.007	524.5
WP3869	Cannabinoid receptor signaling	10	0.007	489
WP3875	ATR signaling	10	0.007	586.5
WP4297	Thiamine metabolic pathways	10	0.007	577.5
WP5037	Riboflavin and CoQ disorders	10	0.007	582.5
WP107	Translation factors	20	0.007	550
WP411	mRNA processing	20	0.007	557
WP4194	Hormonal control of pubertal growth spurt	20	0.007	632.25
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	20	0.007	629
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	20	0.007	607
WP1422	Sphingolipid pathway	30	0.007	528.75
WP1425	Bone morphogenic protein (BMP) signaling and regulation	30	0.007	535
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	30	0.007	642
WP2369	Histone modifications	30	0.007	565.25
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	30	0.007	641.5
WP4271	Vitamin B12 disorders	30	0.007	551.75
WP4688	Serine metabolism	30	0.007	484
WP4725	Sphingolipid metabolism overview	30	0.007	516
WP4726	Sphingolipid metabolism: integrated pathway	30	0.007	516
WP4872	MAP3K1 role in promoting and blocking gonadal determination	30	0.007	508
WP4904	LDLRAD4 and what we know about it	30	0.007	518.5
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	30	0.007	519.75
WP545	Complement activation	30	0.007	550
WP692	Sulfation biotransformation reaction	30	0.007	524.5
WP733	Serotonin receptor 2 and STAT3 signaling	30	0.007	386.5
WP1589	Folate-alcohol and cancer pathway hypotheses	2	0.006	449.5
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	2	0.006	455
WP3930	EDA signaling in hair follicle development	2	0.006	446.5
WP422	MAPK cascade	2	0.006	438.75
WP4271	Vitamin B12 disorders	2	0.006	451.75
WP4846	SARS-CoV-2 and COVID-19 pathway	2	0.006	442.5
WP4872	MAP3K1 role in promoting and blocking gonadal determination	2	0.006	442
WP497	Urea cycle and metabolism of amino groups	2	0.006	448.5
WP22	IL-9 signaling pathway	3	0.006	473
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	3	0.006	474.5
WP2854	Gene regulatory network modelling somitogenesis	3	0.006	480
WP311	Ketone bodies synthesis and degradation	3	0.006	488.5
WP3676	BDNF-TrkB signaling	3	0.006	466
WP4157	GABA metabolism (aka GHB)	3	0.006	489.5
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	3	0.006	486
WP4818	Conversion of angiotensinogen to angiotensin II	3	0.006	487.25
WP3633	Caffeine and theobromine metabolism	4	0.006	511.5
WP3869	Cannabinoid receptor signaling	4	0.006	491
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	4	0.006	504
WP4904	LDLRAD4 and what we know about it	4	0.006	506.5
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	5	0.006	509.5
WP3933	Kennedy pathway from sphingolipids	5	0.006	523.5
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	5	0.006	521.5
WP4504	Cysteine and methionine catabolism	5	0.006	517
WP4656	Joubert syndrome	5	0.006	490.5
WP4804	Cholesterol biosynthesis with skeletal dysplasias	5	0.006	528
WP4940	15q11.2 copy number variation syndrome	5	0.006	524
WP497	Urea cycle and metabolism of amino groups	5	0.006	517.5
WP5074	Kallmann syndrome	5	0.006	508.25
WP692	Sulfation biotransformation reaction	5	0.006	528
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	10	0.006	587
WP2338	miRNA biogenesis	10	0.006	586.5
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	10	0.006	456
WP2805	exRNA mechanism of action and biogenesis	10	0.006	586.5
WP2943	Hypoxia-mediated EMT and stemness	10	0.006	583
WP3871	Valproic acid pathway	10	0.006	580.5
WP3933	Kennedy pathway from sphingolipids	10	0.006	571.75
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	10	0.006	586.5
WP422	MAPK cascade	10	0.006	452.25
WP4532	Intraflagellar transport proteins binding to dynein	10	0.006	585
WP4536	Genes related to primary cilium development (based on CRISPR)	10	0.006	559.75
WP4804	Cholesterol biosynthesis with skeletal dysplasias	10	0.006	582.5
WP545	Complement activation	10	0.006	580.5
WP24	Peptide GPCRs	20	0.006	500
WP368	Mitochondrial long chain fatty acid beta-oxidation	20	0.006	584
WP3933	Kennedy pathway from sphingolipids	20	0.006	530.75
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	20	0.006	562.5
WP4803	Ciliopathies	20	0.006	552.5
WP497	Urea cycle and metabolism of amino groups	20	0.006	554.25
WP2371	Parkinson's disease pathway	30	0.006	549
WP2854	Gene regulatory network modelling somitogenesis	30	0.006	509.25
WP3676	BDNF-TrkB signaling	30	0.006	536.5
WP5037	Riboflavin and CoQ disorders	30	0.006	632.5
WP694	Arylamine metabolism	30	0.006	624.5
WP2290	RalA downstream regulated genes	2	0.005	450.5
WP2338	miRNA biogenesis	2	0.005	454
WP247	Small ligand GPCRs	2	0.005	448
WP2491	Diclofenac metabolic pathway	2	0.005	454
WP2645	Heroin metabolism	2	0.005	454
WP2805	exRNA mechanism of action and biogenesis	2	0.005	454
WP2854	Gene regulatory network modelling somitogenesis	2	0.005	449
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	2	0.005	448.5
WP3858	Toll-like receptor signaling related to MyD88	2	0.005	432.25
WP3871	Valproic acid pathway	2	0.005	453.5
WP4210	Tryptophan catabolism leading to NAD+ production	2	0.005	454
WP4818	Conversion of angiotensinogen to angiotensin II	2	0.005	453.5
WP623	Oxidative phosphorylation	2	0.005	452.5
WP678	Arachidonate epoxygenase / epoxide hydrolase	2	0.005	450.5
WP80	Nucleotide GPCRs	2	0.005	453.25
WP1423	Ganglio sphingolipid metabolism	3	0.005	481.75
WP1589	Folate-alcohol and cancer pathway hypotheses	3	0.005	483
WP2007	Iron metabolism in placenta	3	0.005	482.75
WP2371	Parkinson's disease pathway	3	0.005	473.5
WP3674	Tgif disruption of Shh signaling	3	0.005	476
WP3875	ATR signaling	3	0.005	489
WP3933	Kennedy pathway from sphingolipids	3	0.005	483
WP4504	Cysteine and methionine catabolism	3	0.005	484.5
WP4725	Sphingolipid metabolism overview	3	0.005	479.5
WP4726	Sphingolipid metabolism: integrated pathway	3	0.005	479.5
WP497	Urea cycle and metabolism of amino groups	3	0.005	482
WP2854	Gene regulatory network modelling somitogenesis	4	0.005	504.5
WP4297	Thiamine metabolic pathways	4	0.005	507.5
WP4818	Conversion of angiotensinogen to angiotensin II	4	0.005	509.5
WP690	Polyol pathway	4	0.005	513
WP4030	SCFA and skeletal muscle substrate metabolism	5	0.005	516.5
WP4271	Vitamin B12 disorders	5	0.005	525
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	5	0.005	526.75
WP694	Arylamine metabolism	5	0.005	527.5
WP1438	Influenza A virus infection	10	0.005	217.5
WP247	Small ligand GPCRs	10	0.005	558
WP368	Mitochondrial long chain fatty acid beta-oxidation	10	0.005	573.5
WP4504	Cysteine and methionine catabolism	10	0.005	556.5
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	10	0.005	579
WP4784	Proteoglycan biosynthesis	10	0.005	578.25
WP4940	15q11.2 copy number variation syndrome	10	0.005	578.5
WP528	Acetylcholine synthesis	10	0.005	560.75
WP2369	Histone modifications	20	0.005	543.5
WP4725	Sphingolipid metabolism overview	20	0.005	494.75
WP4726	Sphingolipid metabolism: integrated pathway	20	0.005	494.75
WP4872	MAP3K1 role in promoting and blocking gonadal determination	20	0.005	486
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	20	0.005	496.5
WP692	Sulfation biotransformation reaction	20	0.005	610.75
WP694	Arylamine metabolism	20	0.005	617.5
WP2290	RalA downstream regulated genes	30	0.005	506.75
WP24	Peptide GPCRs	30	0.005	522
WP3679	Cell-type dependent selectivity of CCK2R signaling	30	0.005	436
WP4222	Phosphodiesterases in neuronal function	30	0.005	538
WP4504	Cysteine and methionine catabolism	30	0.005	516.75
WP4784	Proteoglycan biosynthesis	30	0.005	555
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	30	0.005	625.5
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	2	0.004	444.5
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	2	0.004	452
WP438	Non-homologous end joining	2	0.004	453.5
WP4532	Intraflagellar transport proteins binding to dynein	2	0.004	453.5
WP4815	Glycosaminoglycan degradation	2	0.004	454
WP111	Electron transport chain: OXPHOS system in mitochondria	3	0.004	480
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	3	0.004	480.75
WP4150	Wnt signaling in kidney disease	3	0.004	468.75
WP4846	SARS-CoV-2 and COVID-19 pathway	3	0.004	473.5
WP4927	COVID-19, thrombosis and anticoagulation	3	0.004	486
WP5089	Kinin-Kallikrein pathway	3	0.004	486
WP528	Acetylcholine synthesis	3	0.004	483.25
WP545	Complement activation	3	0.004	484
WP690	Polyol pathway	3	0.004	488
WP80	Nucleotide GPCRs	3	0.004	486.75
WP1589	Folate-alcohol and cancer pathway hypotheses	4	0.004	502.5
WP2007	Iron metabolism in placenta	4	0.004	504.25
WP2371	Parkinson's disease pathway	4	0.004	486.25
WP4194	Hormonal control of pubertal growth spurt	4	0.004	514.5
WP422	MAPK cascade	4	0.004	477
WP4504	Cysteine and methionine catabolism	4	0.004	502
WP4815	Glycosaminoglycan degradation	4	0.004	511
WP5074	Kallmann syndrome	4	0.004	497.5
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	4	0.004	509.5
WP694	Arylamine metabolism	4	0.004	509.5
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	5	0.004	530
WP2290	RalA downstream regulated genes	5	0.004	525.5
WP2854	Gene regulatory network modelling somitogenesis	5	0.004	514.5
WP438	Non-homologous end joining	5	0.004	527
WP4589	Major receptors targeted by epinephrine and norepinephrine	5	0.004	524.75
WP528	Acetylcholine synthesis	5	0.004	517.5
WP111	Electron transport chain: OXPHOS system in mitochondria	10	0.004	561
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	10	0.004	573.5
WP4818	Conversion of angiotensinogen to angiotensin II	10	0.004	581.5
WP4872	MAP3K1 role in promoting and blocking gonadal determination	10	0.004	476.5
WP4966	Fluoroacetic acid toxicity	10	0.004	585
WP2533	Glycerophospholipid biosynthetic pathway	20	0.004	533
WP311	Ketone bodies synthesis and degradation	20	0.004	630.5
WP3869	Cannabinoid receptor signaling	20	0.004	500.5
WP438	Non-homologous end joining	20	0.004	615
WP4589	Major receptors targeted by epinephrine and norepinephrine	20	0.004	614.25
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	20	0.004	487.25
WP2267	Synaptic vesicle pathway	30	0.004	563.25
WP247	Small ligand GPCRs	30	0.004	530
WP368	Mitochondrial long chain fatty acid beta-oxidation	30	0.004	571
WP3869	Cannabinoid receptor signaling	30	0.004	528.5
WP411	mRNA processing	30	0.004	588
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	30	0.004	529
WP4803	Ciliopathies	30	0.004	586
WP5074	Kallmann syndrome	30	0.004	530.5
WP5089	Kinin-Kallikrein pathway	30	0.004	598.25
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	30	0.004	518
WP136	Phase I biotransformations, non P450	2	0.003	453.5
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	2	0.003	452
WP311	Ketone bodies synthesis and degradation	2	0.003	455
WP368	Mitochondrial long chain fatty acid beta-oxidation	2	0.003	451.5
WP4297	Thiamine metabolic pathways	2	0.003	451.5
WP4533	Transcription co-factors SKI and SKIL protein partners	2	0.003	446.25
WP4582	Cancer immunotherapy by CTLA4 blockade	2	0.003	442.5
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	2	0.003	452.25
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	3	0.003	485.5
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	3	0.003	485.5
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	3	0.003	469.5
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	3	0.003	469.5
WP2253	Pilocytic astrocytoma	4	0.003	507.5
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	4	0.003	507.5
WP247	Small ligand GPCRs	4	0.003	500
WP311	Ketone bodies synthesis and degradation	4	0.003	513.75
WP3655	Hypothetical craniofacial development pathway	4	0.003	506.5
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	4	0.003	491.25
WP4784	Proteoglycan biosynthesis	4	0.003	508
WP5037	Riboflavin and CoQ disorders	4	0.003	511.75
WP5089	Kinin-Kallikrein pathway	4	0.003	509.5
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	4	0.003	487.5
WP136	Phase I biotransformations, non P450	5	0.003	529
WP3529	Zinc homeostasis	5	0.003	528.5
WP3633	Caffeine and theobromine metabolism	5	0.003	529.5
WP4297	Thiamine metabolic pathways	5	0.003	524.75
WP4532	Intraflagellar transport proteins binding to dynein	5	0.003	529
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	5	0.003	530
WP4784	Proteoglycan biosynthesis	5	0.003	525.25
WP4792	Purine metabolism	5	0.003	525.25
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	5	0.003	526.5
WP4900	Purinergic signaling	5	0.003	515.5
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	5	0.003	525.5
WP5037	Riboflavin and CoQ disorders	5	0.003	529
WP545	Complement activation	5	0.003	525
WP78	TCA cycle (aka Krebs or citric acid cycle)	5	0.003	530.5
WP2533	Glycerophospholipid biosynthetic pathway	10	0.003	560
WP3676	BDNF-TrkB signaling	10	0.003	489
WP4589	Major receptors targeted by epinephrine and norepinephrine	10	0.003	579.5
WP5074	Kallmann syndrome	10	0.003	528.5
WP623	Oxidative phosphorylation	10	0.003	579
WP111	Electron transport chain: OXPHOS system in mitochondria	20	0.003	574.5
WP117	GPCRs, other	20	0.003	507
WP1602	Nicotine effect on dopaminergic neurons	20	0.003	575
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	20	0.003	605.5
WP3529	Zinc homeostasis	20	0.003	614.75
WP3676	BDNF-TrkB signaling	20	0.003	518.25
WP4157	GABA metabolism (aka GHB)	20	0.003	631.5
WP422	MAPK cascade	20	0.003	495
WP4536	Genes related to primary cilium development (based on CRISPR)	20	0.003	562
WP4815	Glycosaminoglycan degradation	20	0.003	624.5
WP4927	COVID-19, thrombosis and anticoagulation	20	0.003	621.75
WP4966	Fluoroacetic acid toxicity	20	0.003	622.25
WP5074	Kallmann syndrome	20	0.003	523.5
WP545	Complement activation	20	0.003	614.25
WP623	Oxidative phosphorylation	20	0.003	617
WP111	Electron transport chain: OXPHOS system in mitochondria	30	0.003	591
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	30	0.003	560
WP3529	Zinc homeostasis	30	0.003	592.25
WP3933	Kennedy pathway from sphingolipids	30	0.003	533
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	30	0.003	585.75
WP4589	Major receptors targeted by epinephrine and norepinephrine	30	0.003	573.5
WP4966	Fluoroacetic acid toxicity	30	0.003	636.5
WP497	Urea cycle and metabolism of amino groups	30	0.003	553.75
WP78	TCA cycle (aka Krebs or citric acid cycle)	30	0.003	645
WP2597	Secretion of hydrochloric acid in parietal cells	2	0.002	453.5
WP3529	Zinc homeostasis	2	0.002	453
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	2	0.002	441.5
WP4583	Biomarkers for urea cycle disorders	2	0.002	452
WP545	Complement activation	2	0.002	452.25
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	2	0.002	443.25
WP2290	RalA downstream regulated genes	3	0.002	486
WP3655	Hypothetical craniofacial development pathway	3	0.002	484
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	3	0.002	482
WP438	Non-homologous end joining	3	0.002	486.5
WP4785	Somitogenesis in the context of spondylocostal dysostosis	3	0.002	486
WP4904	LDLRAD4 and what we know about it	3	0.002	484.5
WP5030	Ethylmalonic encephalopathy	3	0.002	490.75
WP694	Arylamine metabolism	3	0.002	486
WP2338	miRNA biogenesis	4	0.002	513
WP2805	exRNA mechanism of action and biogenesis	4	0.002	513
WP2943	Hypoxia-mediated EMT and stemness	4	0.002	510
WP3645	NAD+ biosynthetic pathways	4	0.002	502.5
WP3891	Benzene metabolism	4	0.002	502.5
WP405	Eukaryotic transcription initiation	4	0.002	504.5
WP4159	GABA receptor signaling	4	0.002	508.5
WP4271	Vitamin B12 disorders	4	0.002	508.25
WP4507	Molybdenum cofactor (Moco) biosynthesis	4	0.002	513
WP4532	Intraflagellar transport proteins binding to dynein	4	0.002	513
WP4589	Major receptors targeted by epinephrine and norepinephrine	4	0.002	510.75
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	4	0.002	509.5
WP545	Complement activation	4	0.002	509.5
WP692	Sulfation biotransformation reaction	4	0.002	510
WP2007	Iron metabolism in placenta	5	0.002	518.5
WP2366	Butyrate-induced histone acetylation	5	0.002	521.5
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	5	0.002	522.75
WP311	Ketone bodies synthesis and degradation	5	0.002	531.5
WP3645	NAD+ biosynthetic pathways	5	0.002	517.5
WP3655	Hypothetical craniofacial development pathway	5	0.002	521.25
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	5	0.002	497.5
WP4785	Somitogenesis in the context of spondylocostal dysostosis	5	0.002	525.75
WP5089	Kinin-Kallikrein pathway	5	0.002	527
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	5	0.002	500
WP1602	Nicotine effect on dopaminergic neurons	10	0.002	572.75
WP2536	Colchicine metabolic pathway	10	0.002	575.75
WP2816	Felbamate metabolism	10	0.002	575.75
WP2854	Gene regulatory network modelling somitogenesis	10	0.002	561
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	10	0.002	574.25
WP3645	NAD+ biosynthetic pathways	10	0.002	566.25
WP4521	Glycosylation and related congenital defects	10	0.002	579.5
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	10	0.002	499.25
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	10	0.002	590
WP4904	LDLRAD4 and what we know about it	10	0.002	569
WP4927	COVID-19, thrombosis and anticoagulation	10	0.002	583
WP497	Urea cycle and metabolism of amino groups	10	0.002	567.5
WP5089	Kinin-Kallikrein pathway	10	0.002	579.5
WP694	Arylamine metabolism	10	0.002	582.5
WP2338	miRNA biogenesis	20	0.002	627.5
WP2805	exRNA mechanism of action and biogenesis	20	0.002	627.5
WP4150	Wnt signaling in kidney disease	20	0.002	515
WP4159	GABA receptor signaling	20	0.002	573.5
WP4236	Krebs cycle disorders	20	0.002	631
WP4271	Vitamin B12 disorders	20	0.002	615
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	20	0.002	551
WP4521	Glycosylation and related congenital defects	20	0.002	617
WP4532	Intraflagellar transport proteins binding to dynein	20	0.002	623.25
WP4742	Ketogenesis and ketolysis	20	0.002	617
WP4792	Purine metabolism	20	0.002	605.25
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	20	0.002	611
WP5037	Riboflavin and CoQ disorders	20	0.002	622.75
WP1602	Nicotine effect on dopaminergic neurons	30	0.002	554.25
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	30	0.002	545
WP3633	Caffeine and theobromine metabolism	30	0.002	642.5
WP3871	Valproic acid pathway	30	0.002	636.25
WP4159	GABA receptor signaling	30	0.002	579.5
WP4194	Hormonal control of pubertal growth spurt	30	0.002	648.5
WP422	MAPK cascade	30	0.002	525.25
WP4225	Pyrimidine metabolism and related diseases	30	0.002	496.75
WP4583	Biomarkers for urea cycle disorders	30	0.002	624.5
WP4742	Ketogenesis and ketolysis	30	0.002	579
WP4792	Purine metabolism	30	0.002	526.75
WP4815	Glycosaminoglycan degradation	30	0.002	642.5
WP4818	Conversion of angiotensinogen to angiotensin II	30	0.002	637
WP4927	COVID-19, thrombosis and anticoagulation	30	0.002	635
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	2	0.001	451.75
WP2533	Glycerophospholipid biosynthetic pathway	2	0.001	450.5
WP3645	NAD+ biosynthetic pathways	2	0.001	448.5
WP3933	Kennedy pathway from sphingolipids	2	0.001	452.5
WP4900	Purinergic signaling	2	0.001	448.75
WP5074	Kallmann syndrome	2	0.001	445
WP528	Acetylcholine synthesis	2	0.001	449.5
WP2338	miRNA biogenesis	3	0.001	488.5
WP247	Small ligand GPCRs	3	0.001	480.75
WP2597	Secretion of hydrochloric acid in parietal cells	3	0.001	488.5
WP2645	Heroin metabolism	3	0.001	489
WP2805	exRNA mechanism of action and biogenesis	3	0.001	488.5
WP3529	Zinc homeostasis	3	0.001	487.5
WP3645	NAD+ biosynthetic pathways	3	0.001	481.75
WP405	Eukaryotic transcription initiation	3	0.001	483
WP4159	GABA receptor signaling	3	0.001	486.25
WP4297	Thiamine metabolic pathways	3	0.001	486
WP4521	Glycosylation and related congenital defects	3	0.001	487.5
WP4784	Proteoglycan biosynthesis	3	0.001	486
WP4792	Purine metabolism	3	0.001	486.5
WP4815	Glycosaminoglycan degradation	3	0.001	488
WP4900	Purinergic signaling	3	0.001	482
WP4966	Fluoroacetic acid toxicity	3	0.001	488
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	3	0.001	486.5
WP692	Sulfation biotransformation reaction	3	0.001	487
WP136	Phase I biotransformations, non P450	4	0.001	511
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	4	0.001	507.5
WP4210	Tryptophan catabolism leading to NAD+ production	4	0.001	511.5
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	4	0.001	508
WP4521	Glycosylation and related congenital defects	4	0.001	510.5
WP4583	Biomarkers for urea cycle disorders	4	0.001	509
WP4792	Purine metabolism	4	0.001	509
WP4927	COVID-19, thrombosis and anticoagulation	4	0.001	509.5
WP4966	Fluoroacetic acid toxicity	4	0.001	511.5
WP5030	Ethylmalonic encephalopathy	4	0.001	516.25
WP80	Nucleotide GPCRs	4	0.001	511.25
WP111	Electron transport chain: OXPHOS system in mitochondria	5	0.001	515.5
WP2338	miRNA biogenesis	5	0.001	529.5
WP2805	exRNA mechanism of action and biogenesis	5	0.001	529.5
WP405	Eukaryotic transcription initiation	5	0.001	519.5
WP4159	GABA receptor signaling	5	0.001	520
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	5	0.001	531
WP4210	Tryptophan catabolism leading to NAD+ production	5	0.001	530.5
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	5	0.001	524
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	5	0.001	526.25
WP4521	Glycosylation and related congenital defects	5	0.001	529.5
WP4583	Biomarkers for urea cycle disorders	5	0.001	525.5
WP4742	Ketogenesis and ketolysis	5	0.001	526.5
WP4818	Conversion of angiotensinogen to angiotensin II	5	0.001	526.75
WP4927	COVID-19, thrombosis and anticoagulation	5	0.001	526.25
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	10	0.001	576.25
WP2597	Secretion of hydrochloric acid in parietal cells	10	0.001	585.5
WP2889	Oxytocin signaling	10	0.001	586.5
WP311	Ketone bodies synthesis and degradation	10	0.001	589
WP3633	Caffeine and theobromine metabolism	10	0.001	587
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	10	0.001	569.5
WP4159	GABA receptor signaling	10	0.001	573.5
WP4210	Tryptophan catabolism leading to NAD+ production	10	0.001	586.75
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	10	0.001	574.5
WP4507	Molybdenum cofactor (Moco) biosynthesis	10	0.001	585
WP4656	Joubert syndrome	10	0.001	495.75
WP4792	Purine metabolism	10	0.001	574.5
WP4815	Glycosaminoglycan degradation	10	0.001	583.5
WP4900	Purinergic signaling	10	0.001	566
WP4921	Mitochondrial complex III assembly	10	0.001	594.75
WP661	Glucose homeostasis	10	0.001	585.5
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	10	0.001	446.5
WP78	TCA cycle (aka Krebs or citric acid cycle)	10	0.001	586.5
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	20	0.001	592
WP247	Small ligand GPCRs	20	0.001	503.75
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	20	0.001	527
WP4656	Joubert syndrome	20	0.001	544
WP5089	Kinin-Kallikrein pathway	20	0.001	617
WP107	Translation factors	30	0.001	579
WP117	GPCRs, other	30	0.001	522.5
WP136	Phase I biotransformations, non P450	30	0.001	636.5
WP1600	Nicotine metabolism in liver cells	30	0.001	635
WP311	Ketone bodies synthesis and degradation	30	0.001	648
WP3940	One-carbon metabolism and related pathways	30	0.001	444.5
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	30	0.001	549
WP4150	Wnt signaling in kidney disease	30	0.001	542
WP4210	Tryptophan catabolism leading to NAD+ production	30	0.001	644.5
WP4521	Glycosylation and related congenital defects	30	0.001	616.5
WP4532	Intraflagellar transport proteins binding to dynein	30	0.001	636.5
WP4536	Genes related to primary cilium development (based on CRISPR)	30	0.001	587
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	30	0.001	545.5
WP4900	Purinergic signaling	30	0.001	563
WP528	Acetylcholine synthesis	30	0.001	502.5
WP623	Oxidative phosphorylation	30	0.001	618.75
WP80	Nucleotide GPCRs	30	0.001	641
WP405	Eukaryotic transcription initiation	2	0	451.5
WP4153	Degradation pathway of sphingolipids, including diseases	2	0	455
WP4159	GABA receptor signaling	2	0	452
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	2	0	451.5
WP4506	Tyrosine metabolism	2	0	455
WP4507	Molybdenum cofactor (Moco) biosynthesis	2	0	454
WP4589	Major receptors targeted by epinephrine and norepinephrine	2	0	453.5
WP4742	Ketogenesis and ketolysis	2	0	452.5
WP4784	Proteoglycan biosynthesis	2	0	453
WP4918	Cellular proteostasis	2	0	455
WP4931	Direct reversal repair	2	0	455
WP4966	Fluoroacetic acid toxicity	2	0	453.5
WP136	Phase I biotransformations, non P450	3	0	488
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	3	0	485
WP4153	Degradation pathway of sphingolipids, including diseases	3	0	490
WP4210	Tryptophan catabolism leading to NAD+ production	3	0	488.5
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	3	0	486
WP4506	Tyrosine metabolism	3	0	490
WP4507	Molybdenum cofactor (Moco) biosynthesis	3	0	488.5
WP4532	Intraflagellar transport proteins binding to dynein	3	0	488
WP4583	Biomarkers for urea cycle disorders	3	0	485.75
WP4589	Major receptors targeted by epinephrine and norepinephrine	3	0	487.5
WP4742	Ketogenesis and ketolysis	3	0	486.5
WP4918	Cellular proteostasis	3	0	490
WP4931	Direct reversal repair	3	0	490
WP2290	RalA downstream regulated genes	4	0	507.5
WP2597	Secretion of hydrochloric acid in parietal cells	4	0	512
WP2645	Heroin metabolism	4	0	513.5
WP3529	Zinc homeostasis	4	0	511.5
WP4153	Degradation pathway of sphingolipids, including diseases	4	0	515
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	4	0	508
WP438	Non-homologous end joining	4	0	508.5
WP4506	Tyrosine metabolism	4	0	515
WP4742	Ketogenesis and ketolysis	4	0	509.5
WP4785	Somitogenesis in the context of spondylocostal dysostosis	4	0	510.25
WP4900	Purinergic signaling	4	0	503.75
WP4918	Cellular proteostasis	4	0	515
WP4931	Direct reversal repair	4	0	515.5
WP247	Small ligand GPCRs	5	0	517
WP2597	Secretion of hydrochloric acid in parietal cells	5	0	530
WP2645	Heroin metabolism	5	0	531.75
WP2943	Hypoxia-mediated EMT and stemness	5	0	528.5
WP4153	Degradation pathway of sphingolipids, including diseases	5	0	532.5
WP4194	Hormonal control of pubertal growth spurt	5	0	531.5
WP4506	Tyrosine metabolism	5	0	532.5
WP4507	Molybdenum cofactor (Moco) biosynthesis	5	0	529.75
WP4815	Glycosaminoglycan degradation	5	0	528.75
WP4918	Cellular proteostasis	5	0	532.5
WP4931	Direct reversal repair	5	0	533.25
WP4966	Fluoroacetic acid toxicity	5	0	529
WP5030	Ethylmalonic encephalopathy	5	0	532.5
WP80	Nucleotide GPCRs	5	0	529.5
WP134	Pentose phosphate metabolism	10	0	594
WP136	Phase I biotransformations, non P450	10	0	582.25
WP2485	NAD biosynthesis II (from tryptophan)	10	0	594
WP2640	Aripiprazole metabolic pathway	10	0	592
WP2645	Heroin metabolism	10	0	588.25
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	10	0	593
WP405	Eukaryotic transcription initiation	10	0	571
WP4153	Degradation pathway of sphingolipids, including diseases	10	0	592
WP4194	Hormonal control of pubertal growth spurt	10	0	592
WP4228	Vitamin B6-dependent and responsive disorders	10	0	593
WP4299	Lamin A-processing pathway	10	0	570.5
WP4317	Mitochondrial fatty acid synthesis pathway	10	0	590
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	10	0	589.25
WP4400	FABP4 in ovarian cancer	10	0	593
WP4506	Tyrosine metabolism	10	0	592
WP4742	Ketogenesis and ketolysis	10	0	578.5
WP4918	Cellular proteostasis	10	0	592
WP4931	Direct reversal repair	10	0	592.5
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	10	0	575.5
WP5030	Ethylmalonic encephalopathy	10	0	592
WP521	Amino acid conjugation of benzoic acid	10	0	592.5
WP134	Pentose phosphate metabolism	20	0	635
WP136	Phase I biotransformations, non P450	20	0	620.5
WP1438	Influenza A virus infection	20	0	259.75
WP2485	NAD biosynthesis II (from tryptophan)	20	0	635
WP2536	Colchicine metabolic pathway	20	0	604.5
WP2597	Secretion of hydrochloric acid in parietal cells	20	0	627
WP2640	Aripiprazole metabolic pathway	20	0	631.5
WP2645	Heroin metabolism	20	0	629.5
WP2816	Felbamate metabolism	20	0	604.5
WP2889	Oxytocin signaling	20	0	628
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	20	0	635
WP3645	NAD+ biosynthetic pathways	20	0	532.5
WP405	Eukaryotic transcription initiation	20	0	573.75
WP4153	Degradation pathway of sphingolipids, including diseases	20	0	633.5
WP4210	Tryptophan catabolism leading to NAD+ production	20	0	629
WP4228	Vitamin B6-dependent and responsive disorders	20	0	634.5
WP4299	Lamin A-processing pathway	20	0	333
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	20	0	607.75
WP4317	Mitochondrial fatty acid synthesis pathway	20	0	631
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	20	0	631
WP4400	FABP4 in ovarian cancer	20	0	634.5
WP4506	Tyrosine metabolism	20	0	633.5
WP4507	Molybdenum cofactor (Moco) biosynthesis	20	0	626
WP4900	Purinergic signaling	20	0	565.75
WP4918	Cellular proteostasis	20	0	633.5
WP4921	Mitochondrial complex III assembly	20	0	634.5
WP4931	Direct reversal repair	20	0	634
WP5030	Ethylmalonic encephalopathy	20	0	633.5
WP521	Amino acid conjugation of benzoic acid	20	0	632
WP661	Glucose homeostasis	20	0	624
WP80	Nucleotide GPCRs	20	0	625.5
WP134	Pentose phosphate metabolism	30	0	651.75
WP1438	Influenza A virus infection	30	0	301.5
WP1495	Glycine metabolism	30	0	640.5
WP2338	miRNA biogenesis	30	0	640.5
WP2485	NAD biosynthesis II (from tryptophan)	30	0	651
WP2536	Colchicine metabolic pathway	30	0	361.5
WP2597	Secretion of hydrochloric acid in parietal cells	30	0	645
WP2640	Aripiprazole metabolic pathway	30	0	648
WP2645	Heroin metabolism	30	0	647.5
WP2805	exRNA mechanism of action and biogenesis	30	0	640.5
WP2816	Felbamate metabolism	30	0	361.5
WP2889	Oxytocin signaling	30	0	644
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	30	0	651
WP3645	NAD+ biosynthetic pathways	30	0	552.75
WP405	Eukaryotic transcription initiation	30	0	571
WP4153	Degradation pathway of sphingolipids, including diseases	30	0	650
WP4228	Vitamin B6-dependent and responsive disorders	30	0	651.75
WP4299	Lamin A-processing pathway	30	0	330.5
WP4317	Mitochondrial fatty acid synthesis pathway	30	0	648
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	30	0	648
WP4400	FABP4 in ovarian cancer	30	0	651
WP4506	Tyrosine metabolism	30	0	650
WP4507	Molybdenum cofactor (Moco) biosynthesis	30	0	644.5
WP4656	Joubert syndrome	30	0	575.75
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	30	0	646.5
WP4918	Cellular proteostasis	30	0	650
WP4921	Mitochondrial complex III assembly	30	0	651.5
WP4931	Direct reversal repair	30	0	650
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	30	0	585
WP5030	Ethylmalonic encephalopathy	30	0	650.5
WP521	Amino acid conjugation of benzoic acid	30	0	649.5
WP661	Glucose homeostasis	30	0	641
